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In the past century, along with further understanding of nature science, human 
civilization has undergone tremendous developments in industrial production, 
economy, cultural diversities and global population growth. Among other aspects of 
natural science research, organic synthesis has become one of the major driving 
forces to this progress.[1] Thus, organic synthesis enabled industrial scale product 
preparation, namely drugs, crop-protecting agents, nitrogen fertilizers, organic fuels 
and polymer materials. Despite diverse applications provided by organic chemistry in 
life-saving pharmaceuticals, agrochemicals and material science, chemical industry 
was considered as one of the most polluting industries, due to the chemical wastes 
generation, toxic reagents usage during the process and greenhouse gases 
emission.[2] With our increasing acknowledgement towards the ecological impact of 
chemical production processes, new concept and sustainable approaches were 
required in designing novel synthetic routes.[3] 
 
In order to overcome the environmental drawbacks of chemical processes, 
environmentally friendly synthetic methods development has become one of the major 
goals for chemists nowadays. In this context, new concepts of sustainable chemistry 
have been introduced in the last few decades. In 1991, Trost proposed the concept of 
atom economy,[4] which has been considered as a guideline for developing sustainable 
synthetic methodologies. In 1998, Anastas and Warner published the “12 Principles of 
Green Chemistry”,[5] which refined how chemists design their synthetic approaches by 
detailed guidance towards environmental-benign chemical processes. Among other 
principles of green chemistry, catalysis, by using catalytic quantities of a reagent 
instead of stoichiometric amounts, stands out as a fundamental tool to achieve 
sustainable chemistry, especially in industry-scale reactions. Catalysis does not only 
minimize the environmental footprint of chemical processes by reducing the waste 






1.1 Transition Metal-Catalyzed C–H Activation 
 
Enabled by organic synthesis methodologies, strategies for molecular construction and 
engineering with applications towards bioactive reagents, material science as well as 
pharmaceutical and agrochemical industries, have been developed over the last 
century. Thus far, due to a high demand for efficient formation of C–C/C–Het bonds in 
molecular synthesis, strategies for selective C–C/C–Het bonds architecture have been 
well-established, especially in transition metal-catalyzed cross-coupling reactions.[7] 
Major achievements in the field of C–C construction using diverse coupling partners 
have been realized by pioneering researchers, giving numerous name reactions, for 
instance Suzuki–Miyaura,[8] Mizoroki-Heck,[9] Tsuji-Trost,[10] Buchwald–Hartwig[11] and 
Sonogashira–Hagihara[12] cross-coupling reactions. Palladium-catalyzed cross-
couplings are nowadays a readily available tool for organic synthesis with wide 
applications in molecular design, late-stage diversification and drug development 
within academia as well as industry.[13] Due to these contributions, the Nobel Prize in 
Chemistry 2010 was awarded jointly to R. F. Heck, E. Negishi and A. Suzuki “for 
palladium-catalyzed cross couplings in organic synthesis”.[14] 
 
However, despite indisputable progress, the cross-coupling reactions possess inherent 
drawbacks that cannot be ignored when ecological impacts are taken into 
consideration. Indeed, traditional cross-coupling transformations largely rely not only 
on prefunctionalized substrates and sensitive, hard-to-handle organometallic reagents, 
but also noble, rare and often toxic transition metal catalysts. These major drawbacks 
lead to multi-step procedures to synthesize the starting materials, stochiometric 
amounts of by-product generation and hazardous, environmentally harmful waste. To 
address these limitations, different strategies have been developed, namely the use of 




development of renewable noble catalysts.[17] These approaches exploited and 
advanced the sustainability of cross-coupling chemistry, however, the major issues 
concerning low level of step-economy and atom-economy of cross-coupling reactions 
stay unfortunately unsolved. 
 
With continuing growth of ecological awareness in novel synthetic strategies design, 
the direct functionalization of otherwise inert C–H bonds appears to be a highly 
attractive alternative to conventional cross-coupling approaches (Scheme 1.1). In 
contrast to cross-couplings, the direct site-selective C–H functionalization replaces the 
organometallic reagents by simple C–H bonds, thus improving the step-economy as 
well as the atom-economy of the overall process. In this context, the past decade has 
witnessed significant development of C–H functionalizations as an efficient and 
sustainable tool for organic synthesis, with notable applications to natural products 
synthesis,[18] material sciences[19] and pharmaceutical development,[20] among others. 
However, the functionalization of C–H bonds largely relies on organic (pseudo-)halide 
electrophiles as coupling partners, which results in stoichiometric quantities of 
undesired by-products. Therefore, to achieve better resource economy, the formation 
of C–C bonds can be realized by activation of two C–H bonds in a dehydrogenative 
fashion. Nearly full atom-economy can be achieved by oxidative C–H activations with 
molecular hydrogen as the only by-product, while the step-economy is improved by 
avoiding the use of prefunctionalized substrates. Recently, merged with 
electrochemistry, the often toxic, sacrificial chemical oxidants for oxidative C–H 
activations can be replaced by sustainable electricity as redox reagents, which further 







Scheme 1.1. Comparison of traditional cross-coupling with C–H activation strategies. 
 
Along with the increasing advance in transition metal catalyzed C–H functionalizations, 
detail mechanistic insights[22] gained from experimental and computational studies 
provided an improved understanding of the reaction mechanism. Herein, a general 
catalytic cycle containing three main steps for C–H functionalization can be 
summarized (Scheme 1.2): (i) C–H activation, (ii) organometallic intermediate 
functionalization, and (iii) regeneration of the active catalyst species as well as release 






Scheme 1.2. General catalytic cycle for transition metal-catalyzed C–H activation. 
 
To understand C–H functionalization process, the C–H cleavage, as the key step of 
the general mechanism proposed above, has been extensively studied. These 
mechanistic findings result in a profound understanding of modes of action for the C–
H metalation procedure, which are governed by the nature of the substrate, the catalyst, 
the ligand and the oxidation state of catalyst.[23] Within this regime, five pathways have 
been proposed, including oxidative addition, σ-bond metathesis, electrophilic 
substitution, 1,2-additon and base-assisted metalation (Scheme 1.3). The oxidative 
addition of C–H bonds is often observed with electron-rich, low-valent complexes of 
late transition metals, which have readily accessible oxidation state. For early transition 
metals with a d0 electron configuration, as well as lanthanides and actinides, σ-bond 
metathesis is the prevalent pathway through the concerted formation and breaking of 
the C–M and C–H bonds without any changes in oxidation state. In contrast to early 
transition metals, late transition metals in higher transition states typically undergo an 
electrophilic substitution pathway. Within this regime, electrophilic attack of the metal 




additon pathway are usually observed for early transition metals complexes bearing a 
metal-ligand unsaturated M=R bond. The base-assisted metalation C–H activation is 
featured by the simultaneous formation of a new C–M bond and transformation of the 
proton to the coordinated carboxylate. 
 
 
Scheme 1.3. Mechanistic pathways for organometallic C–H activation. 
 
Detailed mechanistic studies on base-assisted metalation C–H activation manifolds 
have unraveled several possible scenarios for the key C–H bond cleavage process 
(Scheme 1.4). By proposing a six-membered deprotonative transition state, the 
concept of concerted metalation-deprotonation (CMD) was developed by Gorelsky and 




C–H bond was suggested by Davies and Macgregor, which was named ambiphilic 
metal ligand activation (AMLA).[23d, 25] For the reactions with alkoxide bases involved, 
a four-membered ring transition state pathway was proposed as an internal 
electrophilic substitution (IES).[26] Recently, base-assisted internal electrophilic 
substitution (BIES) was introduced by Ackermann, explaining the preference for 
electron-rich substrates in most catalytic processes by undergoing an electrophilic 
substitution-type pathway.[23a, 27] 
 
Scheme 1.4. Transition states of C–H cleavage through base-assisted C–H metalation. 
 
One of the major challenges of C–H activation chemistry is the selectivity control of 
omnipresent C–H bonds, which have almost identical bond dissociation energies in 
organic molecules. Various strategies have been developed to face this challenge 
(Scheme 1.5). Among these approaches, electronic bias and steric bias require 
heterocycle and/or particular substituents in the substrates, which limit the viable 
scope to a narrowed number of viable manifolds. In stark contrast, the introduction of 
directing groups (DG) expands the selectivity-control of C–H activations.[28] Over the 
years, a variety of directing groups have been applied, for instance amides and N-
heterocyclic bidentate directing groups, to achieve ortho-selective activations of 
arenes.[29] However, the incorporation of the directing group remains a limitation for 
selective C–H activations. Therefore, recently, the strategies of applying weakly-
coordinating,[30] removable[31] and transient[32] directing groups in C–H activation 






Scheme 1.5. Selectivity control of C–H activation. 
 
Major progress in transition metal catalyzed C–H activations have been accomplished 
by the development of precious 4d and 5d transition metals catalysis, such as 
palladium,[33] iridium,[34] rhodium[22b, 35] and ruthenium.[36] However, these noble metal 
catalysts suffer not only their high costs, but also generally high toxicity. In contrast, 
applying less-toxic, earth-abundant 3d transition metals as catalysts for 
functionalization of C–H bonds has emerged as a more sustainable alternative in the 
last decade.[37] 
 
Recent years have witnessed a remarkable renaissance of organic electrosynthesis,[38] 
especially with significant advances in electrocatalysis. Merged with oxidative C–H 
transformations, metallaelectro-catalysis has become an important platform for 
molecular syntheses.[21, 39] By replacing stoichiometric amounts of often toxic redox 
reagents with renewable electricity, the sustainable nature of C–H activation has been 
significantly improved through metallaelectro-catalysis. Early examples of 
electrochemical C–H activations developed by Jutand[40] and Kakiuchi[41] for noble 
palladium catalysis used indirect electrolysis with redox mediators. These approaches 
were restricted to the combination of precious palladium catalysts and redox mediators, 
which lowered the resource-economy of the electrochemical processes. Consequently, 
earth-abundant 3d metals catalyzed electrochemical C–H activation was in high 
demand as a cost-efficient, low-toxic alternative strategy. To this end, Ackermann[21, 42] 
and later Mei,[39a] among others, have disclosed various methodologies in 
cobaltaelectro-catalysis, nickelaelectro-cataysis as well as cupraelectro-catalysis. 




catalyzed electrochemical C–H activation are foreseeable in the near future. 
 
1.2 Cobalt-Catalyzed C–H Activation 
 
Over the last century, cobalt, as an earth-abundant 3d base metal, has been widely 
studied in the field of catalysis due to the cost-efficient nature and identified as versatile 
catalysts for organic transformations. In 1938, while studying the Fischer-Tropsch 
process, Roelen disclosed the promoting effect of cobalt, and further developed 
hydrocarbonylation of ethylene using cobalt catalyst.[43] Thereafter, notable 
achievements have been made in organic chemistry using cobalt catalysts, namely, 
the coupling of Grignard reagents in the Kharasch-coupling,[44] the Pauson-Khand 
reaction,[45] the Nicholas reaction,[46] cross-coupling reactions[47] and C–H 
activations.[48] 
 
1.2.1. Early Contributions 
 
Indeed, cobalt-catalyzed C–H functionalization is not without precedence.[48] In 1955, 
the first chelation-assisted C–H functionalization by cobalt-catalysis has been reported 
by S. Murahashi.[49] By applying high pressure carbon monoxide to benzaldimine 1, 
the synthesis of 2-phenylphthalimidine 2 was achieved with catalytic amounts of a 




Scheme 1.6. Cobalt-catalyzed carbonalytion of benzaldimine 1. 
 




example of cyclometalation reaction with azobenzene 3 was disclosed by Klein using 
a well-defined cobalt complex [Co(CH3)(PMe3)4] 4 (Scheme 1.7).[51] Due to the high 
reactivity of the cobalt complex, further exploration revealed challenging four-
membered ring metallacycles[52] were also obtainable by this cobalt complex. 
 
 
Scheme 1.7. Cyclometalation reaction with well-defined cobalt complex. 
 
Another major contribution in cobalt-catalyzed C–H activation was disclosed in 1994 
by Kisch, who reported the hydroarylation of azobenzene 3 with diphenylacetylene 6a 
using a well-defined cobalt-hydride complex [Co(H)(N2)(PPh3)3] 7 as catalyst (scheme 
1.8).[53] This work was considered as the first C–H hydroarylation of alkynes enabled 
by cobalt complex. 
 
 
Scheme 1.8. Hydroarylation of azobenzene 3 by cobalt complex. 
 
1.2.2. Low-Valent Cobalt-Catalyzed C–H Activation 
 
Ever since the pioneering early research of the first cobalt-catalyzed hydroarylation 
reaction developed by Kisch using cobalt(I) complex,[53] the potential of the so-called 
low-valent cobalt catalysis has been further explored with various approaches. Due to 




approaches are typically achieved with well-defined cobalt complexes or in situ 
generated cobalt complexes, which are formed by the action between cobalt(II) salts 
and Grignard reagents.[37] The combination of a cobalt-NHC catalyst and a Grignard 
reagent enables selectively aromatic C–H functionalizations with electrophiles.  
 
In 2010, Yoshikai and co-workers reported cobalt-catalyzed C–H hydroarylations of 
internal alkyne 6 with phenylpyridine 9 using PMePh2 as the ligand and the 
stoichiometric reductant MeMgCl (Scheme 1.9a).[54] In contrast to a well-defined cobalt 
complex, a simple CoBr2 was introduced as catalyst. Thereafter, the same group 
expanded this approach to aryl imines 11.[55] Hydroarylated products were successfully 
converted at room temperature (Scheme 1.9b). 
 
 
Scheme 1.9. Cobalt-catalyzed hydroarylation of alkynes 6. 
 
Based on the well-established cobalt-catalyzed C–H hydroarylation reactions with 
alkynes 6, the hydroarylation of alkenes 13 proved to be viable by cobalt catalysis as 
well. Yoshikai developed the hydroarylation of phenylpyridine 9 with alkenes 13 under 




Grignard reagent, regioselective formation of linear product 14a and branched product 
14b can be achieved (Scheme 1.10). 
 
Scheme 1.10. Regioselectivity-controlled cobalt-catalyzed hydroarylation. 
 
Based on the early example of Kharasch coupling reactions,[44] Nakamura explored 
cobalt-catalyzed C–H alkylation of amides (Scheme 1.11).[57] By applying Co(acac)3 as 
the catalyst with Grignard reagents, an in situ generated low-valent cobalt catalytic 
species was proposed and successfully delivering the ortho-alkylated product 17. 




Scheme 1.11. Cobalt-catalyzed direct alkylation of amide 15. 
 
Apart from direct alkylations, C–H arylation reactions were also achieved by low-valent 
cobalt catalysis. Ackermann reported the cobalt-catalyzed C–H arylations with 
electrophiles (Scheme 1.12).[58] Arylations of phenylpyridine 9 with various organic 
electrophiles, including aryl carbamates 18a, sulfamates 18b and aryl chloride 18c, 
have been developed using Co(acac)2 as the catalyst with cyclohexylmagnesium 






Scheme 1.12. Cobalt-catalyzed C–H arylation with electrophiles 18. 
 
In 2012, Yoshikai developed a similar cobalt-catalyzed C–H arylation with aryl chloride 
18c (Scheme 1.13).[59] This approach expanded the substrate scope of arylation 
reactions to aryl imines 11. 
 
 
Scheme 1.13. Cobalt-catalyzed C–H arylation of aryl imines 9. 
 
Furthermore, Ackermann and co-workers disclosed the application of low-valent cobalt 
catalysis to C–H alkenylation reactions. The first direct alkenylation of (hetero)arenes 
21 with readily accessible enol esters 22 has thus been developed using a combination 







Scheme 1.14. Cobalt-catalyzed C–H alkenylations. 
 
1.2.3. High-Valent Cobalt-Catalyzed C–H Activation 
 
The introduction of cyclopentadienyl-rhodium(III) catalysts enabled notable 
developments in transition metal catalyzed C–H activation.[35b, 61] However, the less-
abundant and cost-inefficient nature of rhodium catalysts largely limit the wide 
applicability of these approaches. Therefore, the development of alternative earth-
abundant 3d metal catalysts is of high demand. In this context, high-valent cobalt-
catalyzed C–H activations were developed using well-defined Cp*Co(III) complexes 
as catalysts, which represent bench-stable compounds and easy-to-handle reaction 
protocols. 
 
In 2013, Matsunaga, Kanai and coworkers identified the cationic [Cp*Co(C6H6)](PF6)2] 
(24) can be a high active catalyst for C–H activation.[62] It is notable to mention that 
even though the Cp*Co(III) complex 24 have been reported previously,[63] but the use 
of it in C–H activation remained without precedence. This Cp*Co(III) complex 24 
showed high reactivity in addition reactions of phenylpyridine 9 onto α,β-unsaturated 






Scheme 1.15. Cobalt(III)-catalyzed hydroarylation of α,β-unsaturated ketones 25 and N-
sulfonyl imines 26. 
 
Inspired by the elegant work of Matsunaga and Kanai, various C–H activation reactions 
using Cp*Co(III) complexes as catalysts have been developed. Typical examples of 
the high-valent Cp*Co(III)-catalyzed C–H activation reactions are discussed in this 
thesis. In 2015, Ackermann and coworkers reported the first cyanation of 
(hetero)arenes by Cp*Co(III)-catalyzed C–H activation (Scheme 1.16).[64] Different 
types of heteroarenes, including phenylpyridine 7 and N-pyrimidylindoles 19, were 
selectively cyanated with N-cyano-N-phenyl-p-toluenesulfonamide 27 reagent. High 
functional group tolerance and ample substrate scope have been achieved within this 
regime, as well as the traceless removal of the pyrimidyl group. 
 
 
Scheme 1.16. Cp*Co(III)-catalyzed C–H cyanation. 
 
A plausible catalytic cycle was proposed for Cp*Co(III)-catalyzed C–H cyanation 
reactions to have an insight of the catalyst’s mode of action. Reversible C–H bond 
cobaltation of substrate 9 with active cationic cobalt species 32, gives raise to cobalt 
intermediate 33, which undergoes coordination with cyanating reagent 29 and insertion, 




cobalt(III) species 32 is regenerated by proto-demetalation (Scheme 1.17). 
 
 
Scheme 1.17. Plausible catalytic cycle for Cp*Co(III)-catalyzed C–H cyanation. 
 
High-valent cobalt-catalyzed C–H allylations of N-pyrimidylindoles 21 were developed 
by Glorius and coworkers with allyl carbonates 13b using Cp*Co(CO)I2 catalyst 
(scheme 1.18).[65] Notably, 0.5 mol % of the cobalt catalyst proved to be necessary in 
this manifold, giving the desired allylation products in excellent yield. 
 
 
Scheme 1.18. Cp*Co(III)-catalyzed C–H allylation with allyl methyl carbonate 13b. 
 




allylations using well-defined Cp* cobalt complex as catalyst. Highly selective N-
pyrimidylindoles 21 allylations were achieved with allyl acetate 13c (Scheme 1.19a)[66] 
and later Z-selective allylations via C–H/C–O activation (Scheme 1.19b).[67] The 
allylation approaches were not limited to indole substrates, various (hetero)arenes 
proved to be applicable.[66-67] 
 
 
Scheme 1.19. Cp*Co(III)-catalyzed C–H allylation via C–H/C–C activation. 
 
Matsunaga, Kanai and coworkers further developed Co(III) catalysis for C–H cascade 
annulations by alkenylation, using the cationic [Cp*Co(C6H6)](PF6)2] (24) catalyst 
(Scheme 1.20).[68] The annulations of N-carbamoyl indoles 40 with internal alkynes 6 
were enabled by alkenylation addition of Cp* cobalt complex, and cascade annulation 
to deliver the desired products 41. 
 
 
Scheme 1.20. Cp*Co(III)-catalyzed C–H cascade annulation. 
 




and coworkers for the synthesis of indoles 43 and isoquinolines 45 (Scheme 1.21).[69] 
Employing various internal alkynes 6, broad scope and good functional group 
tolerance were achieved. 
 
 
Scheme 1.21. Cp*Co(III)-catalyzed C–H annulation for synthesis of indoles 43 and 
isoquinolines 45. 
 
Cobalt(III)-catalyzed C–H activation reactions are not limited to cyanation, allylation or 
annulation, but cobalt(III)-catalyzed C–H hydroarylation with unactivated alkenes 13 
was realized by Ackermann and coworkers as well (Scheme 1.22).[27b] By tuning the 
reaction conditions, the anti-Markovnikov isomer 47 was obtained in the absence of 
carboxylic acid additive, while the branched product 48 was selectively obtained in the 
presence of 1-AdCO2H. Notably, this manifold also provided support as a proof-of-







Scheme 1.22. Full selectivity control in Co(III)-catalyzed C–H alkylation. 
 
Based on previous hydroarylation results,[27b] Ackermann and coworkers explored the 
possibility of asymmetric alkylation by cobalt catalysis. Indeed, the first 
enantioselective cyclopentadienyl-cobalt(III)-catalyzed C–H activation was developed 
and promoted by a novel chiral carboxylic acid 50 (Scheme 1.23).[70] High regio- and 
enantio-selective alkylations of indoles 49 with alkenes 13 were thus achieved. 
Furthermore, the 5-methylpyridine group proved to be easily removeable, yielding a 
free indole final product. 
 
 
Scheme 1.23. Enantioselective Co(III)-catalyzed C–H alkylation of indole 49. 
 
Indeed, major achievements have been made in Cp*Co(III)-catalyzed C(sp2)–H bond 
functionalizations over the last decade. Unfortunately, only a few reports have been 
devoted to C(sp3)–H bond activation in the field of cobalt(III) catalysis. In this context, 
Sundararaju and coworkers disclosed the C(sp3)–H alkenylation of 8-methylquinolines 
52 (Scheme 1.24).[71] Applying catalytic amounts of Cp*Co(CO)I2, alkenylated products 
were obtained with internal alkynes 6. However, major drawbacks, such as low yields 
of desired products and a narrow scope of alkynes, limited further applications of this 






Scheme 1.24. Cp*Co(III)-catalyzed C(sp3)–H alkenylation. 
 
1.2.4. Cobalt-Catalyzed Oxidative C–H Activation 
 
Despite indisputable developments in low-valent cobalt-catalysis with Grignard 
reagents and high-valent cobalt-catalysis with well-defined cobalt(III) complexes, 
major drawbacks in cobalt-catalyzed C–H activations remain unsolved. As discussed 
above, the low-valent cobalt-catalysis largely depends on a combination of a cobalt-
NHC pre-catalysts with sensitive and highly reactive Grignard reagents, which enables 
aromatic C–H functionalizations with electrophiles. In this context, Grignard reagents 
are not only highly reactive, but also bear the drawbacks of air- and moisture-sensitivity. 
Therefore, bench-stable and easy-to-handle high-valent cobalt-catalysis with well-
defined cyclopentadienyl-cobalt(III) catalysts were widely studied. However, multi-step 
syntheses of Cp*Co(III) complexes are inevitable for these approaches. Thus, another 
major class of cobalt-catalyzed C–H functionalization known as oxidative cobalt-
catalyzed C–H activation was introduced. With the assistance of external or internal 
oxidants, the direct utilization of cost-efficient, air-stable cobalt(II) salts as pre-catalysts 
has been realized. 
 
Based on the early work within palladium-catalyzed C–H activation by Daugulis in 
2005,[72] the use of 8-aminoquinoline (Q) auxiliary and other directing groups was 
further developed into the concept of bidentate directing groups and have been 
explored with various transition metals.[29b, 73] However, not until 2014, the first 
application of 8-aminoquinoline directing group in cobalt-catalyzed oxidative alkyne 6 




1.25).[74] Employing stoichiometric amounts of Mn(OAc)2 oxidant, oxidative C–H/N–H 
annulation reactions with broad scope and excellent functional group tolerance have 




Scheme 1.25. Cobalt-catalyzed C–H/N–H oxidative annulation with benzamide 54a. 
 
Thereafter, cobalt-catalyzed C–H/Het–H annulation reactions have been widely 
explored for the synthesis of cyclic phosphoramides,[76] sultamamides[77] and 
isocoumarines.[78] Notably, Ackermann and co-workers reported the first cobalt-
catalyzed oxidative C–H/N–H annulation using molecular oxygen as the terminal 
oxidant (Scheme 1.26).[79] Applying the bidentate 2-pyridyl-N-oxide (PyO) directing 
group, a site- and rigo-selective C–H activation of amides 56 was achieved with both 
terminal and internal alkynes 6. 
 
 
Scheme 1.26. Cobalt-catalyzed C–H/N–H oxidative annulation by molecular oxygen 
oxidant. 
 
Further studies conducted by Ackermann and co-workers revealed electron-deficient 




reactions (Scheme 1.27).[80] Access to synthetically-useful isoindolones 58 were 
realized by cobalt-catalysis with a wide range of substituted benzamides 54. 
 
 
Scheme 1.26. Cobalt-catalyzed isoindolones 58 synthesis. 
 
A plausible mechanism was proposed to explain the oxidative annulation process 
(Scheme 1.27). The catalytic cycle is initiated by base-assisted C–H activation forming 
the cobalt intermediate 59. Subsequent alkene 13 insertion and β-hydride elimination 









The selective construction of C–O bonds by C–H oxygenation using cobalt-catalyzed 
oxidative C–H activation was realized by Song and Chatani. Song reported cobalt-
catalyzed alkoxylation reactions of 2-pyridyl-N-oxide (PyO) benzamides 56 using the 
corresponding alcohols 64 as the solvent (Scheme 1.28a).[81] Chatani disclosed the 
acyloxylation of quinolinamides 54 with carboxylic acids 66 (Scheme 1.28b).[82] Good 
functional group tolerance and product yields have been achieved in both cases.  
 
 
Scheme 1.28. Cobalt-catalyzed oxidative C–H oxygenation. 
 
In 2016, Balaraman reported the cobalt-catalyzed oxidative C–H alkynylation reactions 
of benzamides 54 (Scheme 1.29).[83] Applying bromoalkynes 70, dialkynylated 
products 69 were formed under oxidative conditions. The functional group tolerance of 
amides is in general good, but the narrow scope of alkynes 70 is one of the major 






Scheme 1.29. Cobalt-catalyzed oxidative C–H alkynylation. 
 
The formation of C–C bonds by using cobalt-catalysis is not limited to alkynylations, 
additionally oxidative allylations by cobalt-catalyzed C–H activation were reported by 
Maiti.[84] Applying Ag2SO4 as the external oxidant, C–H allylations were achieved using 
preferentially ortho-substituted benzamides 54 with non-activated alkenes 13 (Scheme 




Scheme 1.30. Cobalt-catalyzed oxidative C–H allylation. 
 
Moreover, the oxidative cobalt-catalyzed C–H halogenation was developed by Chatani 
and co-workers using molecular iodine 72 as the iodination reagent (Scheme 1.31).[86] 
Diverse benzamides 71 with various functional groups were found applicable. It is 
noteworthy that the commonly applied quinoline directing group needed to be modified 






Scheme 1.31. Cobalt-catalyzed oxidative C–H iodination. 
 
The oxidative cobalt-catalyzed C–H activation manifolds were further expanded to 
challenging C(sp3)–H bonds by versatile cobalt-catalysis. Several cyclization 
strategies have thus been developed. In 2015, an intramolecular C(sp3)–H amination 
was reported by Ge and co-workers (Scheme 1.32).[87] The use of the quinoline 
directing group provided an access to the four-membered cyclization product 75. 
 
 
Scheme 1.32. Intramolecular cobalt-catalyzed oxidative C(sp3)–H amination. 
 
Oxidative cobalt-catalyzed cyclization reactions of C(sp3)–H bonds are not limited to 
intramolecular reactions. Indeed, an elegant example of aliphatic amides 74 cyclization 
with terminal alkynes 76 was developed by Zhang and co-workers using oxidative 
cobalt-catalysis (scheme 1.33a).[88] In the presence of Co(OAc)2∙4H2O as the catalyst 
and Ag2CO3 as the oxidant, the desired pyrrolidones 77 were formed. Another 
approach of C(sp3)–H cyclization using bidentate chelating group were found with 
carbonylation reactions with carbon monoxide.[89] In this context, intramolecular 
oxidative C–H/N–H activation of aliphatic amides 74 was achieved, delivering the 






Scheme 1.33. Cobalt-catalyzed oxidative C(sp3)–H cyclization of aliphatic amides 74. 
 
1.2.5. Cobaltaelectro-Catalyzed C–H Activation 
 
Oxidative cobalt-catalyzed C–H activations enabled the direct use of cost-efficient and 
bench-stable cobalt(II) salts as pre-catalysts, which have significantly broadened the 
toolbox of cobalt-catalysis. However, the success of these strategies greatly depends 
on the external chemical oxidants. The oxidants give rise to a higher oxidation state of 
the cobalt(II) pre-catalysts, which are generated in situ during the reactions and serve 
as the active catalyst species in the catalytic cycle. However, traditional chemical 
oxidants, namely silver(I) and copper(II) salts are rather expensive and toxic, which 
stoichiometric amounts are needed usually. The application of oxidants compromises 
the overall sustainable nature of C–H activations. In recent years, merging with 
electrochemistry, transition metal catalyzed oxidative C–H transformations have been 
largely advanced by replacing the traditional chemical redox reagents with renewable, 
environmental-friendly electricity, which largely improved the environmentally friendly 
nature of C–H activation. In this context, cobaltaelectro-catalyzed C–H activations, as 
the pioneering works in the field of 3d earth-abundant metal catalyzed electrochemical 





In 2017, Ackermann and co-workers reported the first cobaltaelectro-catalyzed C–H 
oxygenation reactions with alcohols 64 (Scheme 1.34).[90] By applying electricity as 
external oxidant, the silver oxidant used in previous example [81] was avoided and a 
milder condition of room temperature was realized by the electrochemical approach as 
well. Detail mechanistic studies using cyclic voltammograms revealed the oxidation 
process of the cobalt(II) catalyst enabled by the electricity. 
 
 
Scheme 1.34. Cobaltaelectro-catalyzed C–H oxygenation. 
 
Later, Ackermann and co-workers expanded the cobaltaelectro-catalysis to C–H 
amination reactions with amines 79 using biomass-derived, renewable γ-valerolactone 
(GVL) (Scheme 1.34).[91] A broad substrate scope with excellent functional group 
tolerance has thereby been achieved. Notably, the use of React-IR analysis in the 
process showed the reaction profile and kinetic studies in great detail. Almost at the 
same time, Lei published a similar cobalt-catalyzed electrochemical amination reaction 






Scheme 1.35. Cobaltaelectro-catalyzed C–H amination. 
 
Based on previous reports,[93] Ackermann and co-workers disclosed the 
cobaltaelectro-catalyzed C–H/N–H annulation reactions using a bidentate directing 
group strategy (Scheme 1.36).[94] Cobalt-catalyzed oxidative C−H/N−H activations with 
internal alkynes 5 were achieved using a traceless removable hydrazide directing 
group. Thereafter, several other manifolds of cobalt-catalyzed electrochemical 
C−H/N−H annulations have been developed, including annulations with olefins,[95] 
allenes,[96] diynes[97] and with renewable forms of solar and wind energy.[98] 
 
 
Scheme 1.36. Cobaltaelectro-catalyzed C–H annulation. 
 
The cobaltaelectro-catalyzed C–H activation reactions were not limited to 
oxygenations, aminations and annulations. Indeed, cobalt-catalyzed oxidative 
electrochemical carbonylations[99] with CO gas were reported recently. Cobalt catalysis 
was identified as a versatile tool for the carbon monoxide insertion of benzamides 81 






Scheme 1.37. Cobaltaelectro-catalyzed C–H carbonylation of CO gas. 
 
1.3 Copper-Catalyzed C–H Activation 
 
Compared to other transition metals, especially noble 4d transition metals, copper 
possesses indisputable advantages in natural abundance and low toxicity.[37] Apart 
from these advantages, copper complexes, as important catalysts in 3d transition 
metal-catalyzed C–H functionalizations, have readily accessible oxidation states, 
which enabled both radical pathway and one- or two-electron transfer manifolds. Due 
to these innate properties of copper-catalysis, numerous attentions have been 
attracted to develop various C–H activation reactions using copper catalysts. 
Therefore, copper-catalyzed C–H activation witnessed considerable development in 
the past few decades.  
 
1.3.1. Copper-Catalyzed Oxidative C–H Activation 
 
Early studies of copper-catalysis can be traced back to the beginning of 20th century. 
In 1905, Ullmann disclosed the first example for catalytical utilization of copper as a 
catalyst in C–O bond formations (Scheme 1.38a).[100] One year later, Goldberg 







Scheme 1.38. Early examples of copper-catalyzed arylation. 
 
Inspired by these pioneering works, tremendous attention has been attracted by the 
field of copper-catalysis. However, recently significant momentum has been gained by 
copper-catalyzed activation of inert C–H bonds. In 2007, Daugulis and co-workers 
explored the copper-catalyzed C–H arylation of benzoxazole 87 (Scheme 1.39a).[102] 
The addition of alkoxide base allows a facile generation of the organo-copper 
intermediate in the catalytic cycle. Later, the same group expanded the scope of this 
manifold into different types of heterocycle substrates (scheme 1.39b).[103] 
 
 





Independently, Ackermann and co-workers developed the copper-catalyzed arylation 
on 1,2,3-triazoles 91 (scheme 1.40).[104] Diversely substituted triazoles 92 syntheses 




Scheme 1.40. Copper-catalyzed arylation of 1,2,3-triazoles 91. 
 
After these primary developments of copper-catalyzed C–H activations, oxidative 
copper-catalyzed arylations with organoboron reagents 94 have recently been 
achieved by Dai and Yu (Scheme 1.41).[105] By introducing an oxazoline-based 
bidentate directing group strategy, ortho-arylated benzamides 95 products were 
formed using stoichiometric amount of Ag2O as oxidant. 
 
 
Scheme 1.41. Oxidative copper-catalyzed C–H arylation. 
 
The oxidative copper-catalysis was not limited to arylation reactions. Indeed, Yu and 
co-workers developed the copper-mediated selective oxidative C–H alkynylation with 




benzamides 93 and alkynes 76 has been noted. Later, Zhang and co-workers further 
developed this manifold and applied catalytic amounts of copper acetate as the 
catalyst and stoichiometric amounts of silver carbonate as oxidant, resulting in the 
alkynylation and cascade annulation with C(sp3)–H and C(sp2)–H bonds activations in 
a decarboxylative fashion.[107] 
 
 
Scheme 1.42. Oxidative copper-catalyzed C–H arylation. 
 
As copper-catalyzed C–H activations are well-developed for the C–C bond 
construction, copper-catalyzed C–Het bond formations gained much attention. Indeed, 
Yu reported in one of his early works on the C–H acyloxylation reactions (Scheme 
1.43).[108] Using O2 as external oxidant, copper-catalyzed C–H acyloxylation reactions 
were achieved, converting diverse decorated 2-arylpyridines 9 into the corresponding 
acyloxylated product 97. 
 
 
Scheme 1.43. Copper-catalyzed C–H acyloxylation. 
 
Additionally, selective copper-catalyzed C–H amination reactions were reported by the 








Scheme 1.44. Copper-catalyzed C–H amination. 
 
In 2009, Fukuzawa and co-workers disclosed the copper-catalyzed C–H sulfenylation 
of benzoxazoles 87 in an oxidative fashion (Scheme 1.45).[110] By applying catalytic 
amount of copper(I) iodide in the presence of O2 as the terminal oxidant, sulfenylated 
products 100 were generated in excellent yields. 
 
 
Scheme 1.45. Copper-catalyzed C–H sulfenylation. 
 
1.3.2. Cupraelectro-Catalyzed C–H Activation 
 
The last decade has witnessed a renaissance on electrochemistry.[21, 38a, 38e] Merged 
with transition metal catalyzed C–H activation, new strategies for electrosynthesis 
have been developed and applied to exploit the innate reactivity of otherwise inert C–
H bonds. Among other manifolds, 3d transition metal catalyzed electrochemical C–H 
activations attracted much attention due to the cost-efficient and low-toxic nature of the 




tremendous development with various oxidative C–H activation reactions, including 
annulation, oxygenation, amination, carbonylation and allylation. These achievements 
largely inspired the exploration of other 3d earth-abundant metal catalyzed 
electrochemical C–H activations. In this context, nickel, iron, manganese and very 
recently copper have been devised for metallaelectro-catalyzed C−H activations.[21] 
Among others, cupraeletro-catalyzed C–H activation will be discussed in detail in this 
thesis. 
 
In 2018, Mei developed the cupraelectro-catalyzed C–H amination reactions of arenes 
101 with secondary amines 79 (scheme 1.46).[111] Using a redox mediator, the copper-
catalysis can be carried out in an undivided cell, without copper disposition on the 
cathode. Detailed mechanistic studies revealed two single electron transfer (SET) 
processes in the oxidation of copper pre-catalyst. 
 
Scheme 1.46. Cupraelectro-catalyzed C–H amination using secondary amines 79. 
 
Later on, a similar amination reaction was reported by Nicholls and co-workers.[112] 
Using a commonly applied quinoline directing group, aminations of benzamides 54 
have been achieved in good yields with further applications using pharmaceutical 






Scheme 1.47. Cupraelectro-catalyzed C–H amination with benzamides 54. 
 
Very recently, Fang and Mei disclosed a cupraelectro-catalyzed C–H bromination with 
quinoline benzamides 54 (Scheme 1.48).[113] Site-selective brominated quinoline 










In recent years, transition metal-catalyzed C–H transformation has emerged as an 
increasingly powerful tool for molecular syntheses. Merged with electrocatalysis, the 
sustainable nature of oxidative C–H transformations has been significantly improved. 
The effective utilization of renewable electricity bears considerable potential towards 
an environmentally friendly resource economy.[39b] Thereby, stoichiometric amounts of 
often toxic traditional chemical oxidants can be replaced by green, renewable electricity. 
Despite indisputable progress in metallaelectro-catalyzed C–H activation using noble 
transition metals,[21, 39a, 39b] 3d base metal-catalyzed electrochemical C–H activation 
continuous to be underdeveloped. Hence, we became attracted to inexpensive, earth-
abundant 3d base metal-catalyzed electrochemical C–H activations.  
 
Recently, earth-abundant, cost-efficient 3d base metal cobalt has been identified as a 
versatile catalyst for C–H transformations.[48] In this context, C–H/N–H activation with 
terminal alkyne has been accomplished by cobalt-catalysis with traditional chemical 
oxidants,[74, 79] which led to undesired by-products and/or generated stoichiometric 
amount of metal waste. To this end, electrochemistry holds great potential for more 
sustainable oxidative C–H transformation by minimizing the waste generation, with H2 
as the only by-product. Therefore, we tested cobaltaelectro-catalyzed C–H/N–H 
annulation with terminal alkyne (Scheme 2.1). 
 
 
Scheme 2.1. Cobaltaelectro-catalyzed C–H/N–H annulation with terminal alkyne. 
 
Based on our pervious report on cobaltaelectro-catalyzed C–H/N–H annulation of 




by terminal alkyne and decarboxylative alkynylations by alkynyl carboxylic acids. 
Oxidative alkynylation using copper catalysts have been well-developed in the last few 
years,[106] while the cupraelectro-catalyzed C–H transformations remain scarce.[111-112] 
In this context, we developed the cupraelectro-catalyzed cascade annulation by C–H 




Scheme 2.2. Cupraelectro-catalyzed cascade annulation by C–H alkynylation. 
 
Cobalt catalyzed electrochemical C–H activations have been widely applied in the 
formation of C–N,[91-92] C–C[93-96, 98] and C–O[90] bonds. Inspired by our previous work 
on cobaltaelectro-catalyzed C–H alkoxylation with alcohols,[90] we further expanded 
this regime of electrochemical construction of C–O band to C–H acyloxylation 
reactions with carboxylic acids (scheme 2.3).  
 
 





Electrochemical C–H activations with alkenes have been reported using precious 
transition metals such as palladium,[114] rhodium[115] and iridium[116] but were largely 
limited to electronically activated styrenes and acrylates. The utilization of non-
activated alkenes by metallaelectro-catalyzed C−H activation is unknown. Herein, we 
disclose the first cobaltaelectro-catalyzed chemo-selective C−H allylation with non-
activated alkenes (scheme 2.4). 
 
 
Scheme 2.4. Cobaltaelectro-catalyzed oxidative C−H allylation with non-activated alkenes. 
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3. Result and Discussion 
3.1 Water-Tolerant Cobaltaelectro-Catalyzed C–H/N–H Activation at 
Room Temperature 
 
Heterocycle syntheses enabled by C–H/N–H activations have been achieved with 
various transition metal catalysts over the last decade.[37, 117] Among these, the versatile 
cobalt catalysis proved to be a powerful tool in C–H/N–H alkyne annulations, enabling 
step-economical isoquinolone synthesis.[74, 79] Despite indisputable advances, these 
approaches normally required high reaction temperature and stoichiometric amounts 
of toxic metal salts as the sacrificial oxidants. In sharp contrast, merging the 
metallaelectro-catalysis with oxidative C–H activations, the use of expensive and toxic 
oxidants has been avoided by anodic oxidation, enhancing the inherent sustainable 
nature of C–H activation. In this context, we disclosed the first unprecedented 
cobaltaelectro-catalyzed C–H/N–H activation for an isoquinolone synthesis at ambient 
temperature with full water-tolerant. The novel electrochemical C–H/N–H 
functionalization is operative in a considerably resource-economical fashion as 
compared to the traditional approaches. 
 
3.1.1. Optimization Studies 
 
To initiate our studies on cobaltaelectro-catalyzed annulation reactions, we probed 
different reaction conditions for the C–H/N–H activation using terminal alkyne 76a 
(Table 3.1). The desired product 104aa was formed within the cobaltaelectro-catalysis 
manifold, using NaOPiv as the optimal additive (entries 1-3). The robust cobalt 
complex was fully tolerant of H2O (entries 5-6). The highest catalyst performance was 
obtained in a mixture of MeOH and H2O 1:1 with 10 mol % of the cobalt catalyst (entries 
3-9). It should be noted that unlike the previous reported cobaltaelectro-catalyzed 
oxygenation reactions with alcohols,[90] the addition of large access of free alcohols as 
cosolvent did not lead to the oxygenation of benzamide 56a, but selectively delivered 
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the annulated product 104aa. Furthermore, control experiments illuminated the 
essential roles of the additive, the cobalt catalyst and the electricity (entries 10-12). 
Nevertheless, several typical 3d or 4d transition metal catalysts were tested. All proved 
to be ineffective (entries 13-17).  
 
Table 3.1. Optimization of the cobaltaelectro-catalyzed C–H/N–H alkyne annulation.[a] 
 
Entry [Co] Solvent Base Yield [%] 
1 Co(OAc)2∙4H2O DMSO NaOAc 28 
2 Co(OAc)2∙4H2O DMSO Na2CO3 - 
3 Co(OAc)2∙4H2O DMSO NaOPiv 31 
4 Co(OAc)2∙4H2O TFE NaOPiv 50 
5 Co(OAc)2∙4H2O H2O NaOPiv 62 
6 CoCl2∙6H2O H2O NaOPiv 56 
7 Co(OAc)2∙4H2O MeOH NaOPiv 64[b] 
8 Co(OAc)2∙4H2O H2O/MeOH (1:1) NaOPiv 76 
9 Co(OAc)2∙4H2O H2O/MeOH (1:1) NaOPiv 76[c] 
10 Co(OAc)2∙4H2O H2O/MeOH (1:1) NaOPiv -[d] 
11 - H2O/MeOH (1:1) NaOPiv - 
12 Co(OAc)2∙4H2O H2O/MeOH (1:1) - - 
13 MnBr(CO)5 H2O/MeOH (1:1) NaOPiv -[c] 
14 Ni(OAc)2 H2O/MeOH (1:1) NaOPiv -[c] 
15 [RuCl2(p-cymene)]2 H2O/MeOH (1:1) NaOPiv -[c] 
16 AuMePPh3 H2O/MeOH (1:1) NaOPiv -[c] 
17 PtCl2 H2O/MeOH (1:1) NaOPiv -[c] 
[a] Reaction conditions: Undivided cell, 56 (0.5 mmol), 76 (1.0 mmol), [Co] (20 mol %), 
base (2.0 equiv), solvent (10 mL), 23 ⁰C, 4.0 mA, 16 h, CF anode, Pt-plate cathode. [b] 
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3.1.2. Scope of Cobaltaelectro-Catalyzed C–H/N–H Annulation 
 
With the optimized reaction conditions in hand, we became interested in the key factor 
of N,O-bidentate coordination pattern of cobaltaelectro-catalysis. Hence, we 
performed a set of electrochemical annulation experiments using different directing 
groups (Scheme 3.1). Quinoline bidentate motif 54 proved to be able to provide the 
corresponding annulated product, albeit with reduced product yield. While, simple 
pyridine group 56b or N-methylbenzamide 15 failed to deliver any product under the 
electrochemical conditions.  
 
 
Scheme 3.1. Effect of N-substitution on cobaltaelectro-catalyzed C–H/N–H activation. 
 
Thereafter, we explored the versatility of the cobaltaelectro-catalyzed C–H/N–H 
annulation regime with various decorated benzamides 56 under the optimized reaction 
condition (Scheme 3.2). Electron-rich as well as electron-poor arenes 56c-56e were 
amenable to yield the corresponding isoquinolones 104 with excellent chemo- and 
positional-selectivity. Notably, synthetically-useful halides such as fluorides, bromides 
and iodides, were well tolerated under the electrochemical conditions with H2O as 
cosolvent, while reductive couplings[118] were not detected. The robust cobaltaelectro-
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catalysis enabled highly efficient C–H/N–H activation on amides 56c-56j with para-, 
meta- or ortho-substitution pattern, as well as di-substituted and tri-substituted amides 
56k-56m. The cobalt catalysis was not limited to arene annulation, but C–H/N–H 
activations of alkenes were also effective delivering the corresponding pyridines 
104na-104oa under the electrochemical reaction conditions. 
 
Scheme 3.2. Cobaltaelectro-catalyzed C–H/N–H activation of benzamides 56. [a] 
Co(OAc)2∙4H2O (20 mol %). 
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Likewise, we tested the versatility of representative alkynes 76 (Scheme 3.3). The 
versatile cobaltaelectro-catalysis proved effective with electron-rich and electron-
deficient acetylenes 76b-76d. Alkyl alkynes 76e-76g, as well as functional cyclopropyl 
alkyne 76h, afforded the desired annulated products in good to excellent yield. 
Valuable alkynes with ester 76i-76j and alkyl chloride 76k functional groups were fully 
tolerated by the cobaltaelectro-catalysis manifold.  
 
 
Scheme 3.3. Cobaltaelectro-catalyzed C–H/N–H activation of alkynes 76. [a] 
Co(OAc)2∙4H2O (20 mol %). 
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Furthermore, the robustness of the cobaltaelectro-catalyzed C–H/N–H annulation was 
reflected by applying H2O as the sole reaction medium. Substituted benzamide, alkene 
and functional ester group-containing alkyne were chemo-selectively transformed into 
the corresponding isoquinolones and pyridines 104 in moderate yields (Scheme 3.4). 
 
 
Scheme 3.4. Cobaltaelectro-catalyzed C–H/N–H annulation in H2O.  
 
3.1.3. Mechanistic Studies 
3.1.3.1. Competition Experiments 
 
Intrigued by the unique cobaltaelectro-catalyzed C–H/N–H annulation manifold, we 
further explored the catalyst’s mode of action. To this end, we started the mechanistic 
studies with intermolecular competition experiments (Scheme 3.5). Different para-
substituted benzamides 56 and acetylenes 76 were submitted under the optimized 
reaction conditions with 20 mol % of the cobalt catalyst to conduct competition 
experiments between electron-donating and electron-withdrawing substrates. In both 
cases, electron-donating substrates proved to feature superior reactivities. The ratio of 
electron-rich benzamide 56c to electron-deficient benzamide 56e is 1.4:1, while a ratio 
of 1.3:1 for electron-rich isoquinolones 104ab to electron-deficient isoquinolones 
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104ad were obtained in the intermolecular competition experiment with substituted 
acetylenes 76. The finding of the competition between benzamides highlighted the 
inherent nature of a base-assisted internal electrophilic substitution (BIES)[27] pattern. 
 
Scheme 3.5. Intermolecular competition experiments.  
 
3.1.3.2. H/D Exchange Experiment 
 
Thereafter, a reaction with isotopically labelled solvent was conducted under the 
electrochemical conditions (Scheme 3.6). Since H2O as the sole reaction medium was 
able to deliver the desired product, isotopically labelled D2O was introduced to perform 
the H/D exchange experiment. No H/D exchange can be found at the ortho-position of 
ether recovered benzamide 56a or isoquinolone product 104aa, which revealed the C–
H cleavage was irreversible. 
 
Scheme 3.6. Cobaltaelectro-catalyzed C–H/N–H annulation in D2O.  




3.1.3.3. Kinetic Isotope Effect Studies 
 
Subsequently, kinetic isotope effect (KIE) studies were performed with two parallel 
reactions using D5-benzamide [D5]-56a and the standard substrate 56a. Initial rates of 
both experiments were recorded within 20% of product yield (Scheme 3.7). A KIE value 
of kH/kD = 1.1 was obtained, suggesting a facile C–H scission.  
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3.1.3.4. Attempted Cyclization 
 
Moreover, the independently prepared ortho-alkynylated substrate 105 was tested 
under the optimized electrochemical condition, which failed to form the desired 
annulated product 104aa (Scheme 3.8). Thus, an organometallic alkyne annulation 
process was suggestive in the catalytic cycle. 
 
 
Scheme 3.8. Attempted cyclization experiment.  
 
3.1.3.5. Cyclic Voltammetry Studies 
 
Detailed cyclic voltammetry studies were conducted by T. H. Meyer to gain mechanistic 
insights into the cobaltaelectro-catalyzed C–H/N–H annulation (Figure 3.1). In the 
absence of the cobalt catalyst, benzamide 56a exhibited an oxidation potential of 1.51 
V versus SCE, while the oxidation potential of cobalt catalyst was found to be 1.19 V 
versus SCE. The oxidation potential of the catalyst was 320 mV lower than substrate 
56a, which provides support for a single-electron oxidation process happening 
between the cobalt catalyst species and the benzamide. No distinguishable redox 
activity was observed on the case of phenylacetylene 76a alone, suggesting an 
organometallic alkyne annulation manifold, which coincides with the attempted 
cyclization reaction result. 
 




Figure 3.1. Cyclic voltammograms at 100 mVs-1: n-Bu4NPF6 (0.1 M in MeOH), 
concentration of substrates 1 mM (NaOPiv 4 mM).  
 
3.1.4. Proposed Mechanism 
 
Based on these mechanistic studies, a plausible catalytic cycle can be proposed to 
illuminate the cobaltaelectro-catalyzed C–H/N–H annulation manifold (Scheme 3.9). 
Initiated by the anodic oxidation of Co(II) into Co(III) catalytically active carboxylate 
species 106, benzamide substrate undergoes a BIES C–H cleavage[27] to deliver 
intermediate 107. Thereafter, insertion of alkyne give rise to cobalt complex 108 and 
reductive elimination gives desired product 104 while releasing a putative cobalt(I) 
species 109. Finally, the catalytically active cobalt(III) species 106 is regenerated by 
anodic oxidation and cathodic reduction gives the only byproduct H2 at the cathode 
surface. 
 




Scheme 3.9. Pausible catalytic cycle.  
 
3.2 Cupraelectro-Catalyzed Cascade Annulation by C–H 
Alkynylation and Decarboxylative C–H/C–C Manifolds 
 
The merger of oxidative C–H transformation with electrocatalysis has substantially 
improved the sustainability of earth-abundant 3d transition metal catalyzed oxidative 
C–H activation.[21, 39b] In this context, stoichiometric amounts of sacrificial chemical 
oxidants are replaced by environmentally-friendly electricity. Thereby, the 
environmental impacts have been minimized and no chemical wastes have been 
generated during the electrochemical process, with H2 as the sole by-product from 
cathodic reduction. Thus, recent momentum was gained by 3d transition metal 
catalyzed electrochemical C–H transformations using cobalt,[90-97, 99, 119] nickel,[120] 
copper,[111-113, 121] manganese[122] and iron[122] catalysts. Despite these inspiring 
achievements, cupraelectro-catalyzed C–H activations remain rare. In this context, 
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only one example of copper-catalyzed electrochemical C–H aminations with electron-
rich anilides has been reported by Mei[111] in 2018. However, electrocatalyzed C–H 
alkynylations have thus far proven elusive. Herein, we disclosed the first cupraelectro-
catalyzed oxidative alkyne cascade annulation enabled by a C–H alkynylation manifold, 
which also set the stage for cupraelectro-catalyzed C–H/C–C decarboxylative 
annulations. Unlike the cobaltaelectro-catalyzed C–H/N–H annulations for 
isoquinolone synthesis,[93] cupraelectro-catalyzed C–H alkynylations selectively 
delivered five-membered bioactive isoindolones.[123] 
 
3.2.1. Optimization Studies 
 
We initiated our studies by probing different reaction conditions for the envisioned 
cupraelectro-catalyzed oxidative alkyne C–H annulation using constant current 
electrolysis (CCE) in an operationally-friendly undivided cell setup (Table 3.2). First, a 
set of commonly used organic solvents were tested under electrochemical condition, 
and we found DMA to be the optimal solvent for cupraelectro-catalyzed isoindolone 
synthesis, while tAmOH, MeCN, MeOH, DMF and NMP proved to be inefficient (entries 
1-6). Second, the test of additives and copper catalysts revealed a combination of 
NaOPiv with Cu(OAc)2∙H2O giving the best catalytic performance for the electrolysis 
(entries 6-10). Higher or lower reaction temperatures did not give rise to higher yields 
(entries 11-12). Unlike the copper-catalyzed electrochemical C–H aminations,[111] the 
addition of redox mediators such as TBAI or TEMPO reduced the isoindolone yield, 
BQ even prevented the product formation completely (entries 13-15). The 
cupraelectro-catalyzed C–H alkynylation was also conducted in a potentiostatic 
manifold at 2.0 V, giving a similar result as was obtained in the galvanostatic regime 
(entry 16). Control experiments verified the essential roles of the electricity, the additive 
and the copper catalyst, with a minor influence of oxygen in the reaction atmosphere 
(entries 17-21). Other representative transition metal catalysts were further tested 
under otherwise identical conditions (entries 22-28). Manganese, cobalt, nickel, 
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ruthenium, rhodium, iridium, and palladium failed to deliver the desired products. 
Notably, when using cobalt(II) acetate tetrahydrate as catalysts, the corresponding 
isoquinolone product was obtained instead of the five-membered isoindolone.  
 
Table 3.2. Optimization of the cupraelectro-catalyzed isoindolones synthesis.[a] 
 
Entry Solvent Additive [TM] E/Z Yield [%] 
1 tAmOH NaOPiv Cu(OAc)2∙H2O – – 
2 DMF NaOPiv Cu(OAc)2∙H2O 1:3 56 
3 MeCN NaOPiv Cu(OAc)2∙H2O – – 
4 MeOH NaOPiv Cu(OAc)2∙H2O – – 
5 NMP NaOPiv Cu(OAc)2∙H2O 1:8 80 
6 DMA NaOPiv Cu(OAc)2∙H2O 1:13 90 
7 DMA NaOAc Cu(OAc)2∙H2O 1:6 58 
8 DMA Na2CO3 Cu(OAc)2∙H2O 1:4 44 
9 DMA KOPiv Cu(OAc)2∙H2O 1:1 51 
10 DMA NaOPiv Cu(OPiv)2 1:12 74 
11 DMA NaOPiv Cu(OAc)2∙H2O 1:6 84[b] 
12 DMA NaOPiv Cu(OAc)2∙H2O 1:8 73[c] 
13 DMA NaOPiv Cu(OAc)2∙H2O 1:10 76[d] 
14 DMA NaOPiv Cu(OAc)2∙H2O 1:8 81[e] 
15 DMA NaOPiv Cu(OAc)2∙H2O – –[f] 
16 DMA NaOPiv Cu(OAc)2∙H2O 1:12 86[g] 
17 DMA NaOPiv Cu(OAc)2∙H2O 1:8 18[h] 
18 DMA NaOPiv Cu(OAc)2∙H2O 1:11 90[i] 
19 DMA NaOPiv Cu(OAc)2∙H2O 1:9 5[j] 
20 DMA NaOPiv – – – 
21 DMA – Cu(OAc)2∙H2O – – 
22 DMA NaOPiv Co(OAc)2∙4H2O – –[k] 
23 DMA NaOPiv Mn(OAc)2 – – 
24 DMA NaOPiv [RuCl2(p-cymene)]2 – – 
25 DMA NaOPiv Ni(OAc)2∙4H2O – – 
26 DMA NaOPiv [Cp*RhCl2]2 – – 
27 DMA NaOPiv [Cp*IrCl2]2 – – 
28 DMA NaOPiv Pd(OAc)2 – – 
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[a] Reaction conditions: Undivided cell, 54a (0.25 mmol), 76a (0.50 mmol) [TM] (5.0 mol %), 
additive (1.0 equiv), solvent (4.0 mL), 100 °C, constant current at 6.0 mA, 6 h, CF anode, 
Pt-plate cathode. All yields are reported as isolated yield. [b] 80 °C. [c] 120 °C. [d] TBAI (50 
mol %) as redox mediator. [e] TEMPO (20 mol %) as redox mediator. [f] BQ (50 mol %) as 
redox mediator. [g] Constant potential at 2.0 V (silver wire as reference electrode). [h] No 
electricity. [i] Under N2. [j] Without electricity, under N2. [k] Isoquinolone product formed in 
65% yield. 
 
3.2.2. Scope of Cupraelectro-Catalyzed Cascade Annulation 
 
With the optimized conditions in hand, we evaluated the coordination mode of N-
substitution pattern for the cupraelectro-catalyzed cascade annulation by C–H 
alkynylation (Scheme 3.10). Therefore, a set of cupraelectro-catalysis experiments 
using different N-substitutions was carried out. Benzamide with the phenyl oxazoline 
93 directing group was able to give the corresponding isoindolinones 111aa product 
but resulted in reduced yield. N,O-bidentate type pyridine-N-oxide 56a proved to be 
ineffective, as was the same result when simple N-phenylbenzamide 15b was applied. 
 
 
Scheme 3.10. Effect of the N-substitution on the cupraelectro-catalysis. 




Furthermore, we probed the versatility of cupraelectro-catalyzed cascade annulation 
by C–H alkynylation with various substituted benzamides 54 and terminal alkynes 76 
(Scheme 3.11). The experiment for the product 110al synthesis was performed by U. 
Dhawa. A wide variety of benzamides 54 with electron-rich and electron-deficient 
substituted arenes 54b-54g were amenable to cupraelectro-catalyzed cascade 
annulation regime, affording the desired isoindolinones in good to excellent yields. 
ortho-, meta- and para-substituted benzamides 54b-54d successfully delivered the 
corresponding products under the electrochemical reaction conditions. Notably, the 
positional selectivity for meta-substituted arenes 54c and 54k was dominated by steric 
interactions. The robust cupraelectro-catalysis tolerated a wide array of halide 
functionalized benzamides 54h-54g, which provided access to further late-stage 
diversifications. Synthetically-useful electrophilic functional groups, including thioether 
(54m) and cyano (54n), were introduced in cupraelectro-catalyzed cascade annulation 
by C–H alkynylation, selectively providing corresponding decorated isoindolinones. 
The copper-catalysis was not limited to benzamides, differently substituted alkynes 
76b and 76d were efficiently transformed into desired product. To be noted, terminal 
alkyne bearing an amino acid functional group 76l was efficiently converted by the 
cupraelectro-catalysis. 
 




Scheme 3.11. Cupraelectro-catalyzed C–H alkynylation for isoindolones 110. [a] 
Cu(OAc)2∙H2O (10 mol %). 




The green and user-friendly nature of the cupraelectro-catalysis for C–H activations 
was further illustrated by the gram-scale synthesis of isoindolone 110aa (Scheme 3.12). 
Slight modifications of the electrochemical setup were necessary for the gram-scale 
synthesis. With appropriate scale-up on electrochemical cell volume for proper 
substrate concentration, stirring device for sufficient mass transfer and electrode size 
for larger current density, the copper-catalyzed electrochemical isoindolones synthesis 
was efficiently proceeded with high catalytic performance on a scale-up experiment 
using 50 mA within 11.5 h, yielding 1.14 g of the desired product 110aa. 
 
 
Scheme 3.12. Gram-scale cupraelectro-catalyzed isoindolone synthesis. 
 
The robustness of cupraelectro-catalyzed C–H alkynylation regime was not limited to 
terminal alkynes 76. Indeed, by applying easily accessible carboxylic acids 112, an 
alternative approach to isoindolones synthesis was realized under otherwise identical 
electrochemical conditions (Scheme 3.13). Substituted alkynyl carboxylic acids 112b-
112d with electron-donating groups as well as electron-withdrawing groups were 
effectively converted to the desired five-membered isoindolones by decarboxylative 
C–H/C–C scission.  
 




Scheme 3.13. Decarboxylative cupraelectro-catalyzed C–H/C–C scission.  
 
3.2.3. Mechanistic Studies 
3.2.3.1. Competition Experiments 
 
Intrigued by the unique catalytic performance of the electrochemical copper-catalyzed 
cascade annulation by C–H alkynylation, we became interested in understanding the 
catalyst’s mode of action. To this end, a set of mechanistic studies was initiated with 
intermolecular competition experiments (Scheme 3.14). Benzamides with electron-rich 
and electron-deficient para-substitution were conducted under the optimized 
electrochemical reaction conditions. As a result, electron-deficient substrate 54g 
revealed to be inherently superior. Likewise, competition experiment between electron-
donating and electron-withdrawing terminal alkynes was converted under the same 
condition. A similar result of electron-withdrawing alkyne 76d provided better reactivity. 
In both cases, substrates with electron-deficient groups proved to be inherently 
favorable, which clearly highlights the complementary nature of our approach 
comparing to the former copper-catalyzed electrochemical C–H amination[111-112] with 
electron-rich anilides by a single electron transform (SET) pathway. 
 




Scheme 3.14. Intermolecular competition experiments.  
 
3.2.3.2. H/D Exchange Experiments 
 
Thereafter, H/D exchange reactions in the presence of isotopically labelled compounds 
were further tested (Scheme 3.15). By applying isotopically labelled CD3OD as co-
solvent under otherwise identical optimized electrochemical condition, the 
cupraelectro-catalysis delivered the corresponding isotopically labelled annulated 
isoindolone product. No H/D exchange was found in either the reisolated benzamide 
54a or product 110aa, which suggested the C–H cleavage step is irreversible. 
 
 
Scheme 3.15. H/D exchange experiment.  
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3.2.3.3. Kinetic Isotope Effect Studies 
 
Furthermore, KIE studies were conducted with two parallel experiments using in-
operando React-IR (Scheme 3.16). Initial rates of both [D5]-54a and 54a substrates 
were analyzed using the data obtained within 2 h of reactions. A KIE value of kH/kD = 
1.2 was obtained, providing support for a facile C–H scission.  
 




Scheme 3.16. Kinetic isotope effect experiments by in-operando React-IR.  




3.2.3.4. Kinetic Profile 
 
With the assistance of in-operando React-IR analysis, we were able to track the 
electrochemical copper C–H alkynylation reaction profiles by in situ IR study (Figure 
3.2). A kinetic profile over the entire reaction time can be plotted with the IR data 
generated by React-IR, using surface plot at 1109 cm–1 and 1327 cm–1 as product 
110aa generation and benzamide 54a consumption respectively.  
 
 
Figure 3.2. Kinetic profile by in-operando React-IR at 1109 cm–1 and 1327 cm–1. 




3.2.3.5. Attempted Cyclization 
 
To gain further mechanistic insights in the alkynylation manifold of the cupraelectro-
catalyzed cascade C–H annulation, we conducted cyclization reactions with an 
independently prepared ortho-alkynylated substrate 54o (Scheme 3.17). Unlike the 
cobaltaelectro-catalyzed C–H/N–H annulation presented above, which formed no 
product with similar studies, ortho-alkynylated substrate 54o successfully delivered the 
desired isoindolone product with or without electricity. Therefore, a cascade annulation 
manifold initiated by C–H alkynylation is suggested instead of the organometallic 
alkyne annulation process in the cobalt catalyzed base-mediated cascade 
electrochemical C–H annulation.[93]  
 
 
Scheme 3.17. Cyclization experiments.  
 
3.2.3.6. Headspace GC Analysis 
 
Moreover, headspace GC analysis was applied to detect the byproduct generation of 
molecular hydrogen by cathodic proton reduction (Scheme 3.18). The reaction vapor 
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phase was collected and submitted to headspace GC, H2 production was hence 
confirmed at 1.59 min in the chromatogram. 
 
 
Scheme 3.18. Headspace GC analysis for cupraelectro-catalysis.  
 
3.2.3.7. Cyclic Voltammetry Studies 
 
Finally, we probed the cupraelectro-catalyzed C–H alkynylation with detailed cyclic 
voltammetry studies by A. Scheremetjew. With the addition of benzamide 54a, the 
copper(II) catalyst exhibited a clear oxidative potential at 0.95 V versus SCE, while the 
copper(II) catalyst alone revealed no significant oxidation potential. These findings give 
support to the formation of a copper(II) complex 113 in the catalytic cycle, which further 
undergoes anodic oxidation to the copper(III) intermediate 114. For the reoxidation 
process of copper catalyst species, the cyclic voltammetry study of copper(I) acetate 
provided support for a facile generation of the initial copper(II) catalyst 118 with a low 
oxidation potential of 0.05 V versus SCE.  
 
3.2.4. Proposed Mechanism 
 
Based on these mechanistic studies, a plausible catalytic cycle is proposed to 
commence with the formation of copper(II) complex 113 by substrate coordination of 
benzamide 52 (scheme 3.19). Thus, under electrochemical conditions, subsequent 
anodic oxidation gives raise to copper(III) species 114. Thereafter, facile carboxylate 
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assisted C–H activation provides the intermediate 115, which undergoes the ligand 
exchange with terminal alkyne to generate the copper(III) intermediate 116. Then, 
reductive elimination delivers the alkynylated product 54o, and forms the copper(I) 
species 117. The alkynylated product 54o further cyclizes the desired isoindolone 108 
with the presence of NaOPiv. The putative copper(I) species 117 is oxidized at the 
anode and regenerates the initial copper(II) catalyst 118. 
 
 
Scheme 3.19. Pausible catalytic cycle.  
 
3.3 Cobaltaelectro-Catalyzed C–H Acyloxylation with Carboxylic 
Acids 
 
The sustainability of oxidative C–H activation approach has been largely advanced by 
metallaelectro-catalyzed C–H activation, which replaced chemical oxidants by 
renewable green electricity. In this context, merging bio-mass derived solvents[124] with 
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electrochemical C–H transformations[91, 98] brings the environmentally friendly nature 
of C–H activation to the next level. Despite significant progress discussed above on 
3d transition metallaelectro-catalysis, electrochemical formation of C–O bond by 3d 
transition metal catalyzed C–H activations remains scarce. Except one report of 
cobaltaelectro-catalyzed oxygenation developed by Ackermann[90] and palladium-
catalyzed electrochemical acyloxylation reported by Mei.[125] Herein, we explored the 
cobaltaelectro-catalyzed C–H acyloxylation with free carboxylic acids using biomass 
derived renewable γ-valerolactone (GVL)[124, 126] as green solvent. 
 
3.3.1. Optimization Studies 
 
The exploration of cobaltaelectro-catalyzed C–H acyloxylation were initiated by 
probing various reaction conditions, using user-friendly undivided cell setup with a 
galvanostatic regime at 5.0 mA (Table 3.3). Our preliminary result of acyloxylated 
product formation was achieved with DCE as the solvent at 60 °C under 
electrochemical conditions (entry 1). Thus, we tested a set of commonly used additives 
for cobalt catalysis. Among others, Na2CO3 proved to be the optimal additive for 
electrochemical C–H acyloxylation (entries 2-4). Reducing the loading of the cobalt 
catalyst from 20 mol % to 10 mol % led to lower desired product yield (entry 5). Different 
representative organic solvents were probed in cobaltaelectro-catalysis (entries 8-16). 
To our delight, in the presence of biomass derived GVL, the cobalt catalyst provided 
the best catalytic performance in electrochemical oxidative C–H acyloxylation. Solvent 
mixtures with GVL as the co-solvent were further probed in cobaltaelectro-catalysis but 
failed to produce higher yields (entries 17-19). Higher or lower reaction temperatures 
did not improve the catalyst performance (entries 20-22). Other cobalt sources were 
tested under electrochemical conditions, but CoCl2, CoSO4∙7H2O, Co(acac)2 and 
Co(acac)3 were found to be inefficient (entries 6-7 and entries 23-24). Control 
experiments provided strong support for the essential roles of electricity and cobalt 
catalyst (entries 25-26). 





Table 3.3. Optimization of cobaltaelectro-catalyzed C–H acyloxylation.[a] 
 
Entry Solvent Additive T [⁰C] Yield [%] 
1 DCE Na2CO3 60 25 
2 DCE NaHCO3 80 27 
3 DCE NaOAc 80 22 
4 DCE Na2CO3 80 51 
5 DCE Na2CO3 80 37[b] 
6 DCE Na2CO3 80 29[c] 
7 DCE Na2CO3 80 45[d] 
8 DMF Na2CO3 80 13 
9 tAmOH Na2CO3 80 - 
10 1,4-dioxane Na2CO3 80 38 
11 iPrOH Na2CO3 80 - 
12 NMP Na2CO3 80 40 
13 MeCN Na2CO3 80 29 




Na2CO3 80 22 
16 GVL Na2CO3 80 66 (22) 
17 GVL/H2O (1:1) Na2CO3 80 - 




Na2CO3 80 31 
20 GVL Na2CO3 40 20 
21 GVL Na2CO3 60 55 
22 GVL Na2CO3 100 50 
23 GVL Na2CO3 80 41[e] 
24 GVL Na2CO3 80 44[f] 
25 GVL Na2CO3 80 -[g] 
26 GVL Na2CO3 80 -[h] 
[a] Reaction conditions: Undivided cell, 54b (0.25 mmol), 66a (0.50 mmol), [Co] (20 mol %), 
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additive (2.0 equiv), nBu4NPF6 (0.25 mmol), solvent (3.0 mL), constant current at 5.0 mA, 
6 h, CF anode, Pt-plate cathode, under air, in parenthesis reisolated 54b. [b] [Co] 10 mol %. 
[c] Co(acac)2 as catalyst. [d] CoCl2 as catalyst. [e] Co(acac)3 as catalyst. [f] CoSO4∙7H2O 
as catalyst. [g] In the absence of a cobalt source. [h] No electricity. 
 
3.3.2. Scope of Cobaltaelectro-Catalyzed C–H Acyloxylation 
 
With the optimized conditions in hand, we tested the versatility of cobaltaelectro-
catalyzed C–H acyloxylation with a set of substituted benzamides 54 (Scheme 3.20), 
experiments of substrate 54p and 54s were conducted by U. Dhawa. Various ortho-, 
meta- and para-substituted benzamides 54p-54s were probed and selectively 
delivered the corresponding ester products 67 under electrochemical oxidative 
conditions. The sterically congestion on arene, such as in substrates 54p and 54l, did 
not affect the catalytic performance of cobalt. These benzamides 54 converted the 
desired products in moderate to good yields.  
 




Scheme 3.20. Cobaltaelectro-catalyzed C–H acyloxylation of benzamides 54. 
 
The robustness of the cobaltaelectro-catalyzed C–H acyloxylation was not limited to 
benzamides 54, different decorated carboxylic acids 66 were appliable in this manifold 
(Scheme 3.21). Substituted carboxylic acids 66b-66e bearing para-, meta- and ortho-
substitution were well-tolerated in cobaltaelectro-catalysis with high level of chemo-
selectivity. Benzoic acids 66g bearing halide functional group was able to convert into 
the desired aromatic ester. Disubstituted benzyl acids 66g-66i proved amenable to 
cobaltaelectro-catalyzed acyloxylation regime, affording the corresponding ester in 
modest yield. To be noted, aliphatic carboxylic acid 66j successfully delivered the 
desired product, albeit in a slightly reduced fashion. 
 




Scheme 3.21. Cobaltaelectro-catalyzed C–H acyloxylation of carboxylic acids 66.  
 
3.3.3. Mechanistic Studies 
3.3.3.1. Competition Experiment 
 
Intrigued by the unique catalytic performance of electrochemical cobalt acyloxylation, 
we became interested in exploring the catalyst’s mode of action. To this end, we started 
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the mechanistic studies with intermolecular competition experiment (Scheme 3.22). 
Competition reaction between electron-rich and electron-deficient carboxylic acids 66d 
and 66k under optimal electrochemical conditions was conducted with benzamide 54b. 
Both acyloxylated products were obtained, while electron-donating ester 67bd proved 
to be inherently more reactive. This result supported a BIES mechanism for the key 




Scheme 3.22. Intermolecular competition experiment.  
 
3.3.3.2. H/D Exchange Experiment 
 
Moreover, H/D exchange reaction using isotopically labelled compound in 
electrochemical condition was further tested (Scheme 3.23). In the presence of 
isotopically labelled CD3OD as the co-solvent, benzamide 54b can be successfully 
converted to corresponding ester. However, we were unable to observe any significant 
H/D exchange in both the reisolated benzamide substrate and the desired aromatic 
ester product. This observation suggests that the C–H cleavage is not reversible. 
 




Scheme 3.23. H/D exchange experiment.  
 
3.3.3.3. Headspace GC Analysis 
 
Thereafter, to confirm the H2 byproduct formation during the cathodic reduction 
process, we applied headspace GC analysis in cobaltaelectro-catalyzed C–H 
acyloxylation (Scheme 3.24). The gas phase was collected and submitted to 
headspace GC analysis. Thus, H2 formation can be detected at 1.59 min in GC-
chromatogram.[91, 121]  
 
 
Scheme 3.24. Headspace GC analysis for cobaltaelectro-catalyzed acyloxylation.  
 
3.3.3.4. Cyclic Voltammetry Studies 
 
To illustrate the key oxidation and reduction events of cobaltaelectro-catalyzed C–H 
acyloxylation, J. Struwe preformed detailed cyclic voltammetry studies (Figure 3.4). An 
irreversible oxidation of benzamide 54b was revealed at 1.46 V versus Fc+/0, while 
carboxylic acid 66a showed no relevant oxidation in MeOH. Meanwhile, cobalt(II) 
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catalyst featured a lower oxidative potential at 1.13 V versus Fc+/0 without addition of 
any other substrates, which is in good agreement with our pervious findings on 
cobaltaelectro-catalysis.[93] The mixture of substrate 54b and cobalt(II) acetate catalyst 
did not give rise to any significant oxidation potential, which indicates the formation of 
cobalt(III) intermediate 119 by anodic oxidation.  
 





Figure 3.4. Cyclic voltammograms at 100 mV/s preformed by J. Struwe: General condition: 
MeOH, 0.1 M nBu4NPF6, 5 mM substrates. 
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3.3.4. Proposed Mechanism 
 
Based on our mechanistic findings, a plausible catalytic cycle for electrochemical 
cobalt catalyzed C–H acyloxylation is proposed (scheme 3.25). To initiate the cycle, an 
anodic oxidation of cobalt(II) acetate is suggested, forming the catalytically active 
cobalt(III) species 119. Thus, carboxylate-assisted C–H activation provides the 
cyclometalated intermediate 120, further salt metathesis with carboxylic acid 66 
delivers cobalt(III) complex 121. Thereafter, reductive elimination provides ester 
product 67 and cobalt(I) complex 122. Finally, the catalytically active cobalt(III) species 
119 is regenerated at anode.  
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3.4 Cobaltaelectro-Catalyzed C–H Allylation with Non-activated 
Alkene 
 
The merger of electrochemistry with oxidative C–H activation has become an 
increasingly powerful platform for molecular syntheses, with transformative potential 
applications towards late-stage diversification,[127] material sciences[19] and 
pharmaceutical industries.[20] One of the appealing advantages of C–H activation is the 
ability to attain full positional- and chemo-selectivity control. Despite the indisputable 
progress on electrochemical C–H transformations in recent years,[21, 38c, 39a] chemo-
selective alkene allylation via metallaelectro-catalysis was as of yet unprecedented. 
Herein, we disclosed the first cobaltaelectro-catayzed C–H allylation with non-
activated alkenes using biomass derived GVL as solvent. 
 
3.4.1. Optimization Studies 
 
Our studies were initiated by probing different conditions for the envisioned 
cobaltaelectro-catalyzed C–H allylation with inactivated alkene 54b (Table 3.4). After 
considerable preliminary experimentations, we were delighted to observe that the 
allylated product 70ba was formed by cobaltaelectro-cataylsis at 4.0 mA in GVL, with 
NaOPiv as the additive at 100 °C (entry 1). A larger access of nBu4NPF6 electrolyte did 
not affect the electrolysis process (entries 2-3). Lowering the additive amount from 2 
equivalent to 1 equivalent decreased the yield of desired product (entry 4). While 
applying higher current in cobaltaelectro-catalyzed allylation failed to achieve a higher 






Result and Discussion 
75 
 
Table 3.4. Optimization of cobaltaelectro-catalyzed C–H allylation.[a] 
 
Entry Deviation from standard condition Yield [%] 
1 none 58 
2 0.50 mmol of nBu4NPF6 55 
3 1.0 mmol of nBu4NPF6 56 
4 1.0 equiv of NaOPiv 32 
5 8.0 mA, 7 h 42 
6 6.0 mA, 9 h 48 
[a] Reaction conditions: Undivided cell, 54b (0.50 mmol), 13a (1.5 mmol), Co(OAc)2∙4H2O 
(10 mol %), NaOPiv (2.0 equiv), nBu4NPF6 (0.25 mmol), GVL (4.0 mL), constant current at 
4.0 mA, 14 h, CF anode, Pt-plate cathode, under ambient air. 
 
3.4.2. Scope of Cobaltaelectro-Catalyzed C–H Allylation 
 
With the optimized reaction conditions in hand, we explored the versatility of 
cobaltaelectro-catalyzed C–H allylation using non-activated n-octene 13a with different 
substituted benzamides 54 (Scheme 3.20). Diverse ortho-substituted benzamides 
54q-54v were evaluated and chemo-selectively delivered the corresponding allylated 
product 70 under electrochemical reaction conditions. Notably, synthetically-useful 
halide groups in benzamides 54t-54v were well tolerated by the cobaltaelectro-
catalyzed C–H allylation, which provided valuable application for further late-stage 
diversification. Quinoline amide 54w proved to be unsuitable in electrochemical cobalt 
allylation. 




Scheme 3.26. Cobaltaelectro-catalyzed C–H allylation of benzamides 54. [a] 
Co(OAc)2∙4H2O (20 mol %). 
 
Likewise, various non-activated alkenes 13 were tested in cobaltaelectro-catalyzed C–
H allylation (Scheme 3.27). Aliphatic alkenes 13b-13c proved to be applicable under 
electrochemical conditions, providing the allylated product with modest yield. 
Allylbiphenyl 13e and homoallylbenzene 13d olefins were well tolerated, chemo-
selectively transformed towards desired product. Unfortunately, para-functionalized 
allylbenzene 13f-13g failed to deliver the corresponding allylated benzamide product 
70. 
 




Scheme 3.27. Cobaltaelectro-catalyzed C–H allylation of alkene 13. [a] Co(OAc)2∙4H2O 
(20 mol %). 
 
3.4.3. Mechanistic Studies 
3.4.3.1. Headspace GC Analysis 
 
Intrigued by the unique catalytic performance of electrochemical cobalt allylation, we 
became attracted to illuminate the catalyst’s mode of action. The mechanistic studies 
were initiated with headspace GC analysis to confirm the byproduct H2 formation 
during the reduction process at the cathode (Scheme 3.28).[119, 121] 
 
 
Scheme 3.28. Headspace GC analysis for cobaltaelectro-catalyzed allylation.  




3.4.3.2. Cyclic Voltammetry Studies 
 
Thereafter, cyclic voltammetry studies were preformed to gain mechanistic insights of 
oxidation and reduction events during cobaltaelectro-catalyzed C–H allylation (figure 
3.5). The oxidation potential of benzamide 54b was found at 1.46 V versus SCE, while 
the olefin 13a revealed no relevant oxidation. After addition of substrate 54b to the 
cobalt(II) catalyst, a significant oxidation potential was showed at 1.13 V versus SCE, 
which is lower than the oxidation potential of the benzamide 54b itself. These findings 
support an anodic single-electron oxidation happening to the cobalt(II) complex 123, 
and forming catalytic active cobalt(III) species 124, which is in good agreement with 
our previous reports on CV studies on cobaltaelectro-cataylsis.[93, 119] 
 





Figure 3.5. Cyclic voltammograms at 100 mV/s: General condition: MeCN, 0.1 M 
nBu4NPF6, 5 mM substrates. 
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3.4.4. Proposed Mechanism 
 
Based on our mechanistic findings, a plausible catalytic cycle for cobaltaelectro-
catalyzed C–H allylation is proposed herein (sheme 3.26). After adding the benzamide 
substrate 54, a cobalt(II) intermediate 123 is formed, which undergoes the single-
electron oxidation to generate the cobalt(III) complex 124. Further carboxylate-
assisted C–H cleavage and insertion of olefin 13 provide cobalt(III) species 127. 
Reductive elimination releases desired allylated product 70 and cobalt(I) complex 128. 
Finally, the catalytically active cobalt(III) species 124 is regenerated by anodic 
oxidation. 
 




Scheme 3.26. Pausible catalytic cycle.  
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4. Summary and Outlook 
Oxidative C–H activation has been considered as an increasingly powerful platform for 
organic synthesis, with applications to material sciences, late-stage diversifications 
and pharmaceutical industries. Merging with metallaelectro-catalysis, the sustainability 
of oxidative C–H activation has been significantly advanced by replacing the often toxic, 
stoichiometric amount of traditional chemical oxidant with green, sustainable electricity. 
In this context, electrochemical C–H activation approaches fulfill the inherent nature of 
resource economy. Despite major progress on noble transition metals, namely, 
palladium, iridium, ruthenium, and rhodium in electrochemical C–H activation, our 
focus has shifted to inexpensive, earth-abundant 3d base metals catalyzed 
electrochemical oxidative C–H activation. Especially less expensive and less toxic 
cobalt and copper catalysts further develop the environmentally friendly nature of 
oxidative electrochemical C–H activation. 
 
In the first project, we disclosed the first electrochemical alkyne annulation by 3d 
transition-metal-catalyzed C–H/N–H activation under ambient reaction conditions. The 
mild C–H/N–H functionalization occurred efficiently with full tolerance of H2O at room 
temperature for arenes and alkenes alike (scheme 4.1). Utilizing a versatile cobalt-
catalysis regime, a sustainable isoquinolone synthesis was achieved with resource-
economical electricity as external oxidant. Ample substrate scope with respect to 
functionalized benzamides, alkenes and alkynes were proved to be applicable in 
cobaltaelectro-catalysis. Detailed mechanistic studies illuminated a base-assisted 
internal electrophilic substitution (BIES) pathway, a facile C–H cleavage and an 
organometallic alkyne annulation process were involved in the catalytic cycle.  
 




Scheme 4.1. Water-tolerant cobaltaelectro-catalyzed C–H/N–H activation at room 
temperature. 
 
In the second project, the first electrochemical oxidative cascade annulation was 
achieved by copper-catalyzed C–H alkynylation (scheme 4.2). The cupraelectro-
catalysis enabled the bioactive isoindolone synthesis in the absence of sacrificial 
oxidants and generated molecular hydrogen as sole by-product. Thus, the versatile 
cupraelectro-catalyzed domino regime enabled excellent access to synthetically useful 
functional groups and broad substrate scope, including electron-deficient benzamides. 
Applying the earth-abundant and non-toxic copper-catalysis manifold, decarboxylative 
metallaelectro-catalysis for C–H/C–C functionalization has been realized in a similar 
fashion. Further mechanistic studies revealed the key C–H alkynylation step in 
cupraelectro-catalysis manifold. 
 




Scheme 4.2. Cupraelectro-catalyzed cascade annulation by C–H alkynylation and 
decarboxylative C–H/C–C manifolds. 
 
In the third project, we reported the first electrochemical cobalt-catalyzed C–H 
acyloxylation (scheme 4.3). Enabled by versatile cobaltaelectro-catalysis, 
oxygenations of functionalized benzamides were accomplished in the absence of toxic 
and expensive silver(I) oxidants, generating H2 as the sole by-product. A broad scope 
of substituted benzamides and carboxylic acids proved applicable in the 
cobaltaelectro-catalyzed C–H acyloxylation regime. Using the biomass-derived γ-
valerolactone as a renewable solvent, the sustainable nature of metallaelectro-
catalysis has been further advanced. 
 




Scheme 4.3. Cobaltaelectro-catalyzed C–H acyloxylation with carboxylic acids. 
 
In the fourth project, we disclosed the first cobaltaelectro-catalyzed C–H allylation with 
electronically non-activated alkenes (scheme 4.4). High levels of chemo-, position- and 
regio-selectivity have been achieved by the versatile cobaltaelectro-catalysis. Instead 
of stoichiometric amount of sacrificial chemical oxidants, sustainable electricity has 
been applied in C–H allylation. The cobaltaelectro-catalysis was characterized by a 
broad substrate scope and excellent functional group tolerance, and proceeded 
efficiently in biomass-derived green γ-valerolactone (GVL) as the reaction media. 
 
 
Scheme 4.4. Cobaltaelectro-catalyzed C–H allylation with nonactivated alkene. 
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With the successful applications of 3d transition metal catalyzed electrochemical C–H 
activations displayed herein, great potential of merging C–H activation with 
metallaelectro-catalysis has been highlighted. Further developments of sustainable 
approaches for oxidative C–H transformations with environmentally-benign electricity 
can be expected in the near future. New strategies to develop novel electrochemical 
C–H activation can be applied to achieve full energy and atom economy, such as 
paired electrolysis[128] and photoelectrocatalysis.[129] Other approaches applied in 
electrolysis, for example electrode materials design[130] and artificial intelligence[131] 
assisted reaction development, also provided unique synthetic possibilities to achieve 





5. Experiment Section 
5.1 General Remarks 
 
The catalysis in water or under an atmosphere of air was conducted in sealed tubes 
or Schlenk tubes. Unless otherwise noted, other reactions were performed under N2 
atmosphere using pre-dried glassware and standard Schlenk techniques. If not 
otherwise noted, yields refer to isolated compounds, estimated to be >95% pure as 
determined by 1H-NMR. 
 
Vacuum 
The following pressures were measured on the used vacuum pump and were not 
corrected: membrane pump vacuum (MPV): 0.5 mbar, oil pump vacuum (OPV): 0.1 
mbar. 
 
Melting Points (M.p.) 
Melting points were measured using a Stuart® Melting Point Apparatus SMP3 from 
BARLOWORLD SCIENTIFIC. The reported values are uncorrected. 
 
Chromatography 
Analytical thin layer chromatography (TLC) was performed on 0.25 mm silica gel 60F-
plates (MACHEREY-NAGEL) with 254 nm fluorescent indicator from MERCK. Plates 
were visualized under UV-light or developed by treatment with a KMnO4 solution 
followed by careful applying a heat gun. Chromatographic purification of products was 
accomplished by flash column chromatography on MERCK silica gel, grade 60 (0.040-
0.063 mm and 0.063-0.200 mm). 
 
Gas Chromatograpgy (GC) 
The conversions of the reactions were monitored applying coupled gas 




5971, 5890 Series II with mass detector HP 5972 from HEWLETT-PACKARD and 
7890A GC-System with mass detector 5975C (Triplex-Axis-Detector) from AGILENT 
TECHNOLOGIES equipped with HP-5MS columns (30 m × 0.25 mm × 0.25 m) were 
used. 
 
Gel permeation chromatography (GPC) 
GPC purifications were performed on a JAI system (JAI-LC-9260 II NEXT) equipped 
with two sequential columns (JAIGEL-2HR, gradient rate: 5.000; JAIGEL-2.5HR, 
gradient rate: 20.000; internal diameter = 20 mm; length = 600 mm; Flush rate = 10.0 




Infrared spectra was recorded at a BRUKER Alpha-P ATR FT-IR spectrometer. Liquid 
samples were measured as a film and solid samples were measured neat. The 
analysis of the spectra was carried out using the software from BRUKER OPUS 6. The 
absorption is given in wave numbers (cm-1) and the spectra were recorded in the range 
of 4000-400 cm-1. In situ-IR studies were performed on METTLER TOLEDO ReactIRTM 
15 with an iC IR 4.3 software. 
 
Mass Spectrometry 
Electrospray Ionization high resolution mass spectra were recorded on a quadrupole - 
time-of-flight instrument maXis and a time-of-flight mass spectrometer micrOTOF both 
from BRUKER DALTONIK. 
 
Nuclear Magnetic Resonance Spectroscopy (NMR) 
Nuclear magnetic resonance (NMR) spectra were recorded on VARIAN Inova 500, 600, 
VARIAN Mercury 300, VX 300, VARIAN Avance 300, VARIAN VNMRS 300 and 




as δ-values in ppm relative to the residual proton peak of the deuterated solvent or its 
carbon atom, respectively. 1H and 13C NMR spectra were referenced using the residual 
proton or solvent carbon peak (see table), respectively. 13C and 19F NMR were 
measured as proton-decoupled spectra. 
 
 1H-NMR 13C-NMR 
CDCl3 7.26 77.16 
[D]6-DMSO 2.50 39.52 
 
The observed resonance-multiplicities were described by the following abbreviations: 
s (singlet), d (doublet), t (triplet), q (quartet), hept (heptet), m (multiplet) or analogous 
representations. The coupling constants J are reported in Hertz (Hz). Analysis of the 
recorded spectra was carried out with MestReNova 10 software. 
 
Electrochemistry 
Platinum electrodes (10 mm × 25 mm × 0.125 mm, 99.9%; obtained from ChemPur® 
Karlsruhe, Germany) and CF electrodes (10 mm × 25 mm × 6 mm, SIGRACELL®GFA 
6 EA, obtained from SGL Carbon, Wiesbaden, Germany) were connected using 
stainless steel adapters. Electrolysis was conducted using an AXIOMET AX-3003P 
potentiostat in constant current mode, CV studies were performed using a Metrohm 
Autolab PGSTAT204 workstation and Nova 2.0 software. Divided cells separated by a 




Solvents for column chromatography or reactions not sensitive to air and moisture 
were distilled under reduced pressure prior to use. All solvents for reactions involving 
air- or moisture-sensitive compounds were dried, distilled and stored under inert 
atmosphere according to the following procedures: 




dimethylformamide (DMF) and ethyl ether (Et2O) were purified using a solvent 
purification system (SPS-800) from M. BRAUN. 
1,2-Dichloroethane (DCE), N-methyl-2-pyrrolidone (NMP), N,N- 
dimethylacetamide (DMA), dimethylsulfoxide (DMSO) and γ-Valerolactone (GVL) 
were dried over CaH2 for 8 h, degassed and distilled under reduced pressure under 
N2. 
Methanol (MeOH), t-amylalcohol (t-AmOH) and 1,4-dioxane were dried over Na for 
8 h, degassed and distilled under reduced pressure under N2. 
2,2,2-Trifluoroethanol (TFE) was stirred over CaSO4 and distilled under reduced 
pressure. 
Acetonitrile (MeCN) was dried over 3 Å molecular sieves and degassed using multiple 
cycles of Freeze-Pump-Thaw degassing procedure. 
Water (H2O) was degassed by repeated Freeze-Pump-Thaw degassing procedure. 
Isopropyl alcohol (i-PrOH) was used as received from Merck. 
 
Chemicals 
Chemicals obtained from commercial sources with purity above 95% were used 
without further purification. The following compounds are known and were synthesized 
according to previously described methods: 
 





Chemicals obtained from commercial sources with purity above 95% were used 
without further purification. The following compounds are known and were synthesized 
according to previously described methods: 
 
2-pyridyl-N-oxide benzamides 56,[79] quinoline benzamides 54,[132] oxazoline 





The following compounds were obtained by the generous courtesy of the following 
persons: 
 
Karsten Rauch: [RuCl2(p-cymene)]2, [Cp*RhCl2]2, dry and/or degassed DCE, NMP, 
H2O, DMA solvents. 
Shou-Kun Zhang: Benzamides 54f-54j, 54n, 54p, deuterated compound [D5]-54a. 
Dr. Ruhuai Mei: Benzamides 56a., deuterated compound [D5]-56a. 







5.2 General Procedures 
 
General Procedure A: Water-Tolerant Cobaltaelectro-Catalyzed C–H/N–H 
Activation at Room Temperature 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
56 (0.50 mmol, 1.0 equiv), alkyne 76 (1.00 mmol, 2.0 equiv), NaOPiv (124 mg, 1.0 
mmol, 2.0 equiv) and Co(OAc)2∙4H2O (12.7 mg, 10 mol %) were placed in a 20 mL cell 
and dissolved in 10 mL of H2O/MeOH (1:1). Electrocatalysis was performed at ambient 
temperature of 23 °C with a constant current of 4.0 mA maintained for 16 h. The 
reaction was stopped by adding saturated aqueous NaHCO3 (10 mL). The CF anode 
was washed with CH2Cl2 (3 × 10 mL) in an ultrasonic bath. The washings were added 
to the reaction mixture and the combined phases were extracted with CH2Cl2 (4 × 10 
mL), then dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography on silica gel afforded the corresponding products 104. 
 
General Procedure B: Cupraelectro-Catalyzed Cascade Annulation by C–H 
Alkynylation and Decarboxylative C–H/C–C Manifolds 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54 (0.25 mmol, 1.0 equiv), alkyne 76 or alkynyl carboxylic acids 112 (0.50 mmol, 2.0 
equiv), NaOPiv (31 mg, 0.25 mmol, 1.0 equiv) and Cu(OAc)2∙H2O (2.5 mg, 5.0 mol %) 
were placed in a 10 mL cell and dissolved in DMA (4.0 mL). Electrocatalysis was 
performed at 100 °C with a constant current of 6.0 mA maintained for 6 h. At ambient 
temperature, saturated aqueous NaHCO3 (4.0 mL) was added. The CF anode was 
washed with EtOAc (3 × 10 mL) in an ultrasonic bath. The washings were added to the 




then dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography on silica gel afforded the corresponding products 110. 
 
General Procedure C: Cobaltaelectro-Catalyzed C–H Acyloxylation with 
Carboxylic Acids 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54 (0.25 mmol, 1.0 equiv), carboxylic acid 66 (0.50 mmol, 2.0 equiv), Na2CO3 (53 mg, 
0.5 mmol, 2.0 equiv) and Co(OAc)2∙4H2O (12.7 mg, 20 mol %) were placed in a 10 mL 
cell and dissolved in GVL (3.0 mL). Electrocatalysis was performed at 80 °C with a 
constant current of 5.0 mA maintained for 6 h. At ambient temperature, the reaction 
was stopped by adding saturated aqueous NaHCO3 (4.0 mL). The CF anode was 
washed with acetone (3 × 10 mL) in an ultrasonic cleaner. The washings were added 
to the reaction mixture and the combined organic phases were evaporated. After 
evaporation of solvents, the mixture was extracted with pentane (4 × 10 mL) and 
successively with EtOAc (3 × 10 mL) then dried over Na2SO4. Evaporation of the 
solvent and subsequent column chromatography on silica gel afforded the products 67. 
 
General Procedure D: Cobaltaelectro-Catalyzed C–H Allylation with 
Nonactivated Alkene 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54 (0.50 mmol, 1.0 equiv), alkene 13 (1.5 mmol, 3.0 equiv), NaOPiv (124 mg, 1.0 mmol, 
1.0 equiv) , nBu4NPF6 (97.0 mg, 0.25 mmol, 0.50 equiv) and Co(OAc)2∙4H2O (12.7 mg, 
10 mol %) were placed in a 10 mL cell and dissolved in GVL (4.0 mL). Electrocatalysis 
was performed at 100 °C with a constant current of 4.0 mA maintained for 14 h. At 




(4 mL). The CF anode was washed with acetone (3 × 10 mL) in an ultrasonic cleaner. 
The washings were added to the reaction mixture and evaporated. The mixture was 
extracted with pentane (4 × 10 mL) and successively with EtOAc (3 × 10 mL) then 
dried over Na2SO4. Evaporation of the solvent and subsequent column 





5.3 Experimental Procedures and Analytical Data 
5.3.1. Water-Tolerant Cobaltaelectro-Catalyzed C–H/N–H Activation 
at Room Temperature 
5.3.1.1. Characterization Data 
 
   
2-[1-Oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104aa) 
The general procedure A was followed using benzamide 56a (107 mg, 0.50 mmol) and 
alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 3:1) yielded 104aa (119 mg, 76%) as a white solid. M. p.: 225–226 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.46–8.37 (m, 1H), 8.23–8.14 (m, 1H), 7.73–7.63 (m, 
1H), 7.53 (dt, J = 7.2, 0.7 Hz, 1H), 7.51–7.44 (m, 1H), 7.44–7.35 (m, 2H), 7.28–7.16 
(m, 3H), 7.16–7.08 (m, 2H), 7.08–7.00 (m, 1H), 6.59 (s, 1H). 13C-NMR (125 MHz, 
CDCl3): δ = 161.7 (Cq), 145.3 (Cq), 142.4 (Cq), 139.8 (CH), 136.9 (Cq), 134.7 (Cq), 133.2 
(CH), 128.9 (CH), 128.2 (CH), 128.0 (CH), 127.8 (CH), 127.5 (CH), 126.9 (CH), 126.2 
(CH), 125.3 (CH), 124.9 (CH), 124.8 (Cq), 107.9 (CH). IR (ATR): 1664, 1624, 1490, 
1261, 889, 843, 764, 526 cm−1. MS (ESI) m/z (relative intensity): 353 (5), 337 (30) 
[M+Na]+, 315 (60) [M+H]+, 221 (20). HR-MS (ESI) m/z calcd for C20H15N2O2 
[M+H]+: 315.1128, found: 315.1128.  
   
3-Phenyl-2-(quinolin-8-yl)-isoquinolin-1(2H)-one (104ba) 
The slightly changed general procedure A was followed using benzamide 54a (124 mg, 




mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ba (34 mg, 20%) as a white solid. M. p.: 210–211 °C. 1H-NMR (400 MHz, 
CDCl3): δ = 8.90 (dd, J = 4.2, 1.7 Hz, 1H), 8.51–8.45 (m, 1H), 8.08 (dd, J = 8.3, 1.7 Hz, 
1H), 7.75–7.67 (m, 2H), 7.63–7.59 (m, 1H), 7.54–7.48 (m, 2H), 7.44–7.39 (m, 1H), 
7.36 (dd, J = 8.3, 4.2 Hz, 1H), 7.15–7.09 (m, 2H), 7.06–6.99 (m, 1H), 6.98–6.92 (m, 
2H), 6.65 (s, 1H). 13C-NMR (100 MHz, CDCl3): δ = 163.2 (Cq), 150.9 (CH), 144.8 (Cq), 
144.5 (Cq), 137.3 (Cq), 137.2 (Cq), 136.3 (Cq), 136.0 (CH), 132.6 (CH), 130.7 (CH), 
128.7 (CH), 128.6 (CH), 128.4 (CH), 127.9 (CH), 127.2 (CH), 126.6 (CH), 126.1 (CH), 
125.7 (CH), 125.5 (Cq), 121.5 (CH), 107.3 (CH). IR (ATR): 3058, 1656, 1624, 1594, 
1382, 1156, 829, 760 cm−1. MS (EI) m/z (relative intensity): 348 (100) [M]+, 347 (30), 
319 (20), 271 (95), 242 (10), 217 (15). HR-MS (EI) m/z calcd for C24H16N2O 
[M]+: 348.1263, found: 348.1268.  
 
2-[6-Methyl-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104ca) 
The general procedure A was followed using benzamide 56c (114 mg, 0.50 mmol) and 
alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 3:1) yielded 104ca (121 mg, 73%) as a white solid. M. p. = 220–
221 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.29 (d, J = 8.0 Hz, 1H), 8.21-8.10 (m, 1H), 
7.43–7.36 (m, 2H), 7.34–7.27 (m, 2H), 7.25–7.17 (m, 3H), 7.17–7.10 (m, 2H), 7.06–
6.97 (m, 1H), 6.52 (s, 1H), 2.48 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 161.8 (Cq), 
145.7 (Cq), 143.9 (Cq), 142.5 (Cq), 140.0 (CH), 137.0 (Cq), 134.8 (Cq), 128.8 (CH), 
128.5 (CH), 128.2 (CH), 128.0 (CH), 127.8 (CH), 127.6 (CH), 126.0 (CH), 125.1 (CH), 
125.0 (CH), 122.6 (Cq), 107.8 (CH), 21.9 (CH3). IR (ATR): 3059, 1664, 1626, 1486, 
1260, 909, 769, 727 cm-1. MS (EI) m/z (relative intensity): 328 (25) [M]+, 283 (15), 208 







The general procedure A was followed using benzamide 56d (135 mg, 0.50 mmol) and 
alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 3:1) yielded 104da (115 mg, 62%) as a white solid. M. p.: 243–244 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.35 (d, J = 8.5 Hz, 1H), 8.20 (d, J = 6.3 Hz, 1H), 7.56 
(dd, J = 8.5, 1.9 Hz, 1H), 7.52 (d, J = 1.8 Hz, 1H), 7.45–7.34 (m, 2H), 7.29–7.17 (m, 
3H), 7.17–7.09 (m, 2H), 7.08–6.99 (m, 1H), 6.60 (s, 1H), 1.40 (s, 9H). 13C-NMR (125 
MHz, CDCl3): δ = 161.7 (Cq), 156.9 (Cq), 145.5 (Cq), 142.4 (Cq), 139.9 (CH), 136.9 (Cq), 
134.9 (Cq), 128.8 (CH), 128.1 (CH), 128.0 (CH), 127.8 (CH), 127.6 (CH), 125.2 (CH), 
125.1 (CH), 124.8 (CH), 122.5 (Cq), 122.3 (CH), 108.4 (CH), 35.2 (Cq), 31.1 (CH3). IR 
(ATR): 1673, 1627, 1608, 1490, 1272, 932, 766, 701 cm−1. MS (EI) m/z (relative 
intensity): 370 (15) [M]+, 354 (12), 250 (15), 235 (20), 181 (100), 78 (35). HR-MS (EI) 




The slightly modified general procedure A was followed using benzamide 56e (141 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ea (97.2 mg, 51%) as a white solid. M. p.: 190–191 °C. 1H-NMR (400 MHz, 
CDCl3): δ = 8.57–8.52 (m, 1H), 8.24 (d, J = 6.4 Hz, 1H), 7.87–7.82 (m, 1H), 7.74–7.66 




6.66 (s, 1H). 13C-NMR (100 MHz, CDCl3): δ = 161.1 (Cq), 145.1 (Cq), 144.3 (Cq), 140.1 
(CH), 137.1 (Cq), 134.9 (q, 2JC–F = 32.6 Hz, Cq), 134.3 (Cq), 129.5 (CH), 129.5 (CH), 
128.4 (CH), 127.9 (CH), 127.6 (CH), 127.1 (Cq), 125.7 (CH), 125.3 (CH), 125.0 (q, 1JC–
F = 273.4 Hz, Cq), 123.6 (q, 3JC–F = 3.9 Hz, CH), 123.1 (q, 3JC–F = 3.2 Hz, CH), 107.5 
(CH). 19F-NMR (376 MHz, CDCl3) δ = –63.13 (s). IR (ATR): 1672, 1490, 1431, 1319, 
1126, 920, 729, 698 cm−1. MS (EI) m/z (relative intensity): 382 (30) [M]+, 365 (20), 337 
(20), 262 (30), 181 (100), 78 (85). HR-MS (EI) m/z calcd for C21H13F3N2O2 
[M]+: 382.0929, found: 382.0928.  
 
2-[6-Fluoro-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104fa) 
The general procedure A was followed using benzamide 56f (116 mg, 0.50 mmol) and 
alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 6:1) yielded 104fa (110 mg, 66%) as a white solid. M. p.: 190–191 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.46–8.37 (m, 1H), 8.18 (d, J = 5.8 Hz, 1H), 7.42–7.34 
(m, 2H), 7.29–7.19 (m, 3H), 7.19–7.12 (m, 3H), 7.12–7.10 (m, 1H), 7.09–7.01 (m, 1H), 
6.53 (s, 1H). 13C-NMR (125 MHz, CDCl3): δ = 165.9 (d, 1JC–F = 254.2 Hz, Cq), 161.2 
(Cq), 145.3 (Cq), 144.1 (Cq), 140.1 (CH), 139.4 (d, 3JC–F = 10.6 Hz, Cq), 134.5 (Cq), 
131.8 (d, 3JC–F = 10.0 Hz, CH), 129.3 (CH), 128.3 (CH), 127.9 (CH), 127.6 (CH), 125.6 
(CH), 125.1 (CH), 121.5 (d, 4JC–F = 1.9 Hz, Cq), 115.7 (d, 2JC–F = 23.4 Hz, CH), 111.3 (d, 
2JC–F = 22.2 Hz, CH), 107.4 (d, 4JC–F = 3.1 Hz, CH). 19F-NMR (471 MHz, CDCl3): δ = –
104.73 (td, J = 8.9, 5.8 Hz). IR (ATR): 1671, 1617, 1504, 1482, 1431, 1272, 868, 
758 cm−1. MS (ESI) m/z (relative intensity): 417 (5), 371 (5), 359 (4), 355 (100) [M+Na]+, 
333 (30) [M+H]+. HR-MS (ESI) m/z calcd for C20H14FN2O2 [M+H]+: 333.1034, 






The slightly modified general procedure A was followed using benzamide 56g (146 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ga (127 mg, 65%) as a white solid. M. p.: 212–215 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.24 (d, J = 8.6 Hz, 1H), 8.19 (d, J = 6.2 Hz, 1H), 7.69 (d, J = 1.9 Hz, 1H), 
7.56 (dd, J = 8.6, 1.9 Hz, 1H), 7.41–7.34 (m, 2H), 7.30–7.17 (m, 3H), 7.17–7.09 (m, 
2H), 7.09–7.00 (m, 1H), 6.49 (s, 1H). 13C-NMR (125 MHz, CDCl3): δ = 161.2 (Cq), 145.1 
(Cq), 144.0 (Cq), 139.9 (CH), 138.3 (Cq), 134.3 (Cq), 130.2 (CH), 130.0 (CH), 129.2 
(CH), 128.6 (CH), 128.4 (Cq), 128.1 (CH), 127.7 (CH), 127.5 (CH), 125.4 (CH), 124.9 
(CH), 123.5 (Cq), 106.7 (CH). IR (ATR): 1666, 1627, 1491, 1428, 1368, 1255, 900, 
727 cm−1. MS (EI) m/z (relative intensity): 394 (10) [M+] (81Br), 392 (10) [M+] (79Br), 377 
(15), 349 (15), 274 (10), 268 (15), 181 (100), 165 (10), 78 (55). HR-MS (EI) m/z calcd 
for C20H1379BrN2O2 [M+] 392.0160, found 392.0160.  
 
2-[6-Iodo-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104ha) 
The slightly modified general procedure A was followed using benzamide 56h (170 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 6:1) 
yielded 104ha (114 mg, 52%) as a white solid. M. p.: 246–248 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.19 (d, J = 6.3 Hz, 1H), 8.09 (d, J = 8.5 Hz, 1H), 7.94 (d, J = 1.6 Hz, 1H), 




2H), 7.10–7.01 (m, 1H), 6.47 (s, 1H). 13C-NMR (100 MHz, CDCl3): δ = 161.7 (Cq), 145.3 
(Cq), 144.0 (Cq), 140.1 (CH), 138.4 (Cq), 136.0 (CH), 135.1 (CH), 134.5 (Cq), 129.8 
(CH), 129.3 (CH), 128.3 (CH), 127.8 (CH), 127.6 (CH), 125.5 (CH), 125.0 (CH), 124.1 
(Cq), 106.6 (CH), 101.4 (Cq). IR (ATR): 1667, 1625, 1598, 1584, 1269, 895, 764, 
728 cm−1. MS (EI) m/z (relative intensity): 440 (25) [M]+, 423 (10), 395 (15), 320 (20), 
181 (100), 78 (55). HR-MS (EI) m/z calcd for C20H13IN2O2 [M]+: 440.0022, 
found: 440.0022.  
 
2-[8-Fluoro-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104ia) 
The slightly modified general procedure A was followed using benzamide 56i (116 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ia (92.8 mg, 56%) as a colorless oil. 1H-NMR (500 MHz, CDCl3): δ = 8.27–
7.97 (m, 1H), 7.62 (td, J = 8.0, 4.8 Hz, 1H), 7.45–7.36 (m, 2H), 7.34–7.29 (m, 1H), 
7.29–7.20 (m, 4H), 7.20–7.15 (m, 1H), 7.12 (ddd, J = 11.2, 8.1, 1.1 Hz, 1H), 7.07–6.88 
(m, 1H), 6.56 (d, J = 2.0 Hz, 1H). 13C-NMR (125 MHz, CDCl3): δ = 162.9 (d, 1JC–F = 
266.2 Hz, Cq), 159.1 (d, 3JC–F = 4.7 Hz, Cq), 143.9 (Cq), 140.4 (CH), 139.7 (Cq), 134.4 
(Cq), 134.4 (d, 3JC–F = 9.8 Hz, CH), 132.0 (CH), 129.3 (CH), 129.1 (CH), 128.3 (CH), 
127.9 (Cq), 127.8 (CH), 125.2 (CH), 122.1 (d, 4JC–F = 4.5 Hz, CH), 114.0 (d, 2JC–F = 5.8 
Hz, CH), 114.0 (d, 2JC–F = 21.3 Hz, Cq), 107.3 (d, 4JC–F = 2.6 Hz, CH). 19F-NMR (471 
MHz, CDCl3) δ = –109.10 (dd, J = 11.8, 4.8 Hz). IR (ATR): 1675, 1630, 1612, 1492, 
1432, 1034, 838, 763 cm−1. MS (EI) m/z (relative intensity): 332 (25) [M]+, 316 (30), 
287 (40), 212 (20), 181 (100), 78 (80). HR-MS (EI) m/z calcd for C20H13FN2O2 







The slightly modified general procedure A was followed using benzamide 56j (114 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ja/104ja’ (146 mg, 89%) as a white solid. M. p.: 230–232 °C. The ratio of 
104ja/104ja’ (79:21) was determined by 1H-NMR spectroscopy. Resonances are 
reported for 104ja. 1H-NMR (500 MHz, CDCl3): δ = 8.24–8.20 (m, 2H), 7.53 (dd, J = 
8.0, 1.8 Hz, 1H), 7.46 (d, J = 8.1 Hz, 1H), 7.41–7.38 (m, 2H), 7.25–7.19 (m, 3H), 7.15–
7.11 (m, 2H), 7.08–7.06 (m, 1H), 6.58 (s, 1H), 2.50 (s, 3H). 13C-NMR (125 MHz, CDCl3): 
δ = 161.9 (Cq), 145.6 (Cq), 141.6 (Cq), 140.0 (CH), 137.3 (Cq), 135.0 (Cq), 134.8 (CH), 
134.7 (Cq), 128.9 (CH), 128.2 (CH), 128.0 (CH), 127.9 (CH), 127.7 (CH), 126.2 (CH), 
125.3 (CH), 125.0 (CH), 124.8 (Cq), 108.0 (CH), 21.5 (CH3). IR (ATR): 1669, 1491, 
1433, 1376, 1271, 848, 760, 706 cm−1. MS (ESI) m/z (relative intensity): 353 (24), 351 
(100) [M+Na]+, 340 (5), 329 (18) [M+H]+. HR-MS (ESI) m/z calcd for C21H17N2O2 
[M+H]+: 329.1285, found: 329.1285. 
 
2-[5,7-Dimethyl-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104ka) 
The general procedure A was followed using benzamide 104k (121 mg, 0.50 mmol) 
and alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica 
gel (CH2Cl2/acetone 3:1) yielded 104ka (132 mg, 77%) as a white solid. M. p.: 238–
239 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.24–8.17 (m, 1H), 8.15–8.07 (m, 1H), 7.47–




1H), 6.68 (d, J = 0.8 Hz, 1H), 2.51 (s, 3H), 2.45 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ 
= 162.0 (Cq), 145.6 (Cq), 141.1 (Cq), 139.9 (CH), 136.7 (Cq), 135.6 (CH), 135.2 (Cq), 
133.4 (Cq), 133.4 (Cq), 128.8 (CH), 128.1 (CH), 128.0 (CH), 127.6 (CH), 125.9 (CH), 
125.2 (CH), 125.0 (Cq), 124.8 (CH), 104.8 (CH), 21.4 (CH3), 18.9 (CH3). IR (ATR): 1711, 
1668, 1491, 1268, 843, 755, 703, 577 cm−1. MS (EI) m/z (relative intensity): 342 (10) 
[M]+, 326 (30), 297 (20), 222 (28), 181 (100), 78 (70). HR-MS (EI) m/z calcd for 
C22H18N2O2 [M]+: 342.1368, found: 342.1363. 
 
2-[5,7-Dimethoxy-1-oxo-3-phenylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104la) 
The general procedure A was followed using benzamide 56l (137 mg, 0.50 mmol) and 
alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 3:1) yielded 104la (150 mg, 80%) as a white solid. M. p.: 246–247 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.25–8.18 (m, 1H), 7.42 (d, J = 2.4 Hz, 1H), 7.40–7.34 
(m, 2H), 7.23–7.15 (m, 3H), 7.15–7.06 (m, 2H), 7.06–6.99 (m, 1H), 6.92 (d, J = 0.6 Hz, 
1H), 6.73 (d, J = 2.3 Hz, 1H), 3.89 (s, 3H), 3.88 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ 
= 161.2 (Cq), 159.4 (Cq), 155.9 (Cq), 145.7 (Cq), 139.8 (CH), 139.4 (Cq), 135.2 (Cq), 
128.6 (CH), 128.0 (CH), 127.9 (CH), 127.4 (CH), 126.4 (Cq), 125.2 (CH), 124.7 (CH), 
122.6 (Cq), 103.8 (CH), 102.4 (CH), 99.6 (CH), 55.9 (CH3), 55.6 (CH3). IR (ATR): 1664, 
1606, 1488, 1433, 1366, 1046, 784, 753 cm−1. MS (EI) m/z (relative intensity): 374 (15) 
[M]+, 330 (10), 269 (10), 254 (15), 181 (100), 78 (60). HR-MS (EI) m/z calcd for 







The general procedure A was followed using benzamide 56m (137 mg, 0.50 mmol) 
and alkyne 76a (102 mg, 1.00 mmol). Purification by column chromatography on silica 
gel (CH2Cl2/acetone 3:1) yielded 104ma (163 mg, 81%) as a white solid. M. p.: 219–
221 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.27–8.18 (m, 1H), 7.67 (s, 1H), 7.43–7.34 (m, 
2H), 7.25–7.17 (m, 3H), 7.17–7.11 (m, 1H), 7.11–7.00 (m, 2H), 6.84 (s, 1H), 4.00 (s, 
3H), 3.97 (s, 3H), 3.95 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 161.0 (Cq), 153.2 (Cq), 
147.8 (Cq), 146.6 (Cq), 145.6 (Cq), 140.6 (Cq), 139.9 (CH), 135.1 (Cq), 128.8 (CH), 
128.1 (CH), 127.9 (CH), 127.5 (CH), 126.7 (Cq), 125.2 (CH), 124.8 (CH), 120.8 (Cq), 
104.8 (CH), 102.3 (CH), 61.5 (CH3), 61.1 (CH3), 56.2 (CH3). IR (ATR): 1665, 1593, 
1483, 1430, 1377, 1129, 843, 758 cm−1. MS (EI) m/z (relative intensity): 404 (10) [M]+, 
388 (50), 373 (15), 195 (25), 181 (100), 78 (50). HR-MS (EI) m/z calcd for C23H20N2O5 
[M]+: 404.1372, found: 404.1384. 
 
3,4-Dimethyl-2-oxo-6-phenyl-2H-[1,2'-bipyridine]-2'-oxide (104na) 
The slightly modified general procedure A was followed using alkene 56n (96 mg, 0.50 
mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 1:1) 
yielded 104na (118 mg, 81%) as a white solid. M. p.: 202–204 °C. 1H-NMR (400 MHz, 
CDCl3): δ = 8.20 (d, J = 6.5 Hz, 1H), 7.41–7.29 (m, 2H), 7.26–7.16 (m, 3H), 7.16–7.09 
(m, 1H), 7.09–7.00 (m, 2H), 6.14 (s, 1H), 2.24 (s, 3H), 2.15 (s, 3H). 13C-NMR (100 MHz, 
CDCl3): δ = 162.1 (Cq), 147.2 (Cq), 145.7 (Cq), 144.3 (Cq), 140.0 (CH), 134.4 (Cq), 129.1 
(CH), 128.2 (CH), 127.7 (CH), 127.3 (CH), 125.4 (Cq), 125.3 (CH), 125.0 (CH), 111.2 
(CH), 20.0 (CH3), 12.4 (CH3). IR (ATR): 1654, 1551, 1490, 1430, 1267, 846, 767, 
702 cm−1. MS (EI) m/z (relative intensity): 292 (30) [M]+, 276 (15), 198 (100), 181 (45), 








The slightly modified general procedure A was followed using alkene 56o (109 mg, 
0.50 mmol) and alkyne 76a (102 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 1:1) 
yielded 104oa (82.4 mg, 52%) as a colorless oil. 1H-NMR (400 MHz, CDCl3): δ = 8.18 
(d, J = 6.4 Hz, 1H), 7.36–7.29 (m, 2H), 7.25–7.15 (m, 3H), 7.12 (td, J = 6.6, 3.0 Hz, 
1H), 7.09–7.00 (m, 2H), 6.05 (s, 1H), 2.74–2.43 (m, 4H), 1.87–1.69 (m, 4H). 13C-NMR 
(100 MHz, CDCl3): δ = 161.8 (Cq), 148.4 (Cq), 145.5 (Cq), 144.1 (Cq), 140.0 (CH), 134.5 
(Cq), 129.0 (CH), 128.2 (CH), 127.7 (CH), 127.4 (CH), 126.5 (Cq), 125.3 (CH), 125.0 
(CH), 110.0 (CH), 29.5 (CH2), 23.3 (CH2), 21.9 (CH2), 21.8 (CH2). IR (ATR): 2931, 1653, 
1490, 1432, 1264, 908, 842, 728 cm−1. MS (EI) m/z (relative intensity): 318 (25) [M]+, 
302 (15), 224 (100), 195 (20), 181 (65), 78 (60). HR-MS (EI) m/z calcd for C20H18N2O2 
[M]+: 318.1368, found: 318.1367. 
 
2-[1-Oxo-3-(p-tolyl)isoquinolin-2(1H)-yl]-pyridine-2-oxide (104ab) 
The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76b (116 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 2:1) 
yielded 104ab (135 mg, 82%) as a white solid. M. p.: 242–243 °C. 1H-NMR (300 MHz, 




1H), 7.52–7.45 (m, 1H), 7.32–7.25 (m, 2H), 7.19–7.06 (m, 3H), 7.04–6.98 (m, 2H), 
6.58 (s, 1H), 2.27 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 161.9 (Cq), 145.5 (Cq), 
142.6 (Cq), 139.9 (CH), 139.0 (Cq), 137.1 (Cq), 133.2 (CH), 131.9 (Cq), 128.8 (CH), 
128.3 (CH), 127.7 (CH), 127.6 (CH), 126.9 (CH), 126.1 (CH), 125.3 (CH), 124.9 (CH), 
124.8 (Cq), 107.8 (CH), 21.3 (CH3). IR (ATR): 1670, 1626, 1482, 1433, 1272, 1024, 
817, 760 cm−1. MS (EI) m/z (relative intensity): 328 (25) [M]+, 283 (15), 208 (30), 195 




The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76c (132 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ac (141 mg, 82%) as a white solid. M. p.: 228–230 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.44–8.38 (m, 1H), 8.25–8.19 (m, 1H), 7.72–7.64 (m, 1H), 7.56–7.51 (m, 
1H), 7.50–7.45 (m, 1H), 7.35–7.30 (m, 2H), 7.18–7.11 (m, 2H), 7.11–7.05 (m, 1H), 
6.76–6.70 (m, 2H), 6.57 (s, 1H), 3.74 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 162.0 
(Cq), 160.0 (Cq), 145.6 (Cq), 142.4 (Cq), 140.0 (CH), 137.2 (Cq), 133.3 (CH), 129.3 (CH), 
128.3 (CH), 127.7 (CH), 127.3 (Cq), 126.9 (CH), 126.2 (CH), 125.4 (CH), 125.1 (CH), 
124.8 (Cq), 113.6 (CH), 107.8 (CH), 55.1 (CH3). IR (ATR): 2359, 2010, 1670, 1511, 
1251, 1028, 762, 561 cm−1. MS (ESI) m/z (relative intensity): 368 (23), 367 (100) 
[M+Na]+, 345 (30) [M+H]+, 337 (5). HR-MS (ESI) m/z calcd for C21H17N2O3 






The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76d (170 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ad (110 mg, 58%) as colorless oil. 1H-NMR (300 MHz, CDCl3): δ = 8.45–
8.39 (m, 1H), 8.24–8.15 (m, 1H), 7.76–7.68 (m, 1H), 7.60–7.51 (m, 4H), 7.51–7.46 (m, 
2H), 7.23–7.16 (m, 2H), 7.16–7.09 (m, 1H), 6.61 (s, 1H). 13C-NMR (125 MHz, CDCl3): 
δ = 161.6 (Cq), 144.9 (Cq), 141.0 (Cq), 140.0 (CH), 138.2 (Cq), 136.6 (Cq), 133.4 (CH), 
131.0 (q, 2JC–F = 32.7 Hz, Cq), 128.4 (CH), 127.6 (CH), 127.5 (CH), 126.4 (CH), 125.7 
(CH), 125.5 (q, 1JC–F = 273.0 Hz, Cq), 125.2 (CH), 125.1 (Cq), 125.1 (q, 3JC–F = 4.0 Hz, 
CH), 124.9 (CH), 108.6 (CH). 19F-NMR (283 MHz, CDCl3) δ = –62.85 (S). IR (ATR): 
1669, 1491, 1321, 1262, 1123, 1020, 760, 730 cm−1. MS (EI) m/z (relative intensity): 
382 (20) [M]+, 337 (15), 262 (25), 249 (90), 193 (15), 78 (100). HR-MS (EI) m/z calcd 
for C21H13F3N2O2 [M]+: 382.0929, found: 382.0930. 
 
2-[5,7-Methoxy-1-oxo-3-n-propylisoquinolin-2(1H)-yl]-pyridine-2-oxide (104le) 
The slightly modified general procedure A was followed using benzamide 56l (137 mg, 
0.50 mmol) and alkyne 76e (68.1 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 1:1) 
yielded 104le (144 mg, 85%) as a yellow oil. 1H-NMR (300 MHz, CDCl3): δ = 8.44–
8.36 (m, 1H), 7.48–7.42 (m, 1H), 7.42–7.35 (m, 2H), 7.34 (d, J = 2.4 Hz, 1H), 6.76 (s, 




(m, 2H), 0.87 (t, J = 7.3 Hz, 3H). 13C-NMR (125 MHz, CDCl3): δ = 162.1 (Cq), 158.8 
(Cq), 155.4 (Cq), 144.7 (Cq), 140.5 (CH), 139.0 (Cq), 127.7 (CH), 125.9 (Cq), 125.8 (CH), 
125.1 (CH), 123.2 (Cq), 103.8 (CH), 99.4 (CH), 99.2 (CH), 55.9 (CH3), 55.7 (CH3), 34.1 
(CH2), 21.0 (CH2), 13.8 (CH3). IR (ATR): 2340, 2167, 1666, 1604, 1379, 1204, 1045, 
840 cm−1. MS (EI) m/z (relative intensity): 340 (15) [M]+, 323 (30), 294 (40), 279 (50), 




The slightly modified general procedure A was followed using benzamide 56l (137 mg, 
0.50 mmol) and alkyne 76f (82.2 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 1:1) 
yielded 104lf (131 mg, 74%) as a yellow oil. 1H-NMR (300 MHz, CDCl3): δ = 8.44–8.36 
(m, 1H), 7.48–7.41 (m, 1H), 7.41–7.35 (m, 2H), 7.34 (dd, J = 2.4, 0.6 Hz, 1H), 6.78–
6.74 (m, 1H), 6.70 (d, J = 2.4 Hz, 1H), 3.92 (s, 3H), 3.87 (s, 3H), 2.36–2.14 (m, 2H), 
1.58–1.46 (m, 2H), 1.31–1.21 (m, 2H), 0.82 (t, J = 7.3 Hz, 3H). 13C-NMR (125 MHz, 
CDCl3): δ = 162.1 (Cq), 158.8 (Cq), 155.4 (Cq), 144.7 (Cq), 140.5 (CH), 139.3 (Cq), 127.8 
(CH), 125.9 (Cq), 125.8 (CH), 125.1 (CH), 123.2 (Cq), 103.8 (CH), 99.4 (CH), 99.2 (CH), 
55.9 (CH3), 55.7 (CH3), 31.8 (CH2), 29.9 (CH2), 22.3 (CH2), 13.8 (CH3). IR (ATR): 2358, 
1668, 1509, 1431, 1379, 1048, 842, 765 cm−1. MS (EI) m/z (relative intensity): 354 (10) 
[M]+, 337 (40), 294 (45), 279 (50), 161 (100), 78 (40). HR-MS (EI) m/z calcd for 






The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76g (96.2 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ag (85.2 mg, 55%) as a yellow oil. 1H-NMR (400 MHz, CDCl3): δ = 8.43–
8.37 (m, 1H), 8.36–8.29 (m, 1H), 7.69–7.60 (m, 1H), 7.50–7.44 (m, 2H), 7.44–7.40 (m, 
1H), 7.40–7.36 (m, 2H), 6.44 (s, 1H), 2.41–2.09 (m, 2H), 1.62–1.47 (m, 2H), 1.28–1.18 
(m, 4H), 0.84 (t, J = 6.9 Hz, 3H). 13C-NMR (100 MHz, CDCl3): δ = 162.6 (Cq), 144.5 
(Cq), 142.5 (Cq), 140.6 (CH), 137.5 (Cq), 133.2 (CH), 128.2 (CH), 128.0 (CH), 126.3 
(CH), 126.0 (CH), 125.7 (CH), 125.3 (CH), 124.4 (Cq), 104.9 (CH), 31.9 (CH2), 31.2 
(CH2), 27.2 (CH2), 22.2 (CH2), 13.8 (CH3). IR (ATR): 2358, 2001, 1667, 1634, 1258, 
824, 773, 749 cm−1. MS (EI) m/z (relative intensity): 308 (45) [M]+, 291 (80), 251 (60), 




The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76h (66.1 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ah (89.6 mg, 64%) as a white solid. M. p.: 216–218 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.43–8.38 (m, 1H), 8.38–8.31 (m, 1H), 7.67–7.60 (m, 1H), 7.51–7.40 (m, 
3H), 7.40–7.38 (m, 1H), 7.38–7.36 (m, 1H), 6.39 (s, 1H), 1.59–1.47 (m, 1H), 0.98–0.90 
(m, 1H), 0.68–0.49 (m, 3H). 13C-NMR (125 MHz, CDCl3): δ = 162.4 (Cq), 145.0 (Cq), 
143.2 (Cq), 140.4 (CH), 137.3 (Cq), 133.0 (CH), 128.1 (CH), 127.8 (CH), 126.4 (CH), 
125.8 (CH), 125.7 (CH), 125.3 (CH), 124.7 (Cq), 104.7 (CH), 13.1 (CH), 7.3 (CH2), 5.2 
(CH2). IR (ATR): 1667, 1631, 1602, 1431, 1390, 1264, 761, 728 cm−1. MS (EI) m/z 




MS (EI) m/z calcd for C17H14N2O2 [M]+: 278.1055, found: 278.1057. 
 
2-[3-(Ethoxycarbonyl)-1-oxoisoquinolin-2(1H)-yl]-pyridine-2-oxide (104ai) 
The general procedure A was followed using benzamide 56a (107 mg, 0.50 mmol) and 
alkyne 76i (100 mg, 1.00 mmol). Purification by column chromatography on silica gel 
(CH2Cl2/acetone 3:1) yielded 104ai (101 mg, 65%) as a white solid. M. p.: 173–175 °C. 
1H-NMR (300 MHz, CDCl3): δ = 8.44–8.37 (m, 1H), 8.26 (dd, J = 7.6, 5.3 Hz, 1H), 
7.78–7.70 (m, 1H), 7.68–7.64 (m, 1H), 7.63–7.55 (m, 2H), 7.48 (s, 1H), 7.40 (td, J = 
7.8, 1.5 Hz, 1H), 7.34–7.27 (m, 1H), 4.22 (q, J = 7.1 Hz, 2H), 1.28 (t, J = 7.1 Hz, 3H). 
13C-NMR (125 MHz, CDCl3): δ = 161.4 (Cq), 161.2 (Cq), 144.2 (Cq), 139.6 (CH), 134.8 
(Cq), 133.5 (CH), 131.3 (Cq), 129.2 (CH), 128.6 (CH), 127.8 (CH), 127.4 (Cq), 127.0 
(CH), 125.4 (CH), 124.7 (CH), 112.7 (CH), 62.0 (CH2), 14.0 (CH3). IR (ATR): 1720, 
1673, 1491, 1433, 1402, 1255, 1215, 766 cm−1. MS (EI) m/z (relative intensity): 310 
(30) [M]+, 237 (100), 109 (95), 181 (20), 89 (40), 78 (90). HR-MS (ESI) m/z calcd for 




The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76j (98.1 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104aj (85.5 mg, 55%) as a white solid. M. p.: 198–200 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.40–8.27 (m, 2H), 7.73–7.64 (m, 1H), 7.59–7.46 (m, 3H), 7.44–7.28 (m, 




169.5 (Cq), 162.1 (Cq), 140.7 (CH), 136.3 (Cq), 135.9 (Cq), 133.3 (CH), 128.2 (CH), 
128.1 (CH), 127.6 (CH), 126.4 (CH), 126.0 (CH), 125.5 (Cq), 125.3 (Cq), 125.3 (CH), 
109.1 (CH), 62.4 (CH2), 20.6 (CH3). IR (ATR): 1731, 1670, 1636, 1603, 1484, 1398, 
1030, 762 cm−1. MS (EI) m/z (relative intensity): 310 (30) [M]+, 267 (90), 251 (100), 234 




The slightly modified general procedure A was followed using benzamide 56a (107 mg, 
0.50 mmol) and alkyne 76k (117 mg, 1.00 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mmol %). Purification by column chromatography on silica gel (CH2Cl2/acetone 3:1) 
yielded 104ak (98.6 mg, 60%) as a white solid. M. p.: 176–177 °C. 1H-NMR (300 MHz, 
CDCl3): δ = 8.43–8.33 (m, 1H), 8.30 (dt, J = 7.4, 0.6 Hz, 1H), 7.68–7.58 (m, 1H), 7.49–
7.43 (m, 2H), 7.43–7.38 (m, 1H), 7.38–7.32 (m, 2H), 6.43 (s, 1H), 3.54–3.36 (m, 2H), 
2.42–2.14 (m, 2H), 1.78–1.62 (m, 4H). 13C-NMR (125 MHz, CDCl3): δ = 162.6 (Cq), 
144.2 (Cq), 141.6 (Cq), 140.6 (CH), 137.2 (Cq), 133.2 (CH), 128.1 (CH), 128.0 (CH), 
126.5 (CH), 126.1 (CH), 125.7 (CH), 125.5 (CH), 124.5 (Cq), 105.1 (CH), 44.4 (CH2), 
31.6 (CH2), 31.1 (CH2), 24.7 (CH2). IR (ATR): 2342, 2003, 1669, 1631, 1484, 1431, 
1266, 761 cm−1. MS (EI) m/z (relative intensity): 328 (40) [M]+, 311 (45), 265 (20), 251 











5.3.1.2. Competition Experiments 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
56c (114 mg, 0.50 mmol), benzamide 56e (141 mg, 0.50 mmol), alkyne 76a 
(0.50 mmol, 1.0 equiv), NaOPiv (124 mg, 1.0 mmol, 2.0 equiv) and Co(OAc)2∙4H2O 
(25.7 mg, 20 mol %) were dissolved in H2O/MeOH (1:1, 10 mL). Electrocatalysis was 
performed at ambient temperature with a constant current of 4.0 mA maintained for 16 
h. The reaction was stopped by adding saturated aqueous NaHCO3 solution (10 mL). 
The CF anode was washed with CH2Cl2 (3 × 10 mL) in an ultrasonic bath. The 
washings were added to the reaction mixture and the combined phases were extracted 
with CH2Cl2 (4 × 10 mL), then dried over Na2SO4. Evaporation of the solvent and 
subsequent column chromatography using CH2Cl2/acetone 6:1 yielded 104ca (68 mg, 
41%) and 104ea (55 mg, 29%). 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
56a (107 mg, 0.50 mmol), alkyne 76b (0.50 mmol, 1.0 equiv), alkyne 76d (0.50 mmol, 
1.0 equiv), NaOPiv (124 mg, 1.0 mmol, 2.0 equiv) and Co(OAc)2∙4H2O (25.7 mg, 20 




ambient temperature with a constant current of 4.0 mA maintained for 16 h. The 
reaction was stopped by adding saturated aqueous NaHCO3 solution (10 mL). The CF 
anode was washed with CH2Cl2 (3 × 10 mL) in an ultrasonic bath. The washings were 
added to the reaction mixture and the combined phases were extracted with CH2Cl2 (4 
× 10 mL), then dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography using CH2Cl2/acetone 6:1 yielded 104ab (55.5 mg, 34%) and 104ad 
(51.5 mg, 27%). 
 
5.3.1.3. H/D Exchange Experiments 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
56a (107 mg, 0.50 mmol, 1.0 equiv), alkyne 76a (102 mg, 2.0 equiv), NaOPiv (124 mg, 
1.0 mmol, 2.0 equiv) and Co(OAc)2∙4H2O (25.7 mg, 20 mol %) were placed in a 20 mL 
cell and dissolved in D2O (10 mL). Electrocatalysis was performed at ambient 
temperature with a constant current of 4.0 mA maintained for 8 h. The reaction was 
stopped by adding saturated aqueous NaHCO3 solution (10 mL). The CF anode was 
washed with CH2Cl2 (3 × 10 mL) in an ultrasonic bath. The washings were added to 
the reaction mixture and the combined phases were extracted with CH2Cl2 (4 × 10 mL), 
then dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography (CH2Cl2/acetone 3:1) yielded [D]n-104aa (78.9 mg, 50%) as a white 
solid (figure 5.1) and [D]n-56a (30 mg, 28%) as a white solid (figure 5.2). The D-






 1H-NMR of 104aa from the deuteration study. 
 
  





5.3.1.4. Kinetic Isotope Effect Studies 
 
Two parallel reactions using substrates 56a and [D5]-56a (0.50 mmol each) were 
carried out to determine the KIE by comparison of the initial rates (figure 5.3). After 10 
minutes to reach a stable constant current of 4.0 mA, aliquots of 0.40 mL were 
removed from the cell every twenty minutes. The reaction mixture was extracted with 
CH2Cl2 (3 × 2.0 mL). After evaporation of solvent, the crude mixture was analyzed by 
1H-NMR spectroscopy using 1,3,5-trimethoxybenzene as an internal standard. 
Time [min] 10 20 40 60 80 100 120 
104aa [%] 2.6 4.8 9.0 12.7 16.3 18.0 22.0 
[D4]-104aa [%] - 1.5 3.4 6.3 9.7 13.2 16.9 
 




5.3.1.5. Cyclization Reactions 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). 105 (157 mg, 
0.50 mmol), NaOPiv (124 mg, 1.0 mmol, 2.0 equiv) and Co(OAc)2∙4H2O (25.7 mg, 
20 mol %) were placed in a 20 mL cell and dissolved in 10 mL of H2O/MeOH (1:1). 
Electrocatalysis was performed at ambient temperature with a constant current of 
4.0 mA maintained for 16 h. The reaction was stopped by adding saturated aqueous 
NaHCO3 (10 mL). The CF anode was washed with CH2Cl2 (3 × 10 mL) in an ultrasonic 
bath. The washings were added to the reaction mixture and the combined phases were 
extracted with CH2Cl2 (4 × 10 mL), then dried over Na2SO4. No product formation was 
detected by GC-MS analysis. 
 
5.3.2. Cupraelectro-Catalyzed Cascade Annulation by C–H 
Alkynylation and Decarboxylative C–H/C–C Manifolds 
5.3.2.1. Characterization Data 
 
 
(Z)-3-Benzylidene-2-(quinolin-8-yl) isoindolin-1-one (110aa) 
The general procedure B was followed using benzamide 54a (62 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 




Mixture with M. p.: 210–215 °C. Resonances are reported for (Z)-110aa. 1H-NMR (300 
MHz, CDCl3): δ = 8.85 (dd, J = 4.2, 1.7 Hz, 1H), 8.02–7.94 (m, 2H), 7.88 (d, J = 7.7 
Hz, 1H), 7.68 (td, J = 7.5, 1.2 Hz, 1H), 7.61–7.53 (m, 2H), 7.48 (dd, J = 7.4, 1.5 Hz, 
1H), 7.34–7.27 (m, 2H), 6.81 (s, 0.93H, Z), 6.71–6.64 (m, 1H), 6.60–6.48 (m, 4H), 6.02 
(s, 0.07H, E). 13C-NMR (125 MHz, CDCl3): δ = 167.9 (Cq), 150.2 (CH), 144.3 (Cq), 
138.6 (Cq), 136.0 (Cq), 135.6 (CH), 134.1 (Cq), 133.4 (Cq), 132.1 (CH), 129.9 (CH), 
128.9 (CH), 128.7 (Cq), 128.2 (Cq), 128.2 (CH), 128.0 (CH), 126.2 (CH), 125.9 (CH), 
125.5 (CH), 123.8 (CH), 121.1 (CH), 119.5 (CH), 107.2 (CH). IR (ATR): 3061, 1704, 
1596, 1472, 1377, 1221, 1024, 716 cm−1. MS (ESI) m/z (relative intensity): 371 (10) 
[M+Na]+, 349 (60) [M+H]+. HR-MS (ESI) m/z calcd for C24H17N2O [M+H]+: 349.1335, 
found: 349.1324.  
   
(Z)-3-Benzylidene-2-(2-(4,5-dihydrooxazol-2-yl) phenyl) isoindolin-1-one (109aa) 
The general procedure B was followed using benzamide 91a (67 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 109aa (18 mg, 20%) as colorless oil. 1H-NMR (400 MHz, 
CDCl3): δ = 7.92 (d, J = 7.6 Hz, 1H), 7.86–7.83 (m, 1H), 7.73 (dd, J = 7.7, 1.7 Hz, 1H), 
7.66 (dd, J = 7.6, 1.2 Hz, 1H), 7.54 (dd, J = 7.5, 0.9 Hz, 1H), 7.13 (dd, J = 7.6, 1.4 Hz, 
1H), 7.06 (dd, J = 7.6, 1.5 Hz, 1H), 6.97–6.87 (m, 6H), 6.81 (s, 1H), 4.21 (t, J = 9.2 Hz, 
2H), 3.98–3.85 (m, 2H). 13C-NMR (100 MHz, CDCl3): δ = 167.8 (Cq), 163.1 (Cq), 138.8 
(Cq), 135.1 (Cq), 134.9 (Cq), 133.5 (Cq), 132.2 (CH), 130.5 (CH), 130.0 (CH), 129.4 
(CH), 129.0 (CH), 128.8 (CH), 128.1 (Cq), 127.4 (CH), 127.2 (CH), 126.5 (CH), 126.3 
(Cq), 123.8 (CH), 119.4 (CH), 107.0 (CH), 67.4 (CH2), 55.1 (CH2). IR (ATR): 2928, 1712, 
1650, 1493, 1396, 1188, 1051, 944 cm−1. MS (ESI) m/z (relative intensity): 389 (10) 






(Z)-3-Benzylidene-7-methyl-2-(quinolin-8-yl) isoindolin-1-one (110ba) 
The general procedure B was followed using benzamide 54b (66 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ba (75.4 mg, 83%, E/Z = 1:10) as a white solid. M. 
p.: 215–220 °C. Resonances are reported for (Z)-110ba. 1H-NMR (300 MHz, CDCl3): 
δ = 8.88 (dd, J = 4.2, 1.7 Hz, 1H), 7.97 (dd, J = 8.3, 1.7 Hz, 1H), 7.71 (d, J = 7.9 Hz, 
1H), 7.60–7.50 (m, 2H), 7.45 (dd, J = 7.4, 1.4 Hz, 1H), 7.33–7.31 (m, 1H), 7.31–7.24 
(m, 2H), 6.77 (s, 0.91H, Z), 6.71–6.63 (m, 1H), 6.61–6.48 (m, 4H), 5.96 (s, 0.09H, E), 
2.78 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 168.7 (Cq), 150.2 (CH), 144.4 (Cq), 139.1 
(Cq), 137.9 (Cq), 135.9 (Cq), 135.6 (CH), 134.3 (Cq), 133.7 (Cq), 131.6 (CH), 130.9 (CH), 
129.9 (CH), 128.7 (Cq), 128.3 (CH), 128.1 (CH), 126.1 (CH), 125.8 (CH), 125.5 (CH), 
125.4 (Cq), 121.0 (CH), 117.0 (CH), 106.3 (CH), 17.6 (CH3). IR (ATR): 3059, 2925, 
1708, 1597, 1474, 1397, 1110, 888 cm−1. MS (EI) m/z (relative intensity): 362 (90) [M]+, 
333 (10), 318 (10), 285 (100), 242 (10), 189 (10). HR-MS (EI) m/z calcd for C25H18N2O 
[M]+: 362.1419, found: 362.1413.  
 
(Z)-3-Benzylidene-6-methyl-2-(quinolin-8-yl) isoindolin-1-one (110ca) 
The general procedure B was followed using benzamide 54c (66 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ca (78.8 mg, 87%, E/Z = 1:13) as yellow oil. 
Resonances are reported for (Z)-110ca. 1H-NMR (400 MHz, CDCl3): δ = 8.84 (dd, J = 
4.2, 1.7 Hz, 1H), 7.96 (dd, J = 8.3, 1.8 Hz, 1H), 7.81–7.78 (m, 1H), 7.76 (d, J = 7.9 Hz, 
1H), 7.57 (dd, J = 8.2, 1.4 Hz, 1H), 7.51–7.45 (m, 2H), 7.31–7.25 (m, 2H), 6.74 (s, 




NMR (100 MHz, CDCl3): δ = 168.2 (Cq), 150.2 (CH), 144.4 (Cq), 139.3 (Cq), 136.2 (Cq), 
136.1 (Cq), 135.7 (CH), 134.3 (Cq), 133.6 (Cq), 133.2 (CH), 129.9 (CH), 128.8 (Cq), 
128.4 (Cq), 128.2 (CH), 128.1 (CH), 126.2 (CH), 125.8 (CH), 125.5 (CH), 123.9 (CH), 
121.1 (CH), 119.4 (CH), 106.5 (CH), 21.5 (CH3). IR (ATR): 3051, 2157, 1713, 1596, 
1474, 1399, 1188, 803 cm−1. MS (EI) m/z (relative intensity): 362 (80) [M]+, 333 (15), 
318 (15), 285 (100), 273 (10), 165 (10). HR-MS (ESI) m/z calcd for C25H19N2O 
[M+H]+: 363.1492, found: 363.1494.  
 
(Z)-4-Benzylidene-6-methyl-2-(quinolin-8-yl) isoindolin-1-one (110da) 
The general procedure B was followed using benzamide 54d (66 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 2/1) yielded 110da (65.2 mg, 72%, E/Z = 1:12) as white solid. M. p.: 
170–176 °C. Resonances are reported for (Z)-110da. 1H-NMR (400 MHz, CDCl3): δ = 
8.82 (dd, J = 4.2, 1.7 Hz, 1H), 7.94 (dd, J = 8.3, 1.8 Hz, 1H), 7.85 (d, J = 7.8 Hz, 1H), 
7.66 (s, 1H), 7.55 (d, J = 8.2 Hz, 1H), 7.45 (dd, J = 7.4, 1.4 Hz, 1H), 7.35 (d, J = 7.8 
Hz, 1H), 7.31–7.24 (m, 2H), 6.75 (s, 0.92H, Z), 6.69–6.60 (m, 1H), 6.57–6.45 (m, 4H), 
5.96 (s, 0.08H, E), 2.54 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 168.2 (Cq), 150.3 
(CH), 144.5 (Cq), 142.9 (CH), 139.1 (Cq), 136.2 (Cq), 135.7 (CH), 134.4 (Cq), 133.7 (Cq), 
130.2 (CH), 130.0 (CH), 128.9 (Cq), 128.3 (Cq), 128.2 (CH), 126.3 (CH), 126.0 (Cq), 
125.9 (CH), 125.6 (CH), 123.8 (CH), 121.2 (CH), 120.0 (CH), 106.9 (CH), 22.2 (CH3). 
IR (ATR): 3020, 1755, 1620, 1464, 1232, 745 cm−1. MS (ESI) m/z (relative intensity): 
385 (30) [M+Na]+, 363 (100) [M+H]+. HR-MS (ESI) m/z calcd for C25H19N2O [M+H]+: 
363.1492, found: 363.1495.  
 




The general procedure B was followed using benzamide 54e (81 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ea (76.5 mg, 72%, E/Z = 1:8) as yellow oil. 
Resonances reported for (Z)-110ea: 1H-NMR (400 MHz, CDCl3): δ = 8.86 (dd, J = 4.2, 
1.7 Hz, 1H), 8.09–8.03 (m, 2H), 7.97 (dd, J = 8.3, 1.7 Hz, 1H), 7.79 (dd, J = 7.9, 1.5 
Hz, 1H), 7.74–7.71 (m, 2H), 7.59 (dd, J = 8.2, 1.4 Hz, 1H), 7.53–7.50 (m, 2H), 7.47–
7.39 (m, 2H), 7.34–7.28 (m, 2H), 6.89 (s, 1H), 6.72–6.66 (m, 1H), 6.60–6.53 (m, 4H). 
13C-NMR (100 MHz, CDCl3): δ = 167.9 (Cq), 150.3 (CH), 145.6 (Cq), 144.3 (Cq), 140.6 
(Cq), 139.2 (Cq), 136.1 (Cq), 135.7 (CH), 134.2 (Cq), 133.5 (Cq), 130.0 (CH), 128.9 (CH), 
128.8 (CH), 128.8 (Cq), 128.4 (CH), 128.3 (CH), 128.1 (CH), 127.5 (CH), 127.1 (Cq), 
126.2 (CH), 126.0 (CH), 125.6 (CH), 124.3 (CH), 121.1 (CH), 118.3 (CH), 107.4 (CH). 
Resonances reported for (E)-110ea: 1H-NMR (400 MHz, CDCl3): δ = 8.93 (dd, J = 4.2, 
1.7 Hz, 1H), 8.23 (dd, J = 8.3, 1.7 Hz, 1H), 8.03 (dd, J = 7.4, 1.3 Hz, 1H), 7.98–7.95 
(m, 1H), 7.86 (dd, J = 7.3, 1.4 Hz, 1H), 7.74–7.72 (m, 1H), 7.71–7.68 (m, 2H), 7.53–
7.53 (m, 1H), 7.53–7.52 (m, 2H), 7.40–7.37 (m, 2H), 7.36–7.35 (m, 1H), 7.34–7.33 (m, 
1H), 6.60–6.53 (m, 4H), 6.07 (s, 1H).  13C-NMR (100 MHz, CDCl3): δ = 166.8 (Cq), 
151.2 (CH), 144.9 (Cq), 144.7 (Cq), 140.3 (Cq), 138.9 (Cq), 136.2 (CH), 135.3 (Cq), 
132.9 (Cq), 131.3 (CH), 129.6 (Cq), 129.5 (CH), 129.4 (CH), 129.2 (Cq), 128.8 (CH), 
128.4 (CH), 127.9 (CH), 127.5 (CH), 127.1 (Cq), 127.1 (CH), 126.3 (CH), 126.2 (CH), 
124.1 (CH), 121.9 (CH), 121.8 (CH), 112.1 (CH). IR (ATR): 3060, 1777, 1709, 1597, 
1474, 1376, 1179, 886 cm−1. MS (EI) m/z (relative intensity): 424 (90) [M]+, 347 (100), 
318 (10), 252 (15), 212 (10), 77 (5). HR-MS (EI) m/z calcd for C30H20N2O 
[M]+: 424.1576, found: 424.1569. 
 
(Z)-3-Benzylidene-5-(tert-butyl)-2-(quinolin-8-yl) isoindolin-1-one (110fa) 
The general procedure B was followed using benzamide 54f (76 mg, 0.25 mmol) and 




(n-hexane/EtOAc: 5/1) yielded 110fa (56.2 mg, 56%) as a yellow solid. M. p.: 213–
219 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.84 (dd, J = 4.2, 1.7 Hz, 1H), 7.97–7.89 (m, 
3H), 7.63 (dd, J = 8.0, 1.6 Hz, 1H), 7.57 (dd, J = 8.2, 1.5 Hz, 1H), 7.49 (dd, J = 7.4, 1.4 
Hz, 1H), 7.33–7.29 (m, 1H), 7.29–7.26 (m, 1H), 6.83 (s, 1H), 6.70–6.63 (m, 1H), 6.58–
6.49 (m, 4H), 1.46 (s, 9H). 13C-NMR (125 MHz, CDCl3): δ = 167.9 (Cq), 156.0 (Cq), 
150.1 (CH), 144.3 (Cq), 138.5 (Cq), 136.3 (Cq), 135.6 (CH), 134.2 (Cq), 133.6 (Cq), 
130.0 (CH), 128.7 (Cq), 128.1 (CH), 128.0 (CH), 126.7 (CH), 126.1 (CH), 125.8 (Cq), 
125.8 (CH), 125.5 (CH), 123.5 (CH), 121.0 (CH), 116.1 (CH), 106.6 (CH), 35.6 (Cq), 
31.4 (CH3). IR (ATR): 2963, 1712, 1597, 1475, 1396, 1221, 1101, 791 cm−1. MS (EI) 
m/z (relative intensity): 404 (85) [M]+, 387 (20), 327 (100), 311 (20), 202 (10), 165 (10). 
HR-MS (EI) m/z calcd for C28H24N2O [M]+: 404.1889, found: 404.1892. 
 
(Z)-3-Benzylidene-2-(quinolin-8-yl)-5-(trifluoromethyl) isoindolin-1-one (110ga) 
The general procedure B was followed using benzamide 54g (79 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ga (80 mg, 77%, E/Z = 1:12) as a yellow solid. M. 
p.: 215–220 °C. Resonances are reported for (Z)-110ga. 1H-NMR (400 MHz, CDCl3): 
δ = 8.83 (dd, J = 4.2, 1.7 Hz, 1H), 8.17–8.14 (m, 1H), 8.11 (dd, J = 8.0, 0.7 Hz, 1H), 
7.97 (dd, J = 8.3, 1.7 Hz, 1H), 7.85–7.81 (m, 1H), 7.61 (dd, J = 8.2, 1.4 Hz, 1H), 7.50 
(dd, J = 7.3, 1.4 Hz, 1H), 7.37–7.29 (m, 2H), 6.90 (s, 0.92H, Z), 6.73–6.67 (m, 1H), 
6.55 (d, J = 4.5 Hz, 4H), 6.14 (s, 0.08H, E). 13C-NMR (100 MHz, CDCl3): δ = 166.7 (Cq), 
150.4 (CH), 144.1 (Cq), 138.8 (Cq), 135.8 (CH), 135.1 (Cq), 134.1 (q, 2JC–F = 32.5 Hz, 
Cq), 133.7 (Cq), 132.8 (Cq), 131.0 (Cq), 129.9 (CH), 128.8 (Cq), 128.6 (CH), 128.0 (CH), 
126.4 (CH), 126.3 (CH), 125.8 (q, 3JC–F = 3.6 Hz, CH), 125.6 (CH), 124.6 (CH), 123.8 
(q, 1JC–F = 273.4 Hz, Cq), 121.3 (CH), 117.1 (q, 3JC–F = 4.1 Hz, CH), 109.2 (CH). 19F-
NMR (375 MHz, CDCl3): δ = –62.43 (s, Z), –62.77 (s, E). IR (ATR): 3060, 1715, 1596, 




(25), 347 (10), 339 (100), 242 (10), 159 (5). HR-MS (EI) m/z calcd for C25H15F3N2O 
[M]+: 416.1136, found: 416.1116.  
 
(Z)-3-Benzylidene-5-fluoro-2-(quinolin-8-yl) isoindolin-1-one (110ha) 
The general procedure B was followed using benzamide 1o (67 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ha (70.2 mg, 77%) as yellow oil. 1H-NMR (400 MHz, 
CDCl3): δ = 8.84 (dd, J = 4.2, 1.7 Hz, 1H), 7.99–7.95 (m, 2H), 7.58 (dd, J = 8.2, 1.4 Hz, 
1H), 7.53 (dd, J = 8.3, 2.3 Hz, 1H), 7.48 (dd, J = 7.4, 1.4 Hz, 1H), 7.32–7.27 (m, 2H), 
7.26–7.23 (m, 1H), 6.75 (s, 1H), 6.71–6.66 (m, 1H), 6.56–6.52 (m, 4H). 13C-NMR (100 
MHz, CDCl3): δ = 167.0 (Cq), 165.8 (d, 1JC–F = 251.3 Hz, Cq), 150.3 (CH), 144.2 (Cq), 
141.1 (d, 3JC–F = 10.4 Hz, Cq), 135.7 (CH), 135.3 (d, 4JC–F = 3.6 Hz, Cq), 133.9 (Cq), 
133.0 (Cq), 129.9 (CH), 128.8 (Cq), 128.4 (CH), 128.0 (CH), 126.3 (CH), 126.2 (CH), 
126.1 (d, 3JC–F = 10.0 Hz, CH), 125.6 (CH), 124.4 (d, 4JC–F = 1.9 Hz, Cq), 121.2 (CH), 
116.9 (d, 2JC–F = 24.0 Hz, CH), 108.3 (CH), 106.7 (d, 2JC–F = 24.8 Hz, CH). 19F-NMR 
(376 MHz, CDCl3): δ = –106.42 (m). IR (ATR): 3060, 1711, 1618, 1475, 1398, 1243, 
776, 699 cm−1. MS (EI) m/z (relative intensity): 366 (65) [M]+, 337 (15), 289 (100), 277 
(60), 183 (15), 128 (10). HR-MS (ESI) m/z calcd for C24H16FN2O [M+H]+: 367.1241, 
found: 367.1241. 
 
(Z)-3-Benzylidene-5-bromo-2-(quinolin-8-yl) isoindolin-1-one (110ia) 
The general procedure B was followed using benzamide 54i (82 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ia (81.3 mg, 76%) as a white solid. M. p.: 217–




7.95 (d, J = 8.1 Hz, 1H), 7.85 (d, J = 8.0 Hz, 1H), 7.71–7.66 (m, 1H), 7.58 (d, J = 8.3 
Hz, 1H), 7.47 (d, J = 7.4 Hz, 1H), 7.33–7.24 (m, 2H), 6.76 (s, 1H), 6.72–6.64 (m, 1H), 
6.55–6.50 (m, 4H). 13C-NMR (125 MHz, CDCl3): δ = 167.0 (Cq), 150.2 (CH), 144.1 (Cq), 
140.2 (Cq), 135.6 (CH), 134.8 (Cq), 133.7 (Cq), 132.9 (Cq), 132.1 (CH), 129.8 (CH), 
128.7 (Cq), 128.4 (CH), 127.9 (CH), 126.9 (Cq), 126.9 (Cq), 126.2 (CH), 126.1 (CH), 
125.5 (CH), 125.2 (CH), 122.9 (CH), 121.1 (CH), 108.5 (CH). IR (ATR): 2992, 2206, 
1720, 1498, 1398, 1045, 791, 395 cm−1. MS (EI) m/z (relative intensity): 428 (65) [M]+ 
(81Br), 426 (60) [M]+ (79Br), 397 (10), 351 (100), 318 (30), 242 (15), 176 (20). HR-MS 
(ESI) m/z calcd for C24H1679BrN2O [M+H]+: 427.0441, found: 427.0443. 
 
(Z)-3-Benzylidene-5-iodo-2-(quinolin-8-yl) isoindolin-1-one (110ja) 
The general procedure B was followed using benzamide 54j (93 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ja (70.2 mg, 59%) as a white solid. M. p.: 243–
247 °C. 1H-NMR (300 MHz, CDCl3): δ = 8.83 (dd, J = 4.2, 1.7 Hz, 1H), 8.26 (d, J = 1.3 
Hz, 1H), 7.96 (dd, J = 8.3, 1.7 Hz, 1H), 7.90 (dd, J = 8.0, 1.3 Hz, 1H), 7.72 (d, J = 8.0 
Hz, 1H), 7.58 (dd, J = 8.2, 1.5 Hz, 1H), 7.47 (dd, J = 7.4, 1.5 Hz, 1H), 7.34–7.24 (m, 
2H), 6.76 (s, 1H), 6.72–6.63 (m, 1H), 6.58–6.47 (m, 4H). 13C-NMR (125 MHz, CDCl3): 
δ = 167.2 (Cq), 150.2 (CH), 144.0 (Cq), 140.1 (Cq), 137.9 (CH), 135.7 (CH), 134.7 (Cq), 
133.7 (Cq), 133.0 (Cq), 129.9 (CH), 128.9 (CH), 128.7 (Cq), 128.4 (CH), 127.9 (CH), 
127.5 (Cq), 126.2 (CH), 126.1 (CH), 125.5 (CH), 125.2 (CH), 121.2 (CH), 108.5 (CH), 
99.1 (Cq). IR (ATR): 3057, 2890, 2029, 1716, 1599, 1396, 788, 695 cm−1. MS (EI) m/z 
(relative intensity): 474 (100) [M]+, 445 (10), 397 (90), 346 (20), 270 (25), 242 (10), 176 





(Z)-3-Benzylidene-5,6-dimethyl-2-(quinolin-8-yl) isoindolin-1-one (110ka) 
The general procedure B was followed using benzamide 54k (69 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ka (48.6 mg, 52%, E/Z = 1:10) as colorless oil. 
Resonances are reported for (Z)-110ka. 1H-NMR (400 MHz, CDCl3): δ = 8.84 (dd, J = 
4.2, 1.7 Hz, 1H), 7.95 (dd, J = 8.3, 1.7 Hz, 1H), 7.76–7.73 (m, 1H), 7.64 (s, 1H), 7.56 
(dd, J = 8.2, 1.4 Hz, 1H), 7.46 (dd, J = 7.4, 1.4 Hz, 1H), 7.31–7.25 (m, 2H), 6.72 (s, 
0.91H, Z), 6.69–6.63 (m, 1H), 6.59–6.46 (m, 4H), 5.93 (s, 0.09H, E), 2.45 (s, 3H), 2.42 
(s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 168.4 (Cq), 150.2 (CH), 144.4 (Cq), 141.7 (Cq), 
138.2 (Cq), 136.9 (Cq), 136.3 (Cq), 135.7 (CH), 134.4 (Cq), 133.8 (Cq), 130.0 (CH), 
128.8 (Cq), 128.1 (CH), 128.1 (CH), 126.3 (Cq), 126.2 (CH), 125.7 (CH), 125.6 (CH), 
124.3 (CH), 121.1 (CH), 120.4 (CH), 106.2 (CH), 20.7 (CH3), 20.1 (CH3). IR (ATR): 
3059, 1714, 1596, 1474, 1395, 1221, 1108, 806 cm−1. MS (EI) m/z (relative intensity): 
376 (75) [M]+, 347 (10), 332 (10), 299 (100), 243 (10), 91 (20). HR-MS (ESI) m/z calcd 




The general procedure B was followed using benzamide 110l (74 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110la (53.5 mg, 54%, E/Z = 1:5) as a brown solid. M. 
p.: 219–226 °C. Resonances are reported for (Z)-110la: 1H-NMR (400 MHz, CDCl3): δ 
= 9.16 (d, J = 8.4 Hz, 1H), 8.87 (dd, J = 4.1, 1.7 Hz, 1H), 8.12 (d, J = 8.5 Hz, 1H), 8.00 
(dd, J = 8.3, 1.7 Hz, 1H), 7.98–7.85 (m, 2H), 7.71–7.65 (m, 1H), 7.64–7.56 (m, 2H), 
7.53 (dd, J = 7.3, 1.4 Hz, 1H), 7.37–7.28 (m, 2H), 6.94 (s, 1H), 6.73–6.68 (m, 1H), 
6.67–6.52 (m, 4H). 13C-NMR (100 MHz, CDCl3): δ = 169.0 (Cq), 150.4 (CH), 144.7 (Cq), 




130.2 (CH), 129.3 (Cq), 128.9 (Cq), 128.4 (CH), 128.3 (CH), 128.2 (CH), 128.2 (CH), 
126.7 (CH), 126.4 (CH), 126.2 (CH), 125.7 (CH), 124.6 (CH), 122.1 (Cq), 121.2 (CH), 
117.0 (CH), 109.1 (CH). Resonances are reported for (E)-110la: 1H-NMR (400 MHz, 
CDCl3): δ = 9.25 (dd, J = 8.3, 1.1 Hz, 1H), 8.94 (dd, J = 4.2, 1.7 Hz, 1H), 8.27 (dd, J = 
8.3, 1.8 Hz, 1H), 7.98–7.85 (m, 2H), 7.82 (d, J = 8.7 Hz, 1H), 7.74 (dd, J = 8.3, 7.3 Hz, 
1H), 7.47–7.42 (m, 3H), 7.41–7.35 (m, 2H), 6.73–6.68 (m, 1H), 6.67–6.52 (m, 4H), 
6.17 (s, 1H). 13C-NMR (100 MHz, CDCl3): δ = 168.0 (Cq), 151.3 (CH), 145.3 (Cq), 138.9 
(Cq), 136.3 (CH), 135.4 (Cq), 135.3 (Cq), 133.9 (Cq), 132.2 (CH), 133.0 (Cq), 131.7 (CH), 
129.7 (CH), 129.6 (Cq), 129.4 (CH), 129.3 (Cq), 128.5 (CH), 128.2 (CH), 127.9 (CH), 
127.8 (CH), 127.0 (CH), 124.9 (CH), 122.1 (Cq), 121.8 (CH), 120.4 (CH), 113.5 (CH), 
110.0 (CH). IR (ATR): 3060, 2057, 1693, 1499, 1398, 1146, 828, 697 cm−1. MS (EI) 
m/z (relative intensity): 398 (80) [M]+, 369 (15), 321 (100), 309 (55), 279 (15), 226 (10). 
HR-MS (EI) m/z calcd for C28H18N2O [M]+: 398.1419, found: 398.1417. 
 
(Z)-3-Benzylidene-5-(methylthio)-2-(quinolin-8-yl) isoindolin-1-one (110ma) 
The general procedure B was followed using benzamide 54m (74 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110ma (80.8 mg, 82%, E/Z = 1:2) as yellow oil. 
Resonances reported for (Z)-110ma: 1H-NMR (300 MHz, CDCl3): δ = 8.83 (dd, J = 4.1, 
1.5 Hz, 1H), 7.99–7.92 (m, 1H), 7.87 (d, J = 8.3 Hz, 1H), 7.73–7.65 (m, 1H), 7.57 (dd, 
J = 8.2, 1.4 Hz, 1H), 7.48 (dd, J = 7.4, 1.2 Hz, 1H), 7.40–7.38 (m, 1H), 7.37–7.34 (m, 
1H), 7.32–7.28 (m, 1H), 6.78 (s, 1H), 6.72–6.62 (m, 1H), 6.57–6.48 (m, 4H), 2.61 (s, 
3H). 13C-NMR (125 MHz, CDCl3): δ = 167.5 (Cq), 150.1 (CH), 144.6 (Cq), 144.2 (Cq), 
139.2 (Cq), 135.6 (Cq), 135.6 (CH), 134.0 (Cq), 133.3 (Cq), 129.9 (CH), 129.3 (CH), 
128.7 (Cq), 128.3 (CH), 127.9 (CH), 125.0 (Cq), 126.5 (CH), 126.1 (CH), 125.9 (CH), 
123.9 (CH), 121.0 (CH), 116.2 (CH), 107.3 (CH), 15.6 (CH3). Resonances reported for  




= 8.3, 1.7 Hz, 1H), 7.99–7.92 (m, 1H), 7.87 (d, J = 8.3 Hz, 1H), 7.85–7.82 (m, 1H), 
7.73–7.65 (m, 1H), 7.46–7.42 (m, 1H), 7.42–7.40 (m, 1H), 7.40–7.38 (m, 1H), 7.37–
7.34 (m, 1H), 7.34–7.32 (m, 1H), 7.32–7.28 (m, 1H), 7.28–7.25 (m, 1H), 7.22 (d, J = 
1.5 Hz, 1H), 6.03 (s, 1H), 2.24 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 166.5 (Cq), 
151.0 (CH), 144.8 (Cq), 143.9 (Cq), 138.5 (Cq), 136.3 (Cq), 136.1 (CH), 135.2 (Cq), 
132.7 (Cq), 131.2 (CH), 129.4 (Cq), 129.3 (CH), 128.1 (CH), 127.6 (CH), 126.9 (Cq), 
126.9 (CH), 126.2 (CH), 125.5 (CH), 123.5 (CH), 121.7 (CH), 119.1 (CH), 111.9 (CH), 
15.0 (CH3).  IR (ATR): 3059, 1775, 1706, 1601, 1474, 1396, 1222, 764 cm−1. MS (EI) 
m/z (relative intensity): 394 (80) [M]+, 378 (15), 317 (100), 302 (30), 229 (10), 159 (10). 
HR-MS (EI) m/z calcd for C25H18N2OS [M]+: 394.1140, found: 394.1136. 
 
(Z)-3-Benzylidene-1-oxo-2-(quinolin-8-yl) isoindoline-5-carbonitrile (110na) 
The general procedure B was followed using benzamide 54n (68 mg, 0.25 mmol) and 
alkyne 76a (51 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 5/1) yielded 110na (51.7 mg, 55%) as a white solid. M. p.: 235–
238 °C. 1H-NMR (400 MHz, CDCl3): δ = 8.82 (d, J = 4.1 Hz, 1H), 8.22–8.16 (m, 1H), 
8.09 (d, J = 7.8 Hz, 1H), 7.98 (d, J = 8.3 Hz, 1H), 7.83 (d, J = 7.9 Hz, 1H), 7.61 (d, J = 
8.2 Hz, 1H), 7.49 (d, J = 7.3 Hz, 1H), 7.36–7.28 (m, 2H), 6.87 (s, 1H), 6.76–6.65 (m, 
1H), 6.60–6.48 (m, 4H). 13C-NMR (100 MHz, CDCl3): δ = 166.3 (Cq), 150.5 (CH), 144.0 
(Cq), 138.9 (Cq), 135.9 (CH), 134.4 (Cq), 133.4 (Cq), 132.6 (Cq), 132.2 (CH), 131.4 (Cq), 
129.9 (CH), 128.9 (Cq), 128.8 (CH), 128.0 (CH), 126.6 (CH), 126.4 (CH), 125.7 (CH), 
124.9 (CH), 124.0 (CH), 121.4 (CH), 118.3 (Cq), 115.7 (Cq), 110.0 (CH). IR (ATR): 3048, 
2231, 1715, 1501, 1474, 1399, 797, 690 cm−1. MS (EI) m/z (relative intensity): 373 (70) 
[M]+, 344 (25), 296 (100), 267 (10), 270 (25), 190 (10), 101 (5). HR-MS (EI) m/z calcd 





(Z)-3-(4-Methybenzylidene)-2-(quinolin-8-yl) isoindolin-1-one (110ab) 
The general procedure B was followed using benzamide 54a (62 mg, 0.25 mmol) and 
alkyne 76b (58 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 2/1) yielded 110ab (69.7 mg, 77%, E/Z = 1:6) as a yellow oil. 
Resonances reported for (Z)-110ab: 1H-NMR (400 MHz, CDCl3): δ = 8.82 (d, J = 3.2 
Hz, 1H), 7.97 (d, J = 7.2 Hz, 2H), 7.86 (d, J = 7.8 Hz, 1H), 7.66 (t, J = 7.6 Hz, 1H), 
7.61–7.55 (m, 1H), 7.52 (dd, J = 7.5, 0.8 Hz, 1H), 7.45 (dd, J = 7.4, 1.2 Hz, 1H), 7.33–
7.24 (m, 2H), 6.77 (s, 1H), 6.41 (d, J = 7.8 Hz, 2H), 6.30 (d, J = 7.8 Hz, 2H), 2.00 (s, 
3H). 13C-NMR (100 MHz, CDCl3): δ = 168.1 (Cq), 150.3 (CH), 144.4 (Cq), 138.7 (Cq), 
135.8 (Cq), 135.8 (CH), 135.6 (Cq), 134.3 (Cq), 132.1 (CH), 130.5 (Cq), 130.0 (CH), 
129.1 (CH), 128.9 (CH), 128.8 (Cq), 128.2 (Cq), 128.0 (CH), 126.9 (CH), 125.6 (CH), 
123.9 (CH), 121.2 (CH), 119.6 (CH), 107.5 (CH), 20.8 (CH3). Resonances reported for 
(E)-3ab: 1H-NMR (400 MHz, CDCl3): δ = 8.91 (dd, J = 4.2, 1.5 Hz, 1H), 8.22 (dd, J = 
8.1, 1.3 Hz, 1H), 7.99–7.93 (m, 2H), 7.82 (dd, J = 7.3, 1.2 Hz, 1H), 7.71–7.68 (m, 1H), 
7.52–7.51 (m, 1H), 7.50–7.47 (m, 1H), 7.43–7.36 (m, 2H), 7.25 (d, J = 3.7 Hz, 2H), 
7.14 (d, J = 7.9 Hz, 2H), 5.98 (s, 1H), 2.35 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 
167.0 (Cq), 151.2 (CH), 145.0 (Cq), 138.5 (Cq), 137.4 (Cq), 136.2 (CH), 135.6 (Cq), 
132.9 (Cq), 132.2 (Cq), 131.6 (CH), 131.4 (CH), 130.4 (Cq), 129.6 (Cq), 129.4 (CH), 
129.2 (CH), 128.0 (CH), 126.9 (CH), 126.3 (CH), 123.7 (CH), 123.3 (CH), 121.8 (CH), 
112.3 (CH), 21.3 (CH3). IR (ATR): 2922, 1718, 1630, 1565, 1255, 1203, 891, 724 cm−1. 
MS (ESI) m/z (relative intensity): 385 (10) [M+Na]+, 363 (100) [M+H]+. HR-MS (ESI): 





(Z)-2-(Quinolin-8-yl)-3-(4-(trifluoromethyl) benzylidene) isoindolin-1-one (110ad) 
The general procedure B was followed using benzamide 54a (73 mg, 0.25 mmol) and 
alkyne 76d (85 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 2/1) yielded 110ad (62.6 mg, 60%, E/Z = 1:20) as a yellow oil. 
Resonances are reported for (Z)-110ad: 1H-NMR (400 MHz, CDCl3): δ = 8.82 (dd, J = 
4.2, 1.7 Hz, 1H), 8.03 (dd, J = 7.6, 1.0 Hz, 1H), 7.95 (dd, J = 8.3, 1.7 Hz, 1H), 7.91 (dd, 
J = 7.8, 1.0 Hz, 1H), 7.73 (dd, J = 7.6, 1.2 Hz, 1H), 7.62 (dd, J = 7.8, 1.2 Hz, 2H), 7.56 
(dd, J = 7.6, 1.4 Hz, 1H), 7.37 (dd, J = 8.3, 7.6 Hz, 1H), 7.31 (dd, J = 8.3, 4.2 Hz, 1H), 
6.80–6.72 (m, 3H), 6.68–6.61 (m, 2H). 13C-NMR (100 MHz, CDCl3): δ = 167.9 (Cq), 
150.4 (CH), 144.1 (Cq), 138.3 (Cq), 137.5 (Cq), 137.4 (Cq), 135.9 (CH), 133.9 (Cq), 
132.5 (CH), 130.2 (CH), 129.5 (CH), 128.9 (Cq), 128.7 (CH), 128.4 (Cq), 128.2 (CH), 
127.7 (q, 2JC–F = 34.2 Hz, Cq), 125.8 (CH), 124.1 (CH), 123.4 (q, 1JC–F = 270 Hz, Cq), 
122.8 (q, 3J C–F = 3.4 Hz, CH), 121.4 (CH), 119.8 (CH), 105.2 (CH). 19F-NMR (375 MHz, 
CDCl3): δ = –63.1 (m). IR (ATR): 3022, 1711, 1609, 1511, 1221, 827, 798, 728 cm−1. 
MS (ESI) m/z (relative intensity): 417 (100) [M+H]+. HR-MS (ESI): m/z calcd for 
C25H16F3N2O [M+H]+: 417.1209, found: 417.1218. 
 
(Z)-3-(4-(tert-butyl)benzylidene)-2-(quinolin-8-yl)isoindolin-1-one (110ac) 
The general procedure B was followed using benzamide 54a (62 mg, 0.25 mmol) and 
alkyne 76c (79 mg, 0.50 mmol). Purification by column chromatography on silica gel 
(n-hexane/EtOAc: 2/1) yielded 110ac (81.8 mg, 81%, E/Z = 1:20) as yellow oil. 




4.2, 1.6 Hz, 1H), 8.02 (d, J = 7.6 Hz, 1H), 7.98–7.88 (m, 2H), 7.70 (dd, J = 7.6, 1.2 Hz, 
1H), 7.63–7.48 (m, 3H), 7.36–7.27 (m, 2H), 6.83 (s, 0.94H, Z), 6.54 (d, J = 8.2 Hz, 2H), 
6.48 (d, J = 8.2 Hz, 2H), 6.01 (s, 0.06H, E), 1.11 (s, 9H).  13C-NMR (100 MHz, CDCl3): 
δ = 168.0 (Cq), 150.2 (CH), 148.7 (Cq), 144.4 (Cq), 138.6 (Cq), 136.1 (Cq), 135.6 (CH), 
134.3 (Cq), 132.1 (CH), 130.5 (Cq), 130.1 (CH), 128.9 (CH), 128.8 (Cq), 128.3 (Cq), 
128.2 (CH), 127.7 (CH), 125.6 (CH), 123.9 (CH), 123.0 (CH), 121.1 (CH), 119.6 (CH), 
107.5 (CH), 34.1 (Cq), 30.9 (CH3). IR (ATR): 2962, 1721, 1607, 1501, 1268, 828, 790, 
718 cm−1. MS (ESI) m/z (relative intensity): 427 (20) [M+Na]+, 405 (100) [M+H]+. HR-
MS (ESI): m/z calcd for C28H24N2ONa [M+Na]+: 427.1781, found: 427.1791.  
 
5.3.2.2. Gram-Scale Reaction 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (50 mm × 
50 mm × 6 mm) and a platinum cathode (50 mm × 50 mm × 0.125 mm). Benzamide 
54a (0.99 g, 4.0 mmol, 1.0 equiv), alkyne 76a (0.61 g, 6.0 mmol, 2.0 equiv), NaOPiv 
(0.50 g, 4.0 mmol, 1.0 equiv) and Cu(OAc)2∙H2O (40 mg, 5.0 mol %) were placed in a 
50 mL cell and dissolved in DMA (20 mL). Electrocatalysis was proformed at 100 °C 
with a constant current of 50 mA maintained for 11.5 h. At ambient temperature, 
saturated aqueous NaHCO3 (20 mL) was added. The CF anode was washed with 
EtOAc (3 × 20 mL) in an ultrasonic bath. The washings were added to the reaction 
mixture and the combined phases were extracted with EtOAc (4 × 20 mL), then dried 
over Na2SO4. Evaporation of the solvent and subsequent column chromatography on 






5.3.2.3. Competition Experiments 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54d (66 mg, 0.25 mmol), benzamide 54g (79 mg, 0.25 mmol), alkyne 76a (26 mg, 
0.50 mmol), NaOPiv (31 mg, 0.25 mmol) and Cu(OAc)2∙H2O (2.5 mg, 5.0 mol %) were 
placed in a 10 mL cell and dissolved in DMA (4.0 mL). Electrocatalysis was proformed 
at 100 °C with a constant current of 6.0 mA maintained for 6 h. At ambient temperature, 
saturated aqueous NaHCO3 (4.0 mL) was added. The CF anode was washed with 
EtOAc (3 × 10 mL) in an ultrasonic bath. The combined phases were extracted with 
EtOAc (4 × 10 mL), then dried over Na2SO4. After removal of the solvents in vacuo, 
110da and 110ga were isolated together by column chromatography on silica gel using 
n-hexane/EtOAc 5:1 as eluent. The ratio of 110da and 110ga was determined by 
means of GC which corresponds to 110da (10%) and 110ga (32%). 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54a (62 mg, 0.25 mmol), alkyne 76b (29 mg, 0.25 mmol), alkyne 76d (43 mg, 




placed in a 10 mL cell and dissolved in DMA (4.0 mL). Electrocatalysis was proformed 
at 100 °C with a constant current of 6.0 mA maintained for 6 h. At ambient temperature, 
saturated aqueous NaHCO3 (4.0 mL) was added. The CF anode was washed with 
EtOAc (3 × 10 mL) in an ultrasonic bath. The combined phases were extracted with 
EtOAc (4 × 10 mL), then dried over Na2SO4. After removal of the solvents in vacuo, 
110ab and 110ad were isolated together by column chromatography on silica gel using 
n-hexane/EtOAc 5:1. The ratio of 110ab and 110ad was determined by means of 1H-
NMR spectroscopy which corresponds to 110ab (12%) and 110ad (27%). 
 
5.3.2.4. H/D Exchange Experiments 
 
 
The electrocatalysis was carried out in an undivided cell, with a RVC anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54a (62 mg, 0.25 mmol), alkyne 76a (51 mg, 0.50 mmol), NaOPiv (31 mg, 0.25 mmol) 
and Cu(OAc)2∙H2O (2.5 mg, 5.0 mol %) were placed in a 10 mL cell and dissolved in 
DMA (3.6 mL) and CD3OD (0.40 mL). Electrocatalysis was preformed at 80 °C with a 
constant current of 6.0 mA maintained for 6 h. At ambient temperature, saturated 
aqueous NaHCO3 (4.0 mL) was added. The RVC anode was washed with EtOAc (3 × 
10 mL) in an ultrasonic bath. The combined phases were extracted with EtOAc (4 × 10 
mL), then dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography (n-hexane/EtOAc: 10/1) yielded [D]n-54a (30.5 mg, 49%) (figure 5.4) 
as a white solid and [D]n-110aa (25.3 mg, 29%, E/Z = 1:12) (figure 5.5) as a white solid. 






Figure 5.4. 1H-NMR of reisolated [D]n-54a from the deuteration study.  
  





5.3.2.5. Kinetic Isotope Effect Studies 
 
 
Two parallel reactions were carried out following the general procedure B by React-IR 
studies using substrates 54a (0.50 mmol) and [D5]-54a (0.50 mmol). An IR spectrum 
was recorded every two minutes, and the KIE was determined by the analysis of the 
initial rates of the increase of the peak at 1721 cm−1 (figure 5.6 and 5.7). The peakarea 
of first 2 h was plotted to analyze the initial rates of the reaction and a linear fit revealed 
a KIE of kH/kD ≈1.2.  
 





Figure 5.7. Initial rates analysis of [D4]-110aa. 
 
 
5.3.2.6. Kinetic Profile 
 
 
The reaction was carried out following the general procedure B by React-IR studies 
using substrates 54a (0.50 mmol). IR spectrum was recorded every two minutes. 
Peaks at 1327 cm-1 and 1109 cm-1 were identified to belong to the starting material 54a 












Figure 5.9. Plot of the observed vibrations over time. 
 
5.3.2.7. Cyclization Reactions 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). 54o (87 mg, 
0.25 mmol), NaOPiv (31 mg, 0.25 mmol) and Cu(OAc)2∙H2O (2.5 mg, 5.0 mol %) were 
placed in a 10 mL cell and dissolved in DMA (4.0 mL). Electrocatalysis was performed 
at 100 °C with a constant current of 6.0 mA maintained for 6 h. At ambient temperature, 
saturated aqueous NaHCO3 (4.0 mL) was added. The CF anode was washed with 




mixture and the combined phases were extracted with EtOAc (4 × 10 mL), then dried 
over Na2SO4. After removal of the solvents in vacuo, 110aa was isolated by column 
chromatography on silica gel using n-hexane/EtOAc 5:1 yield 110aa (70.5 mg, 81%, 
E/Z = 1:13). 
 
The reaction was carried out in an undivided cell, with a CF anode (10 mm × 25 mm × 
6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). 54o (87 mg, 0.25 mmol), 
NaOPiv (31 mg, 0.25 mmol) were placed in a 10 mL cell and dissolved in DMA (4.0 
mL) at 100 °C for 6 h. At ambient temperature, saturated aqueous NaHCO3 (4.0 mL) 
was added. The RVC anode was washed with EtOAc (3 × 10 mL) in an ultrasonic bath. 
The washings were added to the reaction mixture and the combined phases were 
extracted with EtOAc (4 × 10 mL), then dried over Na2SO4. After removal of the 
solvents in vacuo, 110aa was isolated by column chromatography on silica gel using 
n-hexane/EtOAc 5:1 yield 110aa (69.3 mg, 80%, E/Z = 1:5). 
 
The reaction was carried out in an undivided cell, with a CF anode (10 mm × 25 mm × 
6 mm) and a platinum cathode (10 mm × 25 mm × 0.25 mm). 54o (87 mg, 0.25 mmol) 
was placed in a 10 mL cell and dissolved in DMA (4.0 mL) at 100 °C for 6 h. At ambient 
temperature, saturated aqueous NaHCO3 (4.0 mL) was added. No product formation 







5.3.2.8. Headspace GC analysis 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54a (62 mg, 0.25 mmol), alkyne 76a (51 mg, 0.50 mmol), NaOPiv (31 mg, 0.25 mmol) 
and Cu(OAc)2∙H2O (2.5 mg, 5.0 mol %) were placed in a 10 mL cell and dissolved in 
DMA (4.0 mL) under N2. Electrocatalysis was proformed at 100 °C with a constant 
current of 6.0 mA for 6 h. After cooling to ambient temperature, 1.0 mL of the 
headspace volume was removed for GC analysis (figure 5.10). At ambient temperature, 
saturated aqueous NaHCO3 (4.0 mL) was added. The CF anode was washed with 
EtOAc (3 × 10 mL) in an ultrasonic bath. The combined phases were extracted with 
EtOAc (4 × 10 mL), then dried over Na2SO4. Evaporation of the solvent and 
subsequent column chromatography on silica gel (n-hexane/EtOAc: 5/1) yielded 110aa 
(85%). 
 





5.3.2.9. Cyclic voltammograms studies 
 
 




nBu4NPF6, 5 mM HOAc, 5 mM substrates, 100 mV/s. 
 
5.3.3. Cobaltaelectro-Catalyzed C–H Acyloxylation with Carboxylic 
Acids 
5.3.3.1. Characterization Data 
 
   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 2-methylbenzoate (67ba) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66a (68 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67ba (65.5 mg, 66%) as colorless oil. 1H-NMR 
(300 MHz, CDCl3): δ = 10.13 (s, 1H), 8.89 (dd, J = 6.7, 2.3 Hz, 1H), 8.73 (dd, J = 4.2, 
1.7 Hz, 1H), 8.10 (dd, J = 8.3, 1.7 Hz, 1H), 7.98 (dd, J = 7.9, 1.5 Hz, 1H), 7.55–7.48 
(m, 2H), 7.43–7.36 (m, 2H), 7.28–7.18 (m, 3H), 7.08 (d, J = 7.7 Hz, 1H), 6.96–6.90 (m, 
1H), 2.54 (s, 3H), 2.49 (s, 3H). 13C-NMR (125 MHz, CDCl3): δ = 165.5 (Cq), 164.8 (Cq), 
148.0 (CH), 147.6 (Cq), 141.1 (Cq), 138.2 (Cq), 137.4 (Cq), 136.0 (CH), 134.1 (Cq), 
132.4 (CH), 131.4 (CH), 131.1 (CH), 130.9 (Cq), 129.9 (CH), 128.0 (CH), 127.8 (Cq), 
127.7 (Cq), 127.1 (CH), 125.4 (CH), 121.8 (CH), 121.4 (CH), 120.3 (CH), 116.6 (CH), 
21.6 (CH3), 19.5 (CH3). IR (ATR): 2130, 1524, 1219, 1038, 840, 818, 734, 495 cm−1. 
MS (ESI) m/z (relative intensity): 419 (30) [M+Na]+, 397 (100) [M+H]+, 253 (20). HR-
MS (ESI) m/z calcd for C25H21N2O3 [M+H]+: 397.1547, found: 397.1544.  




3,5-Dimethyl-2-(quinolin-8-ylcarbamoyl) phenyl 2-methylbenzoate (67qa) 
The general procedure C was followed using benzamide 54q (69 mg, 0.25 mmol) and 
caboxylic acid 66a (68 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67qa (52.7 mg, 51%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.10 (s, 1H), 8.87 (dd, J = 7.0, 2.0 Hz, 1H), 8.72 (dd, J = 4.2, 
1.7 Hz, 1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.97 (dd, J = 7.9, 1.4 Hz, 1H), 7.54–7.45 
(m, 2H), 7.39 (dd, J = 8.3, 4.2 Hz, 1H), 7.27–7.21 (m, 1H), 7.08 (d, J = 7.7 Hz, 1H), 
7.05–6.98 (m, 2H), 6.97–6.89 (m, 1H), 2.49 (s, 3H), 2.48 (s, 3H), 2.41 (s, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 165.8 (Cq), 165.1 (Cq), 148.1 (CH), 147.7 (Cq), 141.2 (Cq), 
140.5 (Cq), 138.4 (Cq), 137.3 (Cq), 136.1 (CH), 134.4 (Cq), 132.4 (CH), 131.5 (CH), 
131.3 (CH), 129.0 (CH), 128.2 (Cq), 128.0 (Cq), 127.8 (Cq), 127.3 (CH), 125.5 (CH), 
121.8 (CH), 121.5 (CH), 120.9 (CH), 116.6 (CH), 21.6 (CH3), 21.3 (CH3), 19.5 (CH3). 
IR (ATR): 2253, 1735, 1672, 1523, 907, 731, 650, 420 cm−1. MS (EI) m/z (relative 
intensity): 410 (10) [M]+, 291 (5), 267 (35), 218 (5), 119 (100), 91 (50). HR-MS (EI) m/z 
calcd for C26H22N2O3 [M]+: 410.1630, found: 410.1647. 
   
3,6-Dimethyl-2-(quinolin-8-ylcarbamoyl)phenyl 2-methylbenzoate (67ra) 
The general procedure C was followed using benzamide 54r (69 mg, 0.25 mmol) and 
caboxylic acid 66a (68 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67ra (64 mg, 62%) as colorless oil. 1H-NMR (300 
MHz, CDCl3): δ = 10.11 (s, 1H), 8.87 (dd, J = 6.4, 2.6 Hz, 1H), 8.75 (dd, J = 4.2, 1.7 
Hz, 1H), 8.09 (dd, J = 8.3, 1.7 Hz, 1H), 8.02 (dd, J = 7.8, 1.5 Hz, 1H), 7.50–7.45 (m, 
2H), 7.39 (dd, J = 8.3, 4.2 Hz, 1H), 7.30–7.22 (m, 2H), 7.15–7.05 (m, 2H), 7.02 (dd, J 
= 7.6, 1.2 Hz, 1H), 2.48 (s, 3H), 2.43 (s, 3H), 2.26 (s, 3H). 13C-NMR (75 MHz, CDCl3): 
δ = 165.5 (Cq), 165.5 (Cq), 148.2 (CH), 146.3 (Cq), 141.1 (Cq), 138.4 (Cq), 136.1 (CH), 




128.7 (Cq), 128.2 (CH), 128.0 (Cq), 127.8 (Cq), 127.2 (CH), 125.6 (CH), 122.0 (CH), 
121.6 (CH), 116.7 (CH), 21.4 (CH3), 19.1 (CH3), 16.3 (CH3). IR (ATR): 2253, 1734, 
1524, 1385, 1052, 907, 730, 650 cm−1. MS (ESI) m/z (relative intensity): 433 (40) 
[M+Na]+, 411 (80) [M+H]+, 357 (5), 335 (5). HR-MS (ESI): m/z calcd for 
[C26H22N2O3+H]+: 411.1703, found: 411.1708. 
   
1-(Quinolin-8-ylcarbamoyl) naphthalen-2-yl 2-methylbenzoate (67la) 
The general procedure C was followed using benzamide 54l (75 mg, 0.25 mmol) and 
caboxylic acid 66a (68 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67la (56.4 mg, 52%) as colorless oil. 1H-NMR (400 
MHz, CDCl3): δ = 10.37 (s, 1H), 9.04 (dd, J = 7.5, 1.5 Hz, 1H), 8.68 (dd, J = 4.2, 1.7 
Hz, 1H), 8.23–8.18 (m, 1H), 8.10 (td, J = 7.9, 1.6 Hz, 2H), 8.03 (d, J = 8.7 Hz, 1H), 
7.95–7.92 (m, 1H), 7.61–7.50 (m, 4H), 7.48 (d, J = 8.9 Hz, 1H), 7.37 (dd, J = 8.3, 4.2 
Hz, 1H), 7.28 (td, J = 7.7, 1.4 Hz, 1H), 7.12 (d, J = 7.7 Hz, 1H), 7.01–6.95 (m, 1H), 
2.54 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 165.7 (Cq), 164.4 (Cq), 148.1 (CH), 145.4 
(Cq), 141.4 (Cq), 138.3 (Cq), 136.1 (CH), 134.3 (Cq), 132.6 (CH), 131.6 (CH), 131.6 (Cq), 
131.4 (CH), 131.0 (CH), 131.0 (Cq), 128.2 (CH), 127.8 (Cq), 127.7 (Cq), 127.6 (CH), 
127.2 (CH), 126.7 (Cq), 126.2 (CH), 125.5 (CH), 125.2 (CH), 122.1 (CH), 121.7 (CH), 
121.5 (CH), 116.8 (CH), 21.6 (CH3). IR (ATR): 1737, 1673, 1521, 1484, 1207, 1044, 
827, 735 cm−1. MS (EI) m/z (relative intensity): 432 (15) [M]+, 313 (5), 289 (20), 262 





   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 4-methoxybenzoate (67bb) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66b (76 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bb (66.4 mg, 64%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.09 (s, 1H), 8.86 (dd, J = 7.0, 2.0 Hz, 1H), 8.74 (dd, J = 4.2, 
1.7 Hz, 1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.96 (dd, J = 9.0, 2.8 Hz, 2H), 7.54–7.46 
(m, 2H), 7.44–7.38 (m, 2H), 7.24–7.19 (m, 2H), 6.65 (dd, J = 9.0, 2.8 Hz, 2H), 3.74 (s, 
3H), 2.52 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 164.9 (Cq), 164.6 (Cq), 163.6 (Cq), 
148.2 (CH), 147.8 (Cq), 138.4 (Cq), 137.6 (Cq), 136.1 (CH), 134.3 (Cq), 132.3 (CH), 
130.8 (Cq), 130.0 (CH), 127.9 (CH), 127.8 (Cq), 127.3 (CH), 121.9 (CH), 121.5 (CH), 
121.3 (Cq), 120.4 (CH), 116.7 (CH), 113.4 (CH), 55.3 (CH3), 19.5 (CH3). IR (ATR): 2140, 
1957, 1732, 1604, 1523, 1224, 1166, 1067 cm−1. MS (EI) m/z (relative intensity): 412 
(15) [M]+, 278 (5), 269 (50), 218 (5), 135 (100), 77 (20). HR-MS (EI) m/z calcd for 
C25H20N2O4 [M]+: 412.1423, found: 412.1436. The analytical data correspond with 
those reported in the literature.[2] 
   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 4-(tert-butyl)benzoate (67bc) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66c (89 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bc (55.2 mg, 50%) as colorless oil. 1H-NMR 




1.7 Hz, 1H), 8.09 (dd, J = 8.3, 1.7 Hz, 1H), 7.92 (dt, J = 8.8, 2.2 Hz, 2H), 7.54–7.45 (m, 
2H), 7.45–7.37 (m, 2H), 7.25–7.15 (m, 4H), 2.53 (s, 3H), 1.22 (s, 9H). 13C-NMR (100 
MHz, CDCl3): δ = 164.9 (Cq), 164.8 (Cq), 157.0 (Cq), 148.1 (CH), 147.7 (Cq), 138.3 (Cq), 
137.5 (Cq), 136.0 (CH), 134.3 (Cq), 130.7 (Cq), 130.0 (CH), 129.9 (CH), 127.9 (CH), 
127.7 (Cq), 127.2 (CH), 126.1 (Cq), 125.0 (CH), 121.8 (CH), 121.4 (CH), 120.3 (CH), 
116.6 (CH), 34.9 (Cq), 30.9 (CH3), 19.5 (CH3). IR (ATR): 2252, 1735, 1524, 1385, 1224, 
905, 729, 650 cm−1. MS (EI) m/z (relative intensity): 438 (20) [M]+, 295 (60), 260 (10), 
161 (100), 146 (15), 118 (15). HR-MS (EI) m/z calcd for C28H26N2O3 [M]+: 438.1943, 
found: 438.1961. 
   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 3-methylbenzoate (67bd) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66d (68 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bd (44.5 mg, 45%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.13 (s, 1H), 8.88 (dd, J = 6.9, 2.1 Hz, 1H), 8.75 (dd, J = 4.2, 
1.7 Hz, 1H), 8.11 (dd, J = 8.3, 1.7 Hz, 1H), 7.83–7.75 (m, 2H), 7.54–7.47 (m, 2H), 7.45–
7.38 (m, 2H), 7.28–7.24 (m, 1H), 7.22 (dt, J = 7.6, 0.9 Hz, 1H), 7.20–7.16 (m, 1H), 7.08 
(t, J = 7.6 Hz, 1H), 2.54 (s, 3H), 2.06 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 165.0 
(Cq), 164.8 (Cq), 148.2 (CH), 147.7 (Cq), 138.3 (Cq), 137.9 (Cq), 137.6 (Cq), 136.1 (CH), 
134.3 (Cq), 134.1 (CH), 130.7 (Cq), 130.5 (CH), 130.0 (CH), 128.9 (Cq), 128.0 (CH), 
127.8 (Cq), 127.3 (CH), 127.2 (CH), 121.9 (CH), 121.5 (CH), 120.2 (CH), 116.7 (CH), 
20.8 (CH3), 19.5 (CH3). IR (ATR): 2253, 1736, 1525, 1485, 1227, 907, 731, 650 cm−1. 
MS (EI) m/z (relative intensity): 396 (15) [M]+, 379 (5), 253 (40), 119 (100), 91 (40), 65 




   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl [1,1'-biphenyl]-2-carboxylate (67be) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66e (99 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67be (73.3 mg, 64%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.05 (s, 1H), 8.93 (dd, J = 7.1, 1.9 Hz, 1H), 8.73 (dd, J = 4.2, 
1.7 Hz, 1H), 8.15 (dd, J = 8.3, 1.7 Hz, 1H), 7.70 (dd, J = 7.8, 1.2 Hz, 1H), 7.60–7.52 
(m, 2H), 7.42 (dd, J = 8.3, 4.2 Hz, 1H), 7.38 (td, J = 7.6, 1.4 Hz, 1H), 7.34–7.24 (m, 
7H), 7.15 (d, J = 7.7 Hz, 1H), 7.06 (td, J = 7.6, 1.3 Hz, 1H), 6.84 (d, J = 8.2 Hz, 1H), 
2.48 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 166.6 (Cq), 164.7 (Cq), 148.2 (CH), 147.5 
(Cq), 143.0 (Cq), 140.8 (Cq), 138.4 (Cq), 137.3 (Cq), 136.1 (CH), 134.3 (Cq), 131.5 (CH), 
130.8 (Cq), 130.6 (CH), 130.1 (CH), 130.0 (CH), 129.4 (Cq), 128.5 (CH), 128.0 (CH), 
127.9 (CH), 127.8 (Cq), 127.2 (CH), 126.8 (CH), 121.9 (CH), 121.6 (CH), 119.8 (CH), 
116.7 (CH), 19.4 (CH3). IR (ATR): 2253, 1746, 1524, 1220, 1040, 907, 730 cm−1. MS 
(EI) m/z (relative intensity): 458 (20) [M]+, 315 (30), 278 (5), 181 (100), 152 (40), 144 
(15). HR-MS (EI) m/z calcd for C30H22N2O3 [M]+: 458.1630, found: 458.1643. 
   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 2,6-dimethylbenzoate (67bf) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66f (75 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bf (62.4 mg, 61%) as colorless oil. 1H-NMR (400 




Hz, 1H), 8.15 (dd, J = 8.3, 1.7 Hz, 1H), 7.60–7.53 (m, 2H), 7.46–7.39 (m, 2H), 7.24 (dt, 
J = 7.7, 0.9 Hz, 1H), 7.19 (dt, J = 8.1, 0.9 Hz, 1H), 7.10 (t, J = 7.6 Hz, 1H), 6.90 (d, J = 
7.8 Hz, 2H), 2.51 (s, 3H), 2.25 (s, 6H). 13C-NMR (100 MHz, CDCl3): δ = 168.4 (Cq), 
164.9 (Cq), 148.3 (CH), 147.3 (Cq), 138.4 (Cq), 137.3 (Cq), 136.1 (CH), 135.5 (Cq), 
134.3 (Cq), 132.5 (Cq), 131.5 (Cq), 130.1 (CH), 129.7 (CH), 128.2 (CH), 127.8 (Cq), 
127.5 (CH), 127.2 (CH), 122.1 (CH), 121.6 (CH), 120.1 (CH), 116.8 (CH), 19.7 (CH3), 
19.4 (CH3). IR (ATR): 2253, 1675, 1486, 1219, 906, 729, 650, 419 cm−1. MS (EI) m/z 
(relative intensity): 410 (10) [M]+, 267 (10), 218 (5), 133 (100), 105 (35), 79 (15). HR-
MS (EI) m/z calcd for C26H22N2O3 [M]+: 410.1630, found: 410.1636.  
   
3-methyl-2-(quinolin-8-ylcarbamoyl) phenyl 2-chlorobenzoate (67bg) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66g (78 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bg (39.5 mg, 38%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.10 (s, 1H), 8.90 (dd, J = 7.0, 2.0 Hz, 1H), 8.73 (dd, J = 4.2, 
1.7 Hz, 1H), 8.13 (dd, J = 8.3, 1.7 Hz, 1H), 7.81 (dd, J = 7.8, 1.7 Hz, 1H), 7.58–7.51 
(m, 2H), 7.44–7.39 (m, 2H), 7.32–7.22 (m, 4H), 7.01–6.96 (m, 1H), 2.53 (s, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 164.8 (Cq), 163.7 (Cq), 148.3 (CH), 147.4 (Cq), 138.4 (Cq), 
137.5 (Cq), 136.1 (CH), 134.4 (Cq), 134.2 (Cq), 132.9 (CH), 131.9 (CH), 130.9 (CH), 
130.8 (Cq), 130.1 (CH), 128.6 (Cq), 128.4 (CH), 127.8 (Cq), 127.2 (CH), 126.3 (CH), 
122.0 (CH), 121.6 (CH), 120.3 (CH), 116.8 (CH), 19.5 (CH3). IR (ATR): 3017, 1737, 
1674, 1524, 1215, 826, 766, 669 cm−1. MS (EI) m/z (relative intensity): 418 (10) [37Cl-
M]+, 416 (25) [35Cl-M]+, 399 (5), 273 (40), 139 (100), 111 (25), 77 (10). HR-MS (ESI) 




   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 3,5-dimethylbenzoate (67bh) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66h (75 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bh (53.2 mg, 52%) as colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 10.14 (s, 1H), 8.90 (dd, J = 7.0, 2.0 Hz, 1H), 8.75 (dd, J = 4.2, 
1.7 Hz, 1H), 8.12 (dd, J = 8.3, 1.7 Hz, 1H), 7.61–7.55 (m, 2H), 7.55–7.46 (m, 2H), 
7.44–7.42 (m, 1H), 7.42–7.39 (m, 1H), 7.29–7.25 (m, 1H), 7.21 (dt, J = 7.6, 0.9 Hz, 
1H), 7.02–6.96 (m, 1H), 2.54 (s, 3H), 2.04 (s, 6H). 13C-NMR (100 MHz, CDCl3): δ = 
165.1 (Cq), 164.8 (Cq), 148.2 (CH), 147.8 (Cq), 138.3 (Cq), 137.8 (Cq), 137.7 (Cq), 136.1 
(CH), 135.0 (CH), 134.3 (Cq), 130.6 (Cq), 130.0 (CH), 128.8 (Cq), 128.0 (CH), 127.8 
(CH), 127.8 (Cq), 127.3 (CH), 121.8 (CH), 121.5 (CH), 120.2 (CH), 116.7 (CH), 20.7 
(CH3), 19.5 (CH3). IR (ATR): 1736, 1675, 1525, 1486, 1309, 907, 730, 650 cm−1. MS 
(EI) m/z (relative intensity): 410 (15) [M]+, 267 (50), 171 (5), 133 (100), 105 (35), 79 
(15). HR-MS (EI) m/z calcd for C26H22N2O3 [M]+: 410.1630, found: 410.1616. 
   
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl 3,5-dimethoxybenzoate (67bi) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66i (91 mg, 0.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bi (56.2 mg, 51%) as colorless oil. 1H-NMR (400 




Hz, 1H), 8.12 (dd, J = 8.2, 1.7 Hz, 1H), 7.53–7.49 (m, 2H), 7.43–7.38 (m, 2H), 7.28–
7.21 (m, 2H), 7.13 (d, J = 2.3 Hz, 2H), 6.48 (t, J = 2.4 Hz, 1H), 3.53 (s, 6H), 2.53 (s, 
3H). 13C-NMR (100 MHz, CDCl3): δ = 164.8 (Cq), 164.7 (Cq), 160.4 (Cq), 148.3 (CH), 
147.7 (Cq), 138.4 (Cq), 137.6 (Cq), 136.1 (CH), 134.3 (Cq), 130.9 (Cq), 130.7 (Cq), 130.1 
(CH), 128.1 (CH), 127.9 (Cq), 127.3 (CH), 122.0 (CH), 121.6 (CH), 120.2 (CH), 116.7 
(CH), 107.5 (CH), 106.6 (CH), 55.3 (CH3), 19.5 (CH3). IR (ATR): 2166, 1738, 1676, 
1524, 1304, 1047, 908 cm−1. MS (EI) m/z (relative intensity): 442 (20) [M]+, 299 (55), 
264 (5), 165 (100), 137 (25), 122 (20). HR-MS (EI) m/z calcd for C26H22N2O5 
[M]+: 442.1529, found: 442.1516. 
 
3-Methyl-2-(quinolin-8-ylcarbamoyl) phenyl acetate (67bj) 
The general procedure C was followed using benzamide 54b (66 mg, 0.25 mmol) and 
caboxylic acid 66j (60 mg, 1.0 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 10/1) yielded 67bj (25.8 mg, 32%) as colorless oil. 1H-NMR (400 
MHz, CDCl3): δ = 10.02 (s, 1H), 8.94 (dd, J = 7.0, 2.0 Hz, 1H), 8.78 (dd, J = 4.2, 1.7 
Hz, 1H), 8.18 (dd, J = 8.3, 1.7 Hz, 1H), 7.63–7.55 (m, 2H), 7.45 (q, J = 4.1 Hz, 1H), 
7.37 (t, J = 7.9 Hz, 1H), 7.18 (d, J = 7.5 Hz, 1H), 7.07–7.04 (m, 1H), 2.50 (s, 3H), 2.10 
(s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 169.5 (Cq), 164.8 (Cq), 148.4 (CH), 147.4 (Cq), 
138.5 (Cq), 137.5 (Cq), 136.3 (CH), 134.3 (Cq), 130.7 (Cq), 130.0 (CH), 128.2 (CH), 
128.0 (Cq), 127.3 (CH), 122.1 (CH), 121.7 (CH), 120.3 (CH), 116.8 (CH), 20.8 (CH3), 
19.5 (CH3). IR (ATR): 1769, 1679, 1524, 1484, 1326, 1195, 828, 793 cm−1. MS (EI) m/z 
(relative intensity): 320 (20) [M]+, 259 (30), 186 (10), 144 (100), 135 (75), 43 (40). HR-









5.3.3.2. Competition Experiment 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54a (66 mg, 0.25 mmol), carboxylic acid 66b (34 mg, 0.25 mmol), carboxylic acid 66k 
(48 mg, 0.25 mmol), Na2CO3 (53 mg, 0.50 mmol, 2.0 equiv) and Co(OAc)2∙4H2O 
(12.7 mg, 20 mol %) were dissolved in GVL (3.0 mL). Electrocatalysis was performed 
at 80 °C with a constant current of 5.0 mA maintained for 6 h. At ambient temperature, 
the reaction was stopped by adding saturated aqueous NaHCO3 (10 mL). The CF 
anode was washed with acetone (3 × 10 mL) in an ultrasonic bath. The CF anode was 
washed with acetone (3 × 10 mL) in an ultrasonic cleaner. The washings were added 
to the reaction mixture and the combined organic phases were evaporated. After 
evaporation of acetone the mixture was extracted with pentane (4 × 10 mL), and 
successively with EtOAc (3 × 10 mL) then dried over Na2SO4. After removal of the 
solvents under vacuo, 67bb and 67bk were isolated together by column 
chromatography on silica gel using n-hexane/EtOAc 20:1. The ratio of 67bb and 67bk 











5.3.3.3. H/D Exchange Experiment 
 
 
In an undivided cell with a CF anode (10 mm × 25 mm × 6 mm) and a platinum cathode 
(10 mm × 25 mm × 0.125 mm), benzamide 54b (66 mg, 0.25 mmol), carboxylic acid 
66a (68 mg, 0.50 mmol, 2.0 equiv), Na2CO3 (53 mg, 0.50 mmol, 2.0 equiv) and 
Co(OAc)2∙4H2O (12.5 mg, 20 mol %) were placed in a 10 mL cell and dissolved in 
GVL/CD3OD (5:1, 3.0 mL). Electrocatalysis was performed at 80 °C with a constant 
current of 5.0 mA maintained for 3 h. The reaction was stopped by adding saturated 
aqueous NaHCO3 (10 mL). The CF anode was washed with acetone (3 × 10 mL) in an 
ultrasonic bath. The washings were added to the reaction mixture and the combined 
organic phases were evaporated. After evaporation of acetone the mixture was 
extracted with pentane (4 × 10 mL), and successively with EtOAc (3 × 10 mL) then 
dried over Na2SO4. Evaporation of the solvent and subsequent column 
chromatography on silica gel using n-hexane/EtOAc 15:1 yielded 54b (23.1 mg, 35%) 
(figure 5.12) as a white solid and 67ba (38.9 mg, 39%) (figure 5.13) as colorless oil. 















5.3.3.4. Headspace GC analysis 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54b (66 mg, 0.25 mmol), carboxylic acid 66a (68 mg, 0.50 mmol), Na2CO3 (53 mg, 
0.50 mmol, 2.0 equiv) and Co(OAc)2∙4H2O (12.7 mg, 20 mol %) were placed in a 10 
mL cell and dissolved in GVL (3.0 mL) under N2. Electrocatalysis was performed at 
80 °C with a constant current of 5.0 mA maintained for 6 h. After cooling to ambient 
temperature, 1.0 mL of the headspace volume was taken for GC analysis (figure 5.14). 
The CF anode was washed with acetone (3 × 10 mL) in an ultrasonic bath. The 
washings were added to the reaction mixture and the combined organic phases were 
evaporated. The mixture was extracted with pentane (4 × 10 mL) and successively 
with EtOAc (3 × 10 mL) then dried over Na2SO4. Evaporation of the solvent and 






Figure 5.14. Headspace-GC analysis 67ba. 
 
5.3.4. Cobaltaelectro-Catalyzed C–H Acyloxylation with Carboxylic 
Acids 




The general procedure D was followed using benzamide 54b (131.1 mg, 0.50 mmol) 
and alkene 13a (168.0 mg, 1.5 mmol). Isolation by column chromatography (n-
hexane/EtOAc = 10:1) yielded 70ba (112.0 mg, 60%) as a colourless oil. 1H-NMR (400 
MHz, CDCl3): δ = 9.95 (s, 1H), 9.03 (dd, J = 7.4, 1.7 Hz, 1H), 8.75 (dd, J = 4.2, 1.7 Hz, 





7.46 (dd, J = 8.3, 4.2 Hz, 1H), 7.31 (dd, J = 7.4, 1.7 Hz, 1H), 7.21–7.12 (m, 2H), 5.59 
(dtt, J = 14.7, 6.6, 1.4 Hz, 1H), 5.44 (dtt, J = 14.7, 6.6, 1.4 Hz, 1H), 3.48 (d, J = 6.6 Hz, 
2H), 2.47 (s, 3H), 1.93–1.79 (m, 2H), 1.22–1.11 (m, 6H), 0.82 (t, J = 6.2 Hz, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 168.7 (Cq), 148.2 (CH), 138.5 (Cq), 137.8 (Cq), 137.7 (Cq), 
136.3 (CH), 134.7 (Cq), 134.4 (Cq), 132.5 (CH), 129.1 (CH), 128.1 (CH), 128.1 (CH), 
128.0 (Cq), 127.4 (CH), 127.0 (CH), 121.9 (CH), 121.6 (CH), 116.8 (CH), 36.7 (CH2), 
32.4 (CH2), 31.4 (CH2), 28.9 (CH2), 22.4 (CH2), 19.5 (CH3), 14.0 (CH3). IR (ATR): 2947, 
1675, 1582, 1429, 1296, 970, 800, 710 cm–1. MS (ESI) m/z (relative intensity): 395 (20) 
[M+Na]+, 373 (100) [M+H]+. HR-MS (ESI): m/z calcd. for [C25H28N2O+Na]+ 395.2094 
found 395.2087.  
 
(E)-2,4-Dimethyl-6-(oct-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70qa) 
The general procedure D was followed using benzamide 54q (138.0 mg, 0.50 mmol) 
and alkene 13a (168.0 mg, 1.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc = 40:1) yielded 70qa (93.5 mg, 48%) as a colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 9.92 (s, 1H), 9.00 (dd, J = 7.5, 1.5 Hz, 1H), 8.72 (dd, J = 4.2, 
1.7 Hz, 1H), 8.17 (dd, J = 8.3, 1.7 Hz, 1H), 7.64–7.58 (m, 1H), 7.55 (dd, J = 8.3, 1.5 
Hz, 1H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 7.00–6.93 (m, 2H), 5.57 (dtt, J = 14.8, 6.7, 1.3 
Hz, 1H), 5.41 (dtt, J = 14.8, 6.7, 1.3 Hz, 1H), 3.43 (d, J = 6.7 Hz, 2H), 2.41 (s, 3H), 2.36 
(s, 3H), 1.84 (dd, J = 6.7, 1.2 Hz, 2H), 1.22–1.10 (m, 6H), 0.80 (t, J = 6.8 Hz, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 168.9 (Cq), 148.1 (CH), 138.8 (Cq), 138.5 (Cq), 137.7 (Cq), 
136.2 (CH), 135.0 (Cq), 134.6 (Cq), 134.5 (Cq), 132.3 (CH), 128.8 (CH), 128.2 (CH), 
128.0 (Cq), 127.6 (CH), 127.4 (CH), 121.7 (CH), 121.6 (CH), 116.7 (CH), 36.6 (CH2), 
32.3 (CH2), 31.4 (CH2), 28.8 (CH2), 22.4 (CH2), 21.2 (CH3), 19.4 (CH3), 14.0 (CH3). IR 




intensity): 409 (100) [M+Na]+, 387 (15) [M+H]+. HR-MS (ESI) m/z calcd for C26H31N2O 
[M+H]+: 387.2431, found: 387.2429.  
    
(E)-3,6-Dimethyl-2-(oct-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70ra) 
The general procedure D was followed using benzamide 54r (138.0 mg, 0.50 mmol) 
and alkene 13a (168.0 mg, 1.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc = 50:1) yielded 70ra (101.2 mg, 52%) as a colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 9.93 (s, 1H), 9.04 (dd, J = 7.5, 1.5 Hz, 1H), 8.72 (dd, J = 4.2, 
1.7 Hz, 1H), 8.16 (dd, J = 8.3, 1.7 Hz, 1H), 7.61 (t, J = 7.5 Hz, 1H), 7.56 (dd, J = 8.3, 
1.5 Hz, 1H), 7.43 (dd, J = 8.3, 4.2 Hz, 1H), 7.15 (d, J = 7.8 Hz, 1H), 7.06 (d, J = 7.7 
Hz, 1H), 5.58–5.48 (m, 1H), 5.37–5.27 (m, 1H), 3.45 (dd, J = 6.1, 1.2 Hz, 2H), 2.41 (s, 
3H), 2.34 (s, 3H), 1.86–1.78 (m, 2H), 1.18–1.09 (m, 6H), 0.79 (t, J = 7.0 Hz, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 169.2 (Cq), 148.1 (CH), 138.5 (Cq), 138.4 (Cq), 136.2 (CH), 
135.0 (Cq), 134.7 (Cq), 134.4 (Cq), 132.0 (Cq), 131.7 (CH), 130.9 (CH), 128.0 (CH), 
128.0 (Cq), 127.3 (CH), 127.1 (CH), 121.8 (CH), 121.5 (CH), 116.7 (CH), 34.0 (CH2), 
32.3 (CH2), 31.3 (CH2), 28.8 (CH2), 22.3 (CH2), 19.2 (CH3), 19.2 (CH3), 13.9 (CH3). IR 
(ATR): 2983, 1737, 1680, 1521, 1234, 1044, 793, 607 cm−1. MS (ESI) m/z (relative 
intensity): 409 (100) [M+Na]+, 387 (20) [M+H]+. HR-MS (ESI) m/z calcd for C26H31N2O 






    
(E)-4-Chloro-2-methyl-6-(oct-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70ta) 
The slightly modified procedure D was followed using benzamide 54t (148.0 mg, 
0.50 mmol) and alkene 13a (168.0 mg, 1.5 mmol) with Co(OAc)2∙4H2O (25.7 mg, 20 
mol %) . Purification by column chromatography on silica gel (n-hexane/EtOAc = 30:1) 
yielded 70ta (100.0 mg, 50%) as a colorless oil. 1H-NMR (400 MHz, CDCl3): δ = 9.90 
(s, 1H), 8.96 (dd, J = 7.2, 1.8 Hz, 1H), 8.74 (dd, J = 4.2, 1.7 Hz, 1H), 8.18 (dd, J = 8.3, 
1.7 Hz, 1H), 7.64–7.55 (m, 2H), 7.45 (dd, J = 8.3, 4.2 Hz, 1H), 7.13 (s, 2H), 5.57–5.49 
(m, 1H), 5.43 (dtt, J = 15.1, 6.5, 1.0 Hz, 1H), 3.42 (d, J = 6.5 Hz, 2H), 2.41 (s, 3H), 
1.90–1.81 (m, 2H), 1.22–1.10 (m, 6H), 0.81 (t, J = 6.8 Hz, 3H). 13C-NMR (100 MHz, 
CDCl3): δ = 167.7 (Cq), 148.3 (CH), 139.9 (Cq), 138.5 (Cq), 136.7 (Cq), 136.3 (CH), 
136.1 (Cq), 134.7 (Cq), 134.2 (Cq), 133.3 (CH), 128.0 (Cq), 128.0 (CH), 127.4 (CH), 
127.2 (CH), 127.0 (CH), 122.1 (CH), 121.7 (CH), 116.8 (CH), 36.4 (CH2), 32.3 (CH2), 
31.4 (CH2), 28.8 (CH2), 22.4 (CH2), 19.4 (CH3), 14.0 (CH3). IR (ATR): 2984, 1736, 1372, 
1233, 1043, 847, 608, 463 cm−1. MS (ESI) m/z (relative intensity): 429 (100) [M+Na]+, 
407 (10) [M+H]+. HR-MS (ESI) m/z calcd for C25H2835ClN2O [M+H]+: 407.1885, 
found: 407.1884. 
    
(E)-3-Fluoro-6-methyl-2-(oct-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70ua) 
The general procedure D was followed using benzamide 54u (140.0 mg, 0.50 mmol) 




gel (n-hexane/EtOAc = 50:1) yielded 70ua (93.1 mg, 48%) as a colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 9.91 (s, 1H), 8.97 (d, J = 7.2 Hz, 1H), 8.78–8.69 (m, 1H), 8.18 
(d, J = 8.2 Hz, 1H), 7.67–7.55 (m, 2H), 7.45 (dd, J = 8.4, 4.2 Hz, 1H), 7.15–6.98 (m, 
2H), 5.54 (dt, J = 14.6, 6.6 Hz, 1H), 5.36 (dt, J = 14.6, 6.6 Hz, 1H), 3.44 (d, J = 6.6 Hz, 
2H), 2.39 (s, 3H), 1.81–1.72 (m, 2H), 1.15–1.00 (m, 6H), 0.76 (t, J = 6.7 Hz, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 167.3 (d, 4JC–F = 3.1 Hz, Cq), 159.4 (d, 1JC–F = 244.7 Hz, 
Cq), 148.3 (CH), 139.2 (d, 4JC–F = 3.7 Hz, Cq), 138.5 (Cq), 136.3 (CH), 134.2 (Cq), 132.3 
(CH), 130.3 (d, 4JC–F = 3.7 Hz, Cq), 129.4 (d, 2JC–F = 8.1 Hz, Cq), 128.0 (Cq), 127.4 (CH), 
126.6 (CH), 124.9 (d, 3JC–F = 17.4 Hz, CH), 122.1 (CH), 121.7 (CH), 116.9 (CH), 115.9 
(d, 2JC–F = 22.4 Hz, CH), 32.3 (CH2), 31.4 (CH2), 30.1 (d, 3JC–F = 2.8 Hz, CH2), 28.7 
(CH2), 22.4 (CH2), 18.9 (CH3), 14.0 (CH3). 19F-NMR (282 MHz, CDCl3): δ = –120.8. IR 
(ATR): 2984, 1737, 1372, 1233, 1043, 938, 847, 608 cm−1. MS (ESI) m/z (relative 
intensity): 413 (100) [M+Na]+, 391 (20) [M+H]+. HR-MS (ESI) m/z calcd for C25H28FN2O 
[M+H]+: 391.2180, found: 391.2180.  
    
(E)-4-Fluoro-6-methyl-2-(oct-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70va) 
The slightly modified general procedure D was followed using benzamide 54v 
(140.0 mg, 0.50 mmol) and alkene 13a (168.0 mg, 1.5 mmol) with Co(OAc)2∙4H2O 
(25.7 mg, 20 mol %). Purification by column chromatography on silica gel (n-
hexane/EtOAc = 50:1) yielded 70va (90.1 mg, 46%) as a colorless oil. 1H-NMR (400 
MHz, CDCl3): δ = 9.92 (s, 1H), 8.99 (dd, J = 7.3, 1.7 Hz, 1H), 8.75 (dd, J = 4.2, 1.7 Hz, 
1H), 8.17 (dd, J = 8.3, 1.7 Hz, 1H), 7.63–7.55 (m, 2H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 
6.91–6.79 (m, 2H), 5.62–5.50 (m, 1H), 5.49–5.39 (m, 1H), 3.45 (dd, J = 6.5, 1.3 Hz, 
2H), 2.44 (s, 3H), 1.91–1.83 (m, 2H), 1.24–1.12 (m, 6H), 0.81 (t, J = 6.9 Hz, 3H). 13C-




140.7 (d, 3JC–F = 7.8 Hz, Cq), 138.4 (Cq), 137.5 (d, 3JC–F = 8.5 Hz, Cq), 136.3 (CH), 134.2 
(Cq), 133.8 (d, 4JC–F = 3.1 Hz, Cq), 133.2 (CH), 128.0 (Cq), 127.3 (CH), 127.2 (CH), 
122.0 (CH), 121.6 (CH), 116.7 (CH), 114.7 (d, 2JC–F = 21.5 Hz, CH), 113.6 (d, 2JC–F = 
21.4 Hz, CH), 36.5 (d, 4JC–F = 1.7 Hz, CH2), 32.3 (CH2), 31.3 (CH2), 28.7 (CH2), 22.4 
(CH2), 19.6 (d, 4JC–F = 1.8 Hz, CH3) 13.9 (CH3). 19F-NMR (377 MHz, CDCl3): δ = –112.6. 
IR (ATR): 2927, 1737, 1519, 1237, 1138, 1045, 791, 607 cm−1. MS (ESI) m/z (relative 
intensity): 413 (100) [M+Na]+, 391 (20) [M+H]+. HR-MS (ESI) m/z calcd for C25H28FN2O 
[M+H]+: 391.2180, found: 391.2179.  
 
(E)-2-(3-Cyclopentylallyl)-6-methyl-N-(quinolin-8-yl)benzamide (70bb) 
The general procedure D was followed using benzamide 54b (131.1 mg, 0.50 mmol) 
and alkene 13b (165.0 mg, 1.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc = 40:1) yielded 70bb (78.8 mg, 43%) as a colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 9.93 (s, 1H), 9.00 (dd, J = 7.4, 1.6 Hz, 1H), 8.73 (dd, J = 4.2, 
1.7 Hz, 1H), 8.18 (dd, J = 8.3, 1.7 Hz, 1H), 7.64–7.58 (m, 1H), 7.56 (dd, J = 8.3, 1.6 
Hz, 1H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 7.29 (t, J = 7.6 Hz, 1H), 7.18–7.10 (m, 2H), 
5.61–5.48 (m, 1H), 5.48–5.36 (m, 1H), 3.46 (d, J = 6.7 Hz, 2H), 2.44 (s, 3H), 2.27 (q, 
J = 8.0 Hz, 1H), 1.63–1.54 (m, 2H), 1.52–1.38 (m, 4H), 1.15–1.04 (m, 2H). 13C-NMR 
(100 MHz, CDCl3): δ = 168.6 (Cq), 148.2 (CH), 138.5 (Cq), 137.8 (Cq), 137.7 (Cq), 136.9 
(CH), 136.3 (CH), 134.6 (Cq), 134.4 (Cq), 129.0 (CH), 128.0 (CH), 128.0 (Cq), 127.4 
(CH), 127.0 (CH), 126.2 (CH), 121.9 (CH), 121.6 (CH), 116.7 (CH), 42.9 (CH), 36.6 
(CH2), 32.8 (CH2), 25.0 (CH2), 19.5 (CH3). IR (ATR): 2984, 1737, 1447, 1372, 1235, 
1045, 847, 608 cm−1. MS (ESI) m/z (relative intensity): 393 (80) [M+Na]+, 371 (90) 






    
(E)-2-Methyl-6-(4-methylpent-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70bc) 
The general procedure D was followed using benzamide 54b (131.1 mg, 0.50 mmol) 
and alkene 13c (126 mg, 1.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc = 40:1) yielded 70bc (72.0 mg, 42%) as a colorless oil. 1H-NMR 
(400 MHz, CDCl3): δ = 9.95 (s, 1H), 9.02 (dd, J = 7.4, 1.5 Hz, 1H), 8.73 (dd, J = 4.2, 
1.7 Hz, 1H), 8.17 (dd, J = 8.3, 1.7 Hz, 1H), 7.65–7.59 (m, 1H), 7.56 (dd, J = 8.3, 1.5 
Hz, 1H), 7.44 (dd, J = 8.3, 4.2 Hz, 1H), 7.30 (d, J = 7.6 Hz, 1H), 7.18–7.13 (m, 2H), 
5.60–5.50 (m, 1H), 5.42 (ddt, J = 15.3, 6.5, 1.3 Hz, 1H), 3.47 (d, J = 6.5 Hz, 2H), 2.46 
(s, 3H), 2.13 (q, J = 6.8 Hz, 1H), 0.83 (d, J = 6.8 Hz, 6H). 13C-NMR (100 MHz, CDCl3): 
δ = 168.6 (Cq), 148.2 (CH), 139.3 (CH), 138.4 (Cq), 137.8 (Cq), 137.6 (Cq), 136.2 (CH), 
134.6 (Cq), 134.3 (Cq), 129.0 (CH), 128.0 (CH), 127.9 (Cq), 127.3 (CH), 126.9 (CH), 
125.2 (CH), 121.9 (CH), 121.6 (CH), 116.7 (CH), 36.5 (CH2), 30.7 (CH), 22.2 (CH3), 
19.4 (CH3). IR (ATR): 2924, 1676, 1522, 1483, 1326, 826, 637, 575 cm−1. MS (ESI) 
m/z (relative intensity): 367 (80) [M+Na]+, 345 (100) [M+H]+. HR-MS (ESI) m/z calcd 
for C23H25N2O [M+H]+: 345.1961, found: 345.1963. 
    
(E)-2-Methyl-6-(4-phenylbut-2-en-1-yl)-N-(quinolin-8-yl)benzamide (70bd) 
The general procedure D was followed using benzamide 54b (131.1 mg, 0.50 mmol) 
and alkene 13d (198.0 mg, 1.5 mmol). Purification by column chromatography on silica 
gel (n-hexane/EtOAc: 35/1) yielded 70bd (143.0 mg, 73%) as a colorless oil. 1H-NMR 




8.19 (dd, J = 8.2, 2.1 Hz, 1H), 7.69–7.57 (m, 2H), 7.46 (dd, J = 8.4, 4.1 Hz, 1H), 7.34 
(t, J = 7.6 Hz, 1H), 7.25–7.12 (m, 5H), 7.08 (d, J = 7.5 Hz, 2H), 5.75 (dtt, J = 14.8, 6.4, 
1.2 Hz, 1H), 5.65 (dtt, J = 14.8, 6.4, 1.2 Hz, 1H), 3.57 (d, J = 6.4 Hz, 2H), 3.25 (d, J = 
6.4 Hz, 2H), 2.51 (s, 3H). 13C-NMR (100 MHz, CDCl3): δ = 168.7 (Cq), 148.3 (CH), 
140.5 (Cq), 138.6 (Cq), 137.8 (Cq), 137.4 (Cq), 136.4 (CH), 134.8 (Cq), 134.4 (Cq), 130.9 
(CH), 130.0 (CH), 129.3 (CH), 128.5 (CH), 128.3 (CH), 128.3 (CH), 128.1 (Cq), 127.5 
(CH), 127.2 (CH), 125.9 (CH), 122.1 (CH), 121.8 (CH), 116.9 (CH), 38.9 (CH2), 36.7 
(CH2), 19.6 (CH3). IR (ATR): 2924, 1676, 1522, 1483, 1326, 826, 637, 575 cm−1. MS 
(ESI) m/z (relative intensity): 415 (90) [M+Na]+, 393 (80) [M+H]+. HR-MS (ESI) m/z 
calcd for C27H25N2O [M+H]+: 393.1961, found: 393.1963. 
    
(E)-2-(3-([1,1'-biphenyl]-4-yl)allyl)-6-methyl-N-(quinolin-8-yl)benzamide (70be) 
The slightly modified general procedure D was followed using benzamide 54b 
(131.1 mg, 0.50 mmol) and alkene 13e (198.0 mg, 1.5 mmol) with Co(OAc)2∙4H2O 
(25.7 mg, 20 mol %). Purification by column chromatography on silica gel (n-
hexane/EtOAc = 40:1) yielded 70be (115.1 mg, 51%) as a colorless oil. 1H-NMR (400 
MHz, CDCl3): δ = 9.95 (s, 1H), 9.00 (dd, J = 7.6, 1.4 Hz, 1H), 8.47 (dd, J = 4.2, 1.7 Hz, 
1H), 8.07 (dd, J = 8.3, 1.7 Hz, 1H), 7.59 (dd, J = 7.9, 1.7 Hz, 1H), 7.54–7.50 (m, 3H), 
7.44–7.39 (m, 2H), 7.34–7.28 (m, 5H), 7.21 (d, J = 7.5 Hz, 1H), 7.17 (d, J = 7.5 Hz, 
1H), 7.13–7.08 (m, 2H), 6.45–6.26 (m, 2H), 3.66 (d, J = 6.2 Hz, 2H), 2.46 (s, 3H). 13C-
NMR (100 MHz, CDCl3): δ = 168.6 (Cq), 148.1 (CH), 140.8 (Cq), 139.4 (Cq), 138.4 (Cq), 
138.0 (Cq), 136.7 (Cq), 136.2 (Cq), 136.1 (CH), 134.9 (Cq), 134.3 (Cq), 130.8 (CH), 
129.2 (CH), 128.7 (CH), 128.7 (CH), 128.4 (CH), 127.9 (Cq), 127.3 (CH), 127.3 (CH), 
127.1 (CH), 126.8 (CH), 126.8 (CH), 126.3 (CH), 121.9 (CH), 121.5 (CH), 116.7 (CH), 
37.3 (CH2), 19.5 (CH3). IR (ATR): 2984, 1737, 1372, 1233, 1043, 938, 847, 607 cm−1. 




m/z calcd for C32H27N2O [M+H]+: 455.2118, found: 455.2121.  
 
5.3.4.2. Headspace GC analysis 
 
 
The electrocatalysis was carried out in an undivided cell, with a CF anode (10 mm × 
25 mm × 6 mm) and a platinum cathode (10 mm × 25 mm × 0.125 mm). Benzamide 
54b (131.1 mg, 0.50 mmol), n-octene 13a (168.4 mg, 1.50 mmol), NaOPiv (124.0 mg, 
1.0 mmol), n-Bu4NPF6 (97.0 mg, 0.25 mmol)  and Co(OAc)2∙4H2O (12.7 mg, 10 mol %) 
were placed in a 10 mL cell and dissolved in GVL (4.0 mL). Electrocatalysis was 
performed at 100 °C with a constant current of 4.0 mA maintained for 14 h under N2. 
After cooling to ambient temperature, 1.0 mL of the headspace volume was removed 
for GC analysis (figure 5.15).  
 





5.3.4.3. Cyclic Voltammetry 
 
The cyclic voltammetry was carried out with a Metrohm Autolab PGSTAT204 
workstation and the analysis was performed with the Nova 2.0 software (figure 5.16). 
A glassy-carbon electrode (3 mm-diameter, disc-electrode) was used as the working 
electrode, a Pt wire as the auxiliary electrode and a saturated calomel electrode (SCE) 









Figure 5.16. Cyclic voltammograms at 100 mVs-1: n-Bu4NPF6 (0.1 M) in MeCN, 
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